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ABSTRACT 
 
Antibiotics are naturally occurring chemicals in bacteria that were recently discovered and 
utilized by humans.  Despite a relatively short time of use, anthropogenic use of 
antibiotics has increased natural levels of antibiotic resistance, which has caused a 
looming antibiotic resistance crisis, where antibiotics may not work.  Understanding 
resistance patterns is critical to allow for continued therapeutic use of antibiotics.  While 
resistance is often thought of in hospitals, antibiotics and antibiotic resistance genes from 
human activity are disposed of into nature where they are able to interact with naturally 
occurring antibiotics and resistance.  In this dissertation, I examine the ocean as an 
understudied region of the environment for antibiotic resistance.  The ocean represents an 
area of human activity with recreation and food consumption and it is an enormous region 
of the planet that is affected by both land and sea activities.  In Chapter 2, I explore the 
policies that have contributed to the antibiotic resistance crisis. I offer explanations of 
market and political failures that contributed to the situation, areas for growth in terms of 
assessing scientific knowledge, and finally, recommendations for mitigating antibiotic 
resistance. In Chapters 3 and 4, I collected individual bacterial cultures from Cape Cod, 
MA beaches to assess the phenotypic response to antibiotic resistance.  I show that 73% of 
Vibrio-like bacteria and 95% of heterotrophic bacteria (both groups operationally defined) 
are resistant to at least one antibiotic. These results indicate that antibiotic resistance is 
prevalent and persistent on beaches over both spatial and temporal scales. In Chapter 5, I 
used metagenomics to assess the abundance and types of resistance genes at coastal 
impacted Massachusetts sites. I found that, even in sites that seem distinct in terms of 
anthropogenic impact, prevalence of resistance remained the same. Finally, in Appendix 
A, I examined part of the TARA Ocean dataset for prevalence of antibiotic resistance 
genes across the world’s ocean.  Here, I found that there are distinctions between different 
ocean biomes based upon antibiotic, metal, and mobile genetic elements. This 
dissertation has increased the understanding of temporal and spatial dynamics of 
antibiotic resistance in the coastal and open ocean.  
 
Thesis supervisor: Dr. Rebecca J. Gast  
Title: Associate Scientist with Tenure, Woods Hole Oceanographic Institution 
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Introduction to Antibiotics and Antibiotic Resistance 
An antibiotic is a “compound produced by a microorganism that inhibits the growth of 
another microorganism” (1). Antibiotics are natural products and have existed in nature for 
many years.  The exact time of antibiotic production is unknown currently, but estimates 
include from 2 billion years ago to 30 million years ago (2).  Baltz’s estimates that 
aceinomycetes bacteria have produced antibiotics for a million years (3). Antibiotics were 
detected by humans in 1928 with Alexander Fleming’s discovery of penicillin (4). 
However, there is evidence for human use of antibiotics from ancient times (5).  From the 
discovery of penicillin to vancomycin and rifamycin, these molecules have revolutionized 
the way humans interact with the world. These antibiotics have a variety of cellular targets 
to inhibit growth of bacteria or to kill them (Figure 1) (6).  These molecules were quickly 
utilized in a variety of ways ranging from treatment of human (7, 8) and animal health 
issues (9) to sub-therapeutic use in animals for food production (1, 7, 10, 11) and to 
treatment of plants against disease (1, 7, 10).  Use of these drugs changed previously life 
threatening bacterial illnesses to easily cured ailments, leading antibiotics to be called 
“miracle drugs” (12). Despite their dramatic usefulness for the treatment of many diseases, 
the long-term effectiveness of these “miracle drugs” has recently been called into question 
(4, 8, 13–18). The widespread use of antibiotics throughout our society has contributed to 
increased levels of antibiotic resistance within microbes and within the environment.  
Like antibiotics, antibiotic resistance (AR) is a naturally occurring phenomenon where 
an organism is invulnerable to a given chemical. AR has been found in many isolated 
environments such as remote caves (19), ancient terrestrial sediments (2), and in the 
microbiomes of humans isolated from “modern” societies (20). At its most basic level, 
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presence of antibiotics in an environment selects for antibiotic resistant bacteria (ARB) (8). 
In human use of antibiotics, the purpose is to damage or eradicate the bacteria that are 
causing the infection; but cells that are unaffected by the antibiotic are able to continue 
growing. In animal production, antibiotics are often fed to animals at subtherapeutic levels 
to enhance growth, allowing producers to bring the animals to market more quickly (21, 
22), but also unintentionally selecting for the growth/persistence of resistant bacteria. 
Many bacteria can participate in horizontal gene transfer (HGT), facilitating sharing 
antibiotic resistance genes between bacteria of the same or different species (8, 14). While 
the existence of resistance is not dependent on humanity’s use of antibiotics, the 
prevalence of their use contributes to an increase in antibiotic resistant bacteria (7).  
Without better stewardship with respect to antibiotic applications, humans may enter 
into a Post-Antibiotic Era, a time where a majority of presently known antibiotics do not 
work to treat bacterial infections and many now commonplace surgeries would not be 
safe due to the threat of infection (4).  Antibiotic resistance causes at least two million 
infections and 23,000 deaths a year in the United States, which is likely an underestimate 
due to the lack of available data (4). Recent projections for 2050 anticipate ten million 
deaths worldwide from resistant infections each year, resulting in a global cumulative cost 
of $100 trillion United States dollars by 2050 (23).   
Environmental Reservoirs of Resistance 
With the substantial cost of AR anticipated to increase in the coming years, the Centers 
for Disease Control (4), World Health Organization (24), the United Nations (25) and the 
United States government (26) have all become more interested in creating strategies to 
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combat antibiotic resistance. In this effort, it is important to consider the effect of 
environmental reservoirs of resistance.  Understanding the reservoirs is important because 
environments in which humans live, work, and play may serve as the source of resistance 
that presents in clinics (27). Interactions between humans do not stay in the clinic; and 
antibiotic resistant bacteria do not adhere to human boundaries. Pollution from 
anthropogenic sources such as hospitals (28–30), agriculture(13, 31–35), human 
wastewater (36–41), and aquaculture (42–46) can contain antibiotics along with bacteria 
that have antibiotic resistance genes (ARG). Up to 90% of the antibiotic dose passes 
through the body unchanged(47), showing how easily these chemicals can enter into 
waste products that are often routed into streams, rivers, or sediments in landfills. Once 
these wastes are released, they enter into the environment, adding to the amounts of 
antibiotics and ARG that occur naturally.  
Although the presence of antibiotics can select for ARG in the environment (10, 17, 
48–50), it is not required to stimulate the transfer of those genes from non-native bacteria 
to native environmental bacteria and vice versa (51). One of the driving forces behind the 
increase in environmental antibiotic resistance is the ease with which resistance genes can 
be transferred, even between distantly related taxa (52). As a consequence, environmental 
microbes that have little to no effect on human disease, or exposure to clinically relevant 
antibiotics, may acquire clinically relevant antibiotic resistant genes. Together, this creates 
an environment where resistance can be transferred and maintained within the bacterial 
community. As humans interact with the environment, they have the opportunity to 
acquire both pathogenic and non-pathogenic bacteria carrying resistance genes directly 
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by consumption of water, animals, and plants, or indirectly through recreational activity 
such as swimming. Therefore, the environment represents a reservoir for resistance, and 
the potential for resulting in resistant infections (17, 48, 49, 53).  
While the knowledge that the environment is important in antibiotic resistance has 
been disseminated in a wide variety of review and policy papers (1, 10, 11, 17, 48, 49, 
53–63), original research on resistance in the environment pales in comparison to clinical 
research. The majority of environmental research is not equally represented across field 
sites.  Environmental research has focused on wastewater treatment effluents to the 
environment or on agriculture effluents to rivers and streams. The marine environment is 
one of the ultimate sites for anthropogenic pollution because the ocean is used as a 
dumping ground for wastes, either direct intentional releases or indirectly through polluted 
streams and rivers (Figure 2).   
Marine Environment as a Resistance Reservoir  
Early studies of marine AR found that it was present and suggested that more impacted 
areas had greater prevalence of resistance (64). Most studies have been descriptive 
regarding the resistance patterns within the marine environment: examining levels of 
resistance in pigmented versus non-pigmented bacteria (65), between bacteria in surface 
and subsurface water (66, 67), and within bacteria present in sand transects on the beach 
(68, 69). The hypothesis of the marine environment as a resistance reservoir has been 
strengthened by research revealing AR in bacteria present in marine animals (70–74) and 
in a variety of marine bacteria including heterotrophs (69, 75), fecal indicators (76–78), 
and potential pathogens (79–81).    
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Although recent studies have provided evidence of increased AR in areas with greater 
anthropogenic inputs (76, 82), resistance is also seen in the open ocean (83) and at 
isolated beaches (84). The majority of the world’s populations lives within 400 km of a 
coast (4 billion people in 1998) (85). Humans routinely interact with ocean water during 
recreation, such as swimming or surfing, and through consumption of shellfish or fish. Fish 
consumption is not a small factor, as the ocean serves as the source of 17% of the world’s 
animal protein (86). For humans, the concern is that resistance from environmental 
bacteria may be passed to a human’s natural bacterial flora or to pathogenic bacteria 
during ingestion of raw shellfish or fish or through aquatic recreation. For example, the 
origin of a type of quinolone resistance (gene: gnrA), which has been problematic in the 
clinic, has been found to originate from Shewanella, a gamma Proteobacterium readily 
found in freshwater and marine environments (87).   
The most recent research has attempted to assess the potential risks that AR in the 
ocean poses to humans. Leonard et al. 2015 examined the incidences of marine 
recreation activities that led to ingestion of resistant bacteria in England and Wales (88). 
They estimated that there were at least 6.3 million occurrences of ingestion in 2012 for 
E.coli containing resistance to the third-generation cephalosporins; and suggested that this 
is likely an underestimate of the risk of resistance acquisition from oceanic activity 
because they only examined one bacterial species and one antibiotic class for resistance 
(88).  
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 Introduction to this Thesis 
The lack of consistency between studies and the dearth of temporal-spatial studies on 
resistance in the marine environment makes it difficult to adequately and appropriately 
assess these potential human health risks and make appropriate societal 
recommendations.  My doctoral research examines the levels of resistance in local coastal 
marine environments with relatively normal levels of human impact, surveys the 
prevalence and persistence of both resistant bacteria and ARG, and seeks to uncover what 
pollution inputs might be contributing to elevated levels of antibiotic resistance, in order 
to eventually inform assessment of human health risks.   
To better understand resistance, Chapter 2 examines antibiotic resistance as a global 
problem from a policy standpoint and analyzes how this problem developed with market 
and political failures.  The chapter explores what knowledge gaps remain in the clinical 
and environmental fields and provides recommendations that might be made to better 
preserve antibiotics.  This chapter provides an understanding of the complicated nature of 
antibiotic resistance both in the political and scientific realms. Chapters 3-6 then examine 
environmental antibiotic resistance, which is shown to be understudied in Chapter 2.  
Chapters 3-6 provide greater knowledge of patterns of resistance in the environment.  
The first two data chapters assess patterns of resistance in Cape Cod, MA at six 
different beaches over one year.  This approach allows for assessing resistance over spatial 
distances with multiple sites, over temporal changes over one year, and finally over levels 
of human impact. It also allows estimation of the amount of antibiotic resistant bacteria 
encountered by humans through normal marine recreation or food consumption.  Chapter 
3 examines antibiotic resistance in Vibrio-like bacteria found on these beaches, while 
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Chapter 4 examines resistance in general heterotrophic bacteria. These chapters utilize 
cultivable bacteria and test them for their resistance to particular antibiotics, which 
represents antibiotic resistance that is being actively expressed phenotypically.  For 
Chapter 3, five antibiotics were tested: amoxicillin (antibiotic mechanism - cell wall 
synthesis), ciprofloxacin (mechanism - DNA gyrase), doxycycline (mechanism - protein 
synthesis- 30S ribosomal subunit), oxytetracycline (mechanism - protein synthesis- 30S 
ribosomal subunit), and trimethoprim (mechanism - folic acid metabolism) (6).  For 
Chapter 4, four antibiotics were tested: amoxicillin, ciprofloxacin, doxycycline, and 
erythromycin (mechanism: protein synthesis – 50S ribosomal subunit) (6).   
However, the exact mechanism of resistance is not elucidated through this method.  
To examine resistance mechanisms, as indicated by antibiotic resistance genes present in 
the marine environment, metagenomic sequencing is employed.  Metagenomic 
sequencing involves sequencing the total DNA present in an environmental sample, and 
can be used to examine a sample for a variety of resistance genes as well as their genomic 
context (location in plasmid or transposable element).  This method is powerful because it 
allows analysis of many genes/antibiotics, which would not be cost or time effective when 
testing for resistance in the laboratory.  Further, computational processing of metagenomic 
data can be used to discover new types of resistance genes.  The drawback of this method 
is that these genes are simply present in the environment and we have no knowledge of if 
they are being actively expressed in a bacterium.  In this light, metagenomic analyses 
should be seen as illustrating only the potential resistance of an environment instead of 
what is actively being expressed within living bacteria.  
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Chapter 5 and Appendix A include two metagenomic studies examining antibiotic 
resistance in the ocean.  For Chapter 5, local coastal water and sediment samples were 
collected at industrial and wastewater impacted sites to examine if resistance genes vary 
based on human activity compared to reference sites.  Appendix A provides a greater 
understanding of resistance in the global ocean by analyzing the open-access TARA 
Oceans data for antibiotic resistance prevalence and diversity. Overall, this dissertation 
provides an in depth look at antibiotic resistance present in the marine environment, using 
two methods—culture based resistance testing, illustrating active, phenotypic resistance, 
and metagenomic sequencing, indicating potential resistance.  
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Figure 1. Illustration of antibiotic mechanisms.   
Antibiotics have a wide variety of cellular targets.  This diagram shows a few main 
mechanisms of antibiotic targets that relate to this dissertation.  This diagram was modified 
from Lewis 2013 (6).   
 
 
 
 
 
 
  
 
34 
 
 
 
Figure 2. Illustration of antibiotic resistance in the marine environment.  
Anthropogenic usage of antibiotics (white pills) in hospitals, homes, and agriculture make 
their way into the environment through wastes.  In addition, bacteria (purple rod shaped) 
and antibiotic resistant bacteria (orange rods) can make their way into the environment.  
In the ocean, these anthropogenic derived antibiotics and bacteria can interact with the 
naturally present bacteria (teal circles), resistant bacteria (orange circles), and antibiotics.   
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INTRODUCTION 
 
 Antibiotics can easily be considered one of the most important discoveries of the 
20th century and have revolutionized the way healthcare treats bacterial infections.  
However, their immense power comes with a cost.  This cost is antibiotic resistance (AR), 
a phenomenon that is present and rising throughout the world.  
The extensive use of antibiotics has greatly contributed to the increase in 
prevalence of resistance.  In 2013, Tom Friedlan, director of the Center for Disease 
Control (CDC), said, “If we're not careful, we will soon be in a post antibiotic era.  And, in 
fact, for some patients and some microbes, we are already there (1).” If resistance 
continues to spread, this number could undoubtedly increase and humanity could 
advance to a point that antibiotics do not work for a majority of bacterial infections.  In 
this scenario, even more lives would be impacted, as more serious illnesses that cannot be 
easily treated would become the norm. This change would not only affect those with 
bacterial infections, but any surgery or procedure requiring antibiotic as a preventive 
measure (i.e. cosmetic surgeries, hip replacements, chemotherapy) (2).  The impacts of not 
having antibiotics to use would fundamentally change the medical advances the global 
community has made in the last fifty years (3, 4).  
How have we gotten to this point?  What has occurred that has allowed us to take 
something perceived to be “miracle” drugs to turning them into a public health crisis in 
less than a century?  What scientific knowledge is currently known and what knowledge 
needs to be determined before taking action?  What action, if any, should be taken?  The 
goal of this chapter is to address these questions.  The first section will report an analysis 
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of the market and political failures that have occurred that have increased antibiotic use, 
expanded antibiotic resistance, and failed to address the growing nature of resistance.  The 
second section will focus on scientific knowledge of resistance in the clinical environment 
compared to the natural environment.  The third section will address what remains to be 
acquired for greater analysis of antibiotic resistance and what evidence is necessary within 
each field to lead to appropriate action.  The final section will end with recommendations 
for leaders in the field to combat antibiotic resistance.  
What	Went	Wrong?:	Market	Failure	in	Addressing	Antibiotic	Resistance	:	
Cost	of	Research	and	Development	Unequal	to	Market	Share	
 
 Numerous market and political failures have occurred in addressing antibiotics in 
the United States including unstable property rights, externalities, coordination problems, 
collective action, and organizational processes.  Within the United States, policy decisions 
helping to rectify these issues have been relatively minimal.  Market and political failures 
have exacerbated the resistance crisis and further action is necessary to amend these 
issues. 
Research and development into pharmaceutical drugs is an extremely costly 
process with estimations of between $800 million to over two billion dollars to bring a 
new drug to market (5).  To make an investment in research and development into drug 
candidates worthwhile, there has to be a market for these products.  Antibiotics have 
intrinsically different characteristics that limit their market share; therefore, making 
antibiotics less profitable options for pharmaceutical research and development compared 
to other drugs (5).  One of these characteristics is time scale.  Antibiotics are used for short 
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time scales (days-weeks) and therefore require a relatively low number of treatments.  This 
can be compared with products for chronic conditions such as depression, blood pressure, 
or diabetes that would be taken long term (months, years, decades) and would require a 
substantial number of treatments.  Time scale can dramatically increase the market share.  
Therefore, an initial investment in a chronic medication would allow for a larger 
economic incentive compared to antibiotics, influencing pharmaceutical companies to 
products with higher economic payouts.  
Another characteristic is that antibiotic discovery or invention requires even more 
investment and effort to discover new drugs compared to other pharmaceutical products.  
Brogan states that “high cost and significant technical effort” are necessary to discover 
new antibiotics, which further increases the price tag on antibiotic development (5).  The 
increased cost makes it an even higher investment risk and a risker intervention.   
 Even if increased capital is available and if the technical barrier is achieved, a 
given broad-spectrum antibiotic would likely only be useful for a few years before the 
amount of resistance present makes it unfeasible to be prescribed. This phenomenon 
occurs due to the naturally short generation times of bacteria, allowing for resistance to be 
accumulated within a population.  It is also amplified by the extreme amount of 
antibiotics utilized by humans (6).  A way around this dilemma is to develop narrow 
spectrum antibiotics, which are antibiotics to be used for a specific type of bacteria.  
However, narrow spectrum antibiotics reduce the market share for that pharmaceutical.  
Yet, the antibiotic may be effective for a longer period of time than a broad-spectrum 
antibiotic, increasing the market share.    
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These economic issues point to the larger problem that more antibiotics and new 
targets will always be necessary as bacteria constantly evolve and change.  In the words of 
Brogan, economic markets also fail for antibiotics “because the necessity for continual 
development of new antibiotics stems from the impending future threat of resistance, not 
just the current lack of efficacy” (5).  Despite the necessity of antibiotics, these market 
failures have resulted in many pharmaceutical companies reducing or eliminating their 
antibiotic research, including Aventis, Bristol-Myers, Eli Lilly, and Proctor (7).   
 At this juncture, it seems that the market will not correct for failures.   
Economically, it does not benefit pharmaceutical companies to invest in antibiotic 
discovery because they will not be able to retrieve their initial (expensive) investments.  To 
allow for discovery of antibiotics that are necessary to protect human health, it is urgent to 
correct these market failures by creating policy.  One currently popular suggestion is for 
push-pull mechanisms with drug discovery and synthesis.  Push incentives are to 
encourage research and development and involve giving initial investments to spur 
innovation (5, 8).  This allows the cost (and therefore risk) to the industry completing the 
discovery process to be lower (5).  Ways to achieve this would be to create funding from 
grants, adding tax breaks, or to increase the patent pool (5).  The purpose of pull 
mechanisms are to increase the revenues for successful antibiotic development, further 
incentivizing pharmaceutical companies to invest in these products (5).  These can 
include extended market exclusivity (8), other market guarantees (5), or prizes for 
establishment of a given drug (5).  Spellberg et al. state that push incentives are likely 
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more beneficial compared to pull mechanisms because they allow for a smaller economic 
input, for the same value (8).  
Obstacles to Addressing the Market Failures of Antibiotic Resistance  
 
Market failures are not the only issue that has led to this resistance crisis.  There have also 
been numerous political failures that have acted as obstacles towards obscuring solutions.  
This section will explore these failures, which include externalities, coordination 
problems, organizational processes, and collective action.   
Mainly Negative Externalities Result from Resistance due to Antibiotic Use. 
 
Use of antibiotics globally results in both positive and negative externalities, factors that affect 
individuals that they did not choose.  One positive externality from antibiotic use is that proper 
use of antibiotics decreases the likelihood that the bacterial infection will be spread to others (9). 
If antibiotics were not used, the person with the illness could spread their infection to others in 
their community, generating a negative externality of disease that would then be shared to other 
individuals.  
Sensitivity to antibiotics can be considered a natural resource—something that exists 
without human intervention as antibiotic sensitivity is a naturally occurring process.  Despite the 
natural state of antibiotic sensitivity, this resource is affected by how we utilize it.  In Hardin’s 
Tragedy of the Commons, individual’s self-interest overrides the best interest of the group (10).  In 
the classic case, individuals would choose to put more and more sheep on the collective grazing 
land, allowing each individual to maximize their profits, even though it leads to the detriment of 
the resource (the grazing land), for the public (10).  Antibiotic resistance can be examined as an 
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example of this framework.  Individuals will use antibiotics as much as possible to maximize 
their benefits.  For example, a farmer may feed his or her chickens with feed enhanced with 
antibiotics to promote growth and to reduce infections that may result from overcrowding (11).  A 
patient may take more of an antibiotic than prescribed in order to feel better faster and to return 
to work.  These individuals are acting in their own best self interest; however, these examples 
lead to increased overall resistance, which then erodes the natural resource creating a negative 
externality (12).  
When antibiotics are used improperly—for viral infection instead of bacterial infection, 
when the full period of treatment is not followed, or when antibiotics are utilized for non-
essential purposes (i.e. growth promoters in animals)—negative externalities are increased both 
locally and globally (9).  These improper uses expand and increase antibiotic resistance in the 
world in a way beyond the control of both the market and private industry. Increased prevalence 
of resistance inflates the likelihood that an individual will become ill with a resistant infection.  
There will then be a rise in the cost of treatment for the patient, in terms of financial capabilities 
(more time in hospital, more expensive treatments), in terms of time (longer time away from work 
and family obligations), and in terms of health (reduced health, potential amputations, or even 
death in severe cases) (9, 13).   
One solution to reduce these negative externalities is to price antibiotics using the “real” 
cost of antibiotics.  Currently, most antibiotics are relatively inexpensive and one could argue 
that this results in misuse because the real cost is masked.  The real cost should include loss of 
productivity and sick days to employers for employees who encounter resistant infections or 
higher taxes for Medicaid and Medicare for enhanced medical expenses due to a resistant 
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infection.  Pigovian taxes, taxes to correct for negative externalities that result from inefficient 
markets, could be used to “levy a tax that equals the marginal external cost on consumption or 
production” (14).  This additional economic cost has the potential to change behavior by forcing 
individuals to think through their actions.  Instead of going to a physician’s office and requesting 
an antibiotic for a viral infection, the cost could cause individuals to be willing to wait for a 
diagnostic test or to invest in over the counter remedies for the symptoms of their infection.  
Farmers may need to invest in more appropriate care for their animals instead of just routinely 
treating them with antibiotics in their feed to stimulate growth.  The money collected from this 
tax could be used to fund antibiotic development (14), further helping the public health good.   
There are two disadvantages of this Pigovian tax.  One is that it is hard to determine the 
cost of resistance (14). The argument that we cannot completely determine resistance costs does 
not absolve us of the effort to work for rough estimations.  The other disadvantage is that a tax 
may price out antibiotics as a treatment option for individuals in lower socioeconomic classes.   
This means that there would have to be an alternative mechanism to make these affordable for 
these individuals while still limiting widespread access to these goods.  Despite these 
disadvantages, monetary costs of resistance as assessed with Pigovian taxes may be the incentive 
that allows for real change to be made to human use of antibiotics in a way that has not yet 
occurred through extensive education programs by public health programs across the globe.  
Many Public and Private Stakeholders in the Process Increase Coordination Problems.  
 
Another failure is the coordination problems that occur due to the necessity of integration of 
different private and governmental institutions.  In the United States, there are multiple 
stakeholders in the development and regulation of pharmaceuticals and their subsequent use in 
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the market.  Predominantly private industry develops antibiotics, though some private 
pharmaceutical companies have partnered with laboratories in academia to complete screenings 
of potential targets (15).  This requires coordination between research and academic laboratories 
to allow development of the most marketable products.  To bring a product to market in the US, 
a private industry is required to go through a governmental approval and regulation process.  The 
Food and Drug Administration (FDA) regulates and licenses pharmaceuticals and other goods 
used not only by us, but also animals, and requires a lengthy process of clinical trials that can last 
many years (16).  
Not only does the US government have agencies that regulate drugs, in addition, there are 
many agencies that have an interest in how antibiotics are used. The Centers for Disease Control 
and Prevention (CDC) focuses on public health (mainly human) and they track resistance trends, 
spearhead campaigns to encourage prudent use of antibiotics, and work to protect human health.  
The CDC released a recent report on the threat of antibiotic resistance, calling attention to their 
growing problem (17).  National Institutes of Health funds research related to discovering better 
treatments for antibiotic resistant infections (18).   
Beyond these agencies for which antibiotic resistance is a pressing issue and a large part 
of their organization, there are also many agencies where their policies affect how we use 
antibiotics.  Six agencies addressing concerns ranging from veteran affairs to Medicaid to 
healthcare research all participated in developing a plan for combatting antimicrobial resistance 
(19).  All of the agencies mentioned work with human health.  Their agency policies on 
antibiotics will impact how much and what kinds of resistance are developed within the United 
States and throughout the world.  In terms of crops and food animal use of antibiotics, the 
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Department of Agriculture can set regulations on what farmers are allowed to use on their crops.  
The Environmental Protection Agency is charged with protection of the natural environment and 
how antibiotics affect the world around us.  These examples show the extreme scope of 
governmental agencies interested in antibiotic use and the development of antibiotic resistance. 
This is further complicated by non-governmental organizations (pharmaceutical companies, 
environmental organizations, non-governmental organizations for the preservation of public 
health, medical facilities, etc.) that also would need to be included for effective policy and 
regulation.     
Organizational Processes Unable to Adequately Cope with Antibiotic Resistance Crisis.  
Not only are the many agencies a political and institutional failure in dealing with this 
crisis, but also the organizational processes contribute to failure.  The governmental agencies 
work on relatively slow time scales, with their own bureaucratic interests and politics also being 
a factor (20). One specific example of an organizational failure is the substantial time and effort 
to go through the entire process with industry, FDA, and governmental agencies to bring a drug 
to market.  This, coupled with the fact that drug discovery is itself slow and requires testing many, 
many more compounds than actually end up being successful, means that fruitful compounds do 
not make it to market for a number of years after they have been discovered or their efficacy for a 
given treatment have been determined.  There have been attempts to hasten this process, but this 
can result in unsafe conditions for the consumers of these products with products that have not 
been sufficiently tested.   
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Collective Action Dilemma: How Rational Choice Limits Public Goods of Antibiotics.  
 Development of novel antibiotics to combat resistant infections can be considered an 
example of Mancur Olson’s collective action dilemma (21).  Having access to antibiotics that 
work benefits everyone in the entire world, regardless of if they expend effort or buy into the 
costs of research and development of these drugs.  Essentially, this allows the majority of 
individuals to be “free riders” in having access to effective antibiotics to treat infections without 
paying the costs.  The costs of these resources were previously borne by pharmaceutical 
companies, which represent a small group, compared with the all people that benefit from 
having antibiotics that work.  Pharmaceutical companies were willing to take on this role 
because they gained economically from taking action, creating products that had a viable market 
that they could pursue.  In contrast, many fewer pharmaceutical companies are completing this 
research now due to the lower economic incentives.  This problem has the potential to impact 
every person.  However, it would be nearly impossible for an individual, a group of individuals, 
or even one pharmaceutical company to take on this problem of their own accord.  Not only 
would it be an irrational choice for an individual or a group in terms of the amount of energy and 
time expended, but also it would be difficult to gain the expertise and connections to interact 
with all the relevant agencies and companies.  A solution to collective action problems is often 
that the government takes on providing (and regulating) a resource so thereby the energy and 
time is shared more equally between individuals.  This is likely a necessary outcome for the 
antibiotic resistance case.  
Conclusion of Market and Political Failures  
 Both market and political failures have had substantial impacts on the ability to address 
and begin to solve the crisis of antibiotic resistance.  There has been a failure to create 
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appropriate economic incentives for development of new antibiotics, especially compared to 
more lucrative drugs.  There are large, mainly negative externalities that result from the extensive 
use of antibiotics and further increase resistance in the world around us.  These externalities 
result predominantly from the relatively easy access and inexpensive cost of antibiotics in the 
United States.  However, antibiotic resistance is a global problem and affects high, medium, and 
low income countries.  Coordination problems between numerous government agencies, slow 
moving and ill-suited organizational processes, and rational choice all further increase the 
problems of making any sort of action regarding antibiotic resistance.  These problems are not the 
cause of one person or one institution, but instead indicate an interconnected issue.  To address 
this global issue, knowledge assessment on the topic to lead to effective policy is necessary.    
Importance of knowledge assessment	
To make improved progress on the large-scale problem of antibiotic resistance market 
failures, effective policy is necessary. The market correcting itself is unlikely to happen, 
and individual actors do not have substantial power to impact this global problem.  
However, there is a large leap between market failures occurring and appropriate policy 
being created. This leap is knowledge assessment.  Knowledge assessment refers to the 
ways we examine evidence, determine its reliability, and eventually use that knowledge to 
figure out if policy is needed and what aspects that policy may contain.   
Knowledge assessment is not a trivial fight; it involves pointing out legitimate and 
illegitimate studies, facts, figures, and statistics.  There are always downfalls with scientific 
studies—one could always obtain more samples, look in more locations for a given 
phenomenon, or have a longer time series.  But, like in many things, scientists are limited 
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by time and funding.  Furthermore, individuals (or organizations) can select scientific 
studies and knowledge that validate their opinions. We see this with climate change as 
individuals can select research that fits the conclusion or the decision they want to make.  
However, less nebulous processes can also occur. Information that might be important to 
determining a policy may be unknown, underfunded, or uncertain; thereby making it 
more difficult to assess what the correct scientific principles are and then, what policy 
may be most effective.  Determining what knowledge to utilize in policy is crucial to 
addressing creation of effective and relevant recommendations.   
In the case of antibiotic resistance, the critical issue is not if antibiotic resistance is 
a public health risk.  This information is well established and accepted, even within 
disparate sectors (17, 22–25).  The issue most prominent in the antibiotic resistance case is 
a failure to examine the entire process holistically, leading to extreme differences in 
knowledge between different sectors (e.g. greater amounts of research in the clinical 
environment compared to the natural environment) and a lack of integrated information 
leading to successful policy implementations. This section aims to uncover the process of 
knowledge assessment in addressing antibiotic resistance and provide recommendations 
of how to move towards a more holistic process.     
Antibiotic Resistance is a Holistic Process involving both the Clinic and the Natural 
Environment.  
Antibiotic resistance is a holistic process that involves inputs and outputs from 
various sectors of both natural and anthropogenic environments.  A review paper by 
Davies and Davies illustrates the combined interactions of antibiotic and antibiotic 
resistance by cross cutting through various sectors in which we use antibiotics (agriculture, 
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wastewater, hospitals, communities) (6).  Environmental resistance is critical to examine 
because pristine environments (with less impact from humans), hospitals, waste streams, 
and natural environments (soils, waters, animals, plants) are all linked together.  A holistic 
approach recognizing that these aspects are linked, instead of viewing them as separate 
processes, would increase our knowledge and allow for approaches about policy that 
could be critical to impacting the world’s ability to assess antibiotic resistance.   
The environment represents a reservoir for antibiotic resistance (26–29). In fact, 
some of the clinically important resistances, such as class A extended spectrum beta-
lactamase CTX-M gene and the quinolone resistance gene, are believed to have originated 
in the environment and transferred from the environment to humans, causing substantial 
health issues (30). Understanding environmental resistance can allow for mitigation of 
these transfers, increasing human safety and health and decreasing antibiotic resistance 
overall, especially in the clinic.  
Explaining Why a Holistic Approach to Antibiotic Resistance Has Not Yet Been Taken. 
Despite this knowledge that resistance is natural and exists in many environments, 
the manner that antibiotic resistance research is carried out has largely been completed in 
a sectored fashion that mirrors the way we think about the “natural” world and the 
“human” world.  In general, the concept of pristine environments tends to conjure images 
of lakes, rivers, or remote regions like Antarctica or the Arctic, that are considered devoid 
of human impacts.  Human environments such as cities, highways, and small towns are 
directly impacted by our processes.  However, this dichotomy is not so well defined in 
reality.  Human impacts go beyond our cities lines, past our highways, and further than 
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our individual country borders.  Even what may be considered a pristine region can be 
impacted by human activities (31, 32).   
Just as environments tend to be defined as “natural” or “human”, the same occurs 
in antibiotic resistance research. The clinical environment can be described as areas of 
treatment for humans including a hospital, doctor’s offices, rehabilitation centers, or 
nursing homes.  Natural environments are the environments that exist beyond human 
created spaces. Humans can be affected by these environments and also affect these 
environments.  These natural environments include water bodies such as lakes, rivers, 
streams, and the ocean, soil environments such as the beach or forests, wild animals such 
as deer, seals, and whales, and domesticated animals such as dogs, cattle, or chickens.   
As might be expected, there are large differences between the knowledge 
accumulated about resistance in hospital environments compared to the natural 
environment.  More funding, effort, and time has been spent focusing on antibiotic 
resistance within clinical areas.  This is necessary and has helped dramatically reduce the 
spread of resistant infections in hospitals and has led to greater understandings of 
resistance dynamics.  However, the issue is that this idea of resistance in hospitals tends to 
emphasize that resistance stops at hospital doors and does not move out into the natural 
environment.  This idea has tended to reduce the importance of examining environmental 
resistance.  Instead, the reality is that a resistant bacteria or resistance gene knows nothing 
of human created boundaries.  This distinction between the clinical and natural 
environment is superficial at best.  It certainly makes for more difficult studies to combine 
both the clinical and environmental sectors, especially when funding agencies and 
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scientists are often focused on only one of the sectors (EPA-on natural environment, NSF- 
on basic scientific questions, not health or environment related, NIH-on clinical 
environments).  However, creating these false dichotomies between humans and nature 
only harms our ability to truly respond and mitigate the issues of antibiotic resistance.   
Strategies to standardize testing antibiotic resistance in the natural environment. 
The first hurdle to tackle is the definition of resistance itself. The operational 
definition of resistance is defined primarily in clinical ways, by how that bacteria would 
be affected by a given therapeutic treatment of the antibiotic.  Currently, the procedure to 
analyze if a given bacterial isolate is resistant involves culturing that isolate and testing it 
to determine if the isolate is resistant or sensitive to the antibiotic(s) to be used for 
treatment of the infection (33, 34). This is very informative for choosing appropriate 
antibiotic treatment options.  While this works in the clinical environment, it poses issues 
when it is transferred to environmental bacteria.  One aspect is at what level of antibiotic 
resistance should environmental bacteria be categorized as resistant. Some resistances can 
be passed to other bacteria, including those that are pathogenic, showing how critical 
these impacts can be.  One current option for this is proposed by Berendonk et al. 2015 
and states that epidemiological cut-off values (ECOFF) be utilized instead.  The ECOFF 
value looks at a given taxonomic grouping of bacteria and determines acquired resistance 
compared with populations that have no resistance (22).  The ECOFF database values are 
relatively limited in terms of environmental bacteria, so this would require some 
concerted effort to expand the current database (22).   
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The next hurdle to overcome is how to appropriately assess resistance in a 
laboratory setting.  Currently, disk diffusion or minimum inhibitory concentration methods 
are utilized to assess sensitivity or resistance to antibiotics.  This occurs by growing the 
bacterial isolate, testing it in culture against discs embedded with antibiotics, and 
measuring the zones of inhibition, allowing for the assessment of resistance (CLSI method).  
This works very well for pathogenic clinical bacteria, which are well established in their 
growth patterns and knowledge of their resistances.  This also allows clinical bacteria 
resistances to be compared over time and location, leading to a greater understanding of 
resistance trends and patterns (35, 36).  However, this culturing process can be time-
intensive and requires twenty four or more hours, which can be critical for treatment in 
some cases.  Environmental bacteria do not as easily fall within this framework as it is 
thought that only 1% of all environmental bacteria are able to be cultured (37, 38).  
Therefore, culture-based methods leave the vast majority of bacteria unstudied- potentially 
hiding important insights into antibiotic resistance dynamics.  Culture based AR 
techniques have been used in the environment (39–42), but in general, there is no 
consistent method to their application, leaving results difficult to compare between studies 
(22).  Further, the exact procedures different researchers utilize are often not published in 
full detail, making it hard to replicate these techniques.  To circumvent these culture-
based application downfalls, non-culture based techniques, such as sequencing or 
polymerase chain reaction (PCR), may be utilized instead.  However, this change in 
procedure may make it difficult to compare environmental results with the clinical 
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procedures that are already in place.  Therefore, some way to compare these two 
divergent procedures would be necessary.        
With an appropriate definition of resistance in place and useful standardized 
methods, global assessment of antibiotic resistance in the environment could be readily 
examined and compared between studies, locations, and regions.  A standardized 
procedure would allow analysis of large-scale questions like: is antibiotic resistance in the 
environment increasing over time?  Is environmental antibiotic resistance consistent over 
locations (i.e. are there “hotspots” for antibiotic resistance within or between countries)?  
What environments have the highest levels of antibiotic resistance?  Is there a greater 
public health risk for interacting with one environment compared to another?   
Delving deeply into the environment resistance would allow us to readily close the 
gap on questions regarding environmental resistance and better understand connections to 
the clinical environment.  Analysis of many separate clinical data sources has been 
compiled and investigations of these larger data sets have been seen in the past few years 
in a variety of publications/open visualization sources from the Center for Disease 
Dynamics, Economics, and Policy and the World Health Organization (35, 36).  These 
immense studies have allowed for analysis of changing resistance over time (36), 
resistance levels in different states (36), and resistance levels throughout the world (35, 
36).  If a standardized system is in place for the natural environment, similar levels of 
analysis could be completed.  Then, the knowledge gained from the environment could 
be combined with the clinical knowledge that has already accumulated, hopefully leading 
to effective policy.  
  
 
53 
There is Enough Evidence and Scientific Consensus to Take Action on Public Policy. 
 At the crux of knowledge assessment is determining what action can or should be 
made from the given scientific research.  In the case of antibiotic resistance, there are parts 
that are well established and action should be taken to make policy changes to impact 
human health.  However, there are other environmental sectors that require increased 
research.  Despite the need for increased research for the natural environment, the 
knowledge already obtained from the clinical environment and the overall impacts of the 
substantial use of antibiotics by humans illustrate enough evidence and consensus to 
create public policy and action.   
Some actions are already being taken both from research obtained in the clinical 
and environmental fields. Certainly in the clinical realm, there is a known desire to reduce 
the amount of antibiotics being used by the general public.  Many campaigns by the CDC 
and other governmental and non-governmental agencies throughout the world have tried 
to focus public attention on why antibiotics are only useful in the case of a bacterial 
infection, helping to reduce resistance by reducing improper use of antibiotics. In the 
environment, it is relatively well established that use of antibiotics in agriculture increases 
resistance (43).  Actions are being taken to reduce the amount of antibiotics in this sector 
by major agricultural producers (Perdue) and first level large-scale consumers 
(McDonalds, Chipotle, Panera) due predominantly to consumer demand and interest (44).  
These large-scale consumers can have a heightened impact due to their large amount of 
consumption, allowing them to force producers into adopting their policies because 
otherwise the producers risk losing a large buyer.  Consumer demand for antibiotic-free 
products may in turn drive restaurants and grocery stores to require antibiotic-free items, 
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thereby further encouraging producers to adopt these policies.  However, optional 
procedures and campaigns will likely not contain enough power to fully address the scale 
of this global problem.   
 More research needs to be completed to fully understand the full impacts of 
environmental antibiotic resistance.  However, the main actions to be taken for antibiotic 
use are reducing consumption of antibiotics and increasing novel treatment options for 
resistant infections.  These actions are known to be effective from other sectors (i.e. 
clinical and environmental research that has already been completed).  In this light, there 
is no reason not to act on the policies and treatment that are known to be effective.  
Research on lesser-known issues can be continued.  It will likely take substantial time and 
effort to implement procedures and policies on reducing consumption and increasing 
novel treatment, so working on both sectors of taking action and continuing research is 
necessary.  
For matters that are relatively unknown, further research needs to be undertaken 
before action is taken.  For example, evidence suggests that wastewater treatment plants 
serve as hotspots of antibiotic resistance transfer because of the various waste inputs from 
many diverse locations that contain antibiotics, antibiotic resistance genes, and antibiotic 
resistant bacteria (45–48).  All of these inputs along with the process of wastewater 
treatment provide selective pressures—increasing gene transfer or selecting for resistance. 
Increased research on intervention possibilities would need to be done to find a relevant 
technological change and then policy should be utilized to enact the best possible 
manipulation.  
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Meeting the Needs of Key Players in the Antibiotic Resistance Crisis. 
 Examination of those who utilize antibiotics should first be completed and include 
the general public and farmers of fish, meat, and plants.  The general public often wants 
fast fixes to their illnesses in order to feel better sooner and to get back to work and to 
their lives.  A competing factor at play here is that much of the general public in the 
United States does not understand how antibiotics work and that antibiotics are only 
effective for bacterial infections. Due to their large number, the general public does have a 
large amount of power in terms of economic capital.  If they are able to organize, which is 
often difficult due to diffuse interests (Olson), they can make change.  For example, use of 
antibiotic treated food in certain restaurants has decreased in part to consumer demands 
(44).  
There are also key players in the United States in prescribing antibiotics.  These 
individuals often act as the gatekeepers between antibiotic production and the general 
public. These include predominantly physicians/clinicians and veterinarians (for 
therapeutic or sub-therapeutic uses of antibiotics for animals). The need for a prescription 
leaves clinicians with two opposing ideas: 1.) desire to care for their patients and a need 
to maintain their client base and 2.) knowledge that use of antibiotics for inappropriate 
conditions increases resistance. A patient may want an antibiotic and may go to another 
doctor or veterinarian if the patient deems they were treated inappropriately or unfairly by 
not getting what, in their eyes, is the appropriate treatment.  These practitioners essentially 
are forced to choose between patient satisfaction or being scientifically correct and 
limiting resistance from developing.  
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Another key player in terms of access to antibiotics are makers of animal feed, 
which can often contain antibiotics. For animals, the FDA has instituted a collaborative 
(voluntary) approach to reduce the use of antibiotics in animal feed and to only use 
antibiotics for therapeutic purposes instead of growth promotion.  However, for the food 
producers and antibiotic producers- this would reduce their market share, leading to lower 
financial gains for their products.  It seems unlikely that this voluntary approach will be 
successful, but only time will tell.  
As illustrated in this section, there are a diverse group of stakeholders in this topic 
and their needs are varied.  This makes it difficult to create policy because it is impossible 
to have policies that are going to be appropriate for everyone’s needs.  However, these 
burdensome realities should not be used as an excuse to avoid creating policy.   Instead, 
there should be an acknowledgement of winners and losers within given policies.  Value 
judgments regarding the importance of various sectors must be made in creating these 
policies as well.  With these factors in mind, recommendations for where to go and how 
to move forward are discussed below. 
What scientific and policy evidence recommendations exist for these fields?	
Recommendations for the Clinical Field 
Recommendation 1: Acknowledge and examine the interdisciplinary framework of 
antibiotic resistance.  
Recommendation 2: Research the intersections of the clinical field and the environment to 
determine what effects these may have.  
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Recommendations for the Environmental Field 
Recommendation 1: Acknowledge and understand the interdisciplinary framework this 
research fits into.  
Recommendation 2: As discussed earlier, creation of standardized methods, which are:  
• able to be compared between both fields (clinical and the environment)  
• relatively inexpensive (in terms of equipment usage as well as on a per sample 
basis) 
• do not require advanced machinery (so as to be readily available for a greater 
number of locations) 
• able to be compared with the data already existing from the disk diffusion method 
used predominantly by the clinical realm.  
New methods (such as sequencing) or indicator organisms for an environment may prove 
helpful in this recommendation.  
Recommendation 3: Increase sectors that are involved in testing. What other environments 
are important and need to be studied?  What incentives can be placed to examine these 
regions?  Should a collective group of experts determine priorities along with funding 
agencies?  
Collective Recommendations for Both Clinical and Environmental Groups Interested in 
Antibiotic Resistance 
Recommendation 1: Create methods the evaluate risk of antibiotic resistance within a 
given environment.  Port et al. 2014 has a method to evaluate risk using community 
composition, gene transfer potential, antibiotic resistance gene potential, and 
pathogenicity potential (49, 50).  
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Recommendation 2: Collaborate with others’ expertise to answer interdisciplinary 
questions.  Clinical microbiologists and environmental microbiologists should work 
together to answer scientific questions relating to antibiotic resistance. These fields are 
interconnected and that the only way to control antibiotic resistance is with a 
collaborative approach (22).  
Recommendation 3: Create ways to disseminate results so that both communities are 
aware of the conclusions.  Currently, it seems that results are fragmented—environmental 
microbiologists publish in journals such as Marine Pollution Bulletin (51), Applied and 
Environmental Microbiology (52–54), or Environmental Science and Technology (55–57) 
whereas clinical microbiologists publish in journals such as Clinical Infectious Diseases 
(58–60), Expert Opinion on Pharmacotherapy (61), Clinical Microbiology and Infection 
(62), or Clinical Microbiology Reviews (63).  This leads researchers to fail to find results 
and collaborations that could be very relevant to their work.   
 A solution to this would be encourage an interdisciplinary journal or alternatively, 
to encourage (in tenure packages or through funding agencies) dissemination of antibiotic 
resistance work across other relevant fields.  Creation of a specific interdisciplinary 
conference of clinical and environmental microbiologists interested in antibiotic resistance 
could also be extremely relevant and useful to addressing these problems.        
General Policy Recommendations for the United States 
General Recommendation 1: Reduce use of antibiotics  
1.) Incentives to hospitals to reduce use. One way to reduce use of antibiotics in hospitals 
could be to provide incentives to hospitals to reduce their use.  There are a variety of ways 
  
 
59 
that this has been proposed including allocation of antibiotic prescriptions per hospital or 
per doctor (64) and docking funding reimbursements by the government if resistant 
infections are rampant (some of these policies already exist for hospital acquired 
conditions with Medicare) (65, 66). This is a somewhat problematic idea as it is difficult to 
force individuals to complete the entire dose of their prescription and it may not be fair to 
tie reimbursements to individuals’ actions.  However, having financial incentives often 
spurs individuals to take action so perhaps this is a relevant and useful way to proceed.   
2.) Reduce use in food production.  The United States uses significantly more antibiotics in 
animal production than for humans- roughly three times more (67).  Work has been in 
progress to reduce the amount of antibiotics in agriculture and aquaculture and this work 
is continuing and should likely be expanded (68–71).  Innovation will likely be a critical 
tool in determining new methods for food production with reduced antibiotics.  
Passing legislation so that it is illegal to use antibiotics in food products for growth 
production would reduce use.  Though, of course, there would be loopholes around this 
legislation- individuals could state that they are using the antibiotics for disease prevention 
or disease treatment when really they are using it for growth promotion.  Perhaps a way 
around the issue of continuing to use antibiotics for their growth promotion capabilities 
might be to require oversight as to how often antibiotics are being utilized on larger farms.  
This legislation would be difficult to initially pass as many producers would be against it, 
but it has been successful in other countries (Denmark for example) (72, 73) and could 
greatly reduce use of antibiotics.  
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 It is possible that this legislation would spur innovation and force food producers 
to increase efficiencies as the Porter Hypothesis would predict (74, 75).  Part of the reason 
producers use subtherapeutic levels of antibiotics is to control infection because of the 
densely populated farms where infection can run rampant.  Legislating antibiotic use in 
food production could create efficiencies to care for those animals in a more sustainable 
manner.  If this legislation is passed and prices increase, there may be a need to provide 
subsidies to individuals in lower socioeconomic classes for the increase cost of meat and 
other food products (eggs, cheese).  
3.) Increase science education.  A large reason that individuals request antibiotics for 
illnesses is because they do not understand the differences between bacterial versus viral 
infections.  Informal and formal education to increase scientific literacy would help to 
address this lack of knowledge.  
4.) Create incentives for rapid diagnostics.  Rapid diagnostics for testing of individuals’ 
infections for the type of infection (bacterial, viral, fungal, etc.) would be critical to 
determining appropriate treatment, especially for individuals who are severely ill.  Further, 
the diagnostic could then determine to what antibiotics the infectious agent might show 
resistance (76–78).  Overall, this would allow for a more efficient way of utilizing 
antibiotics. Subsidies or incentives may be necessary to create these diagnostics and 
subsidies may also be necessary to ensure they are utilized in hospitals.  
General Recommendation 2: Increase amount of new antibiotics 
 
1.) Provide incentives for companies to take on antibiotic development.  As discussed in 
the first half of this paper, there are not adequate market incentives for companies to take 
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on drug development.  This means that the government either needs to designate an 
agency for this task or incentivize companies to take this on themselves.  This is a 
potential downfall because it is another factor that government and bureaucracy has 
control of, which may not lead to the most efficient process.   
2.) Provide research grants to academic laboratories to screen for new antibiotics.  Often 
in drug development, academic laboratories screen many promising products and then 
these products are sold to pharmaceutical companies if they are found to be effective.  
Further grant money could be provided to academic laboratories to screen for specific 
types of antibiotics that are effective against certain bacteria.  It may be wise to incentivize 
screening from the natural environment, since that is where the majority of antibiotics 
come from and where there is an abundance of untapped potential resources.    
Recommendation 3: Reduce resistance and infections  
 
1.) Create and increase monitoring programs for resistant infections.  Some infections are 
already monitored by the CDC (17) and include : Streptococcus pneumoniae, Methicillin-
resistant Staphylococcus aureus, Salmonella, Enterococcus, and Mycobacterium 
tuberculosis(17).  However, a larger resource would be helpful to track infections and to 
better understand the dynamics of these infections.  A global registry would be 
phenomenal, but would require much undertaking, especially for unstable or 
undeveloped regions (35, 79, 80).  However, with the ease of travel in our global world 
(81), knowledge of antibiotic resistance threats are critical to global preparedness.  
2.) Increase research into the environment.  The environment is likely a source of 
resistance to be passed to our food products and ourselves when we interact with the 
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environment (54, 82, 83).  Understanding resistance transfer in the environment could 
allow minimization of resistance.   Additionally, if there are hotspots that are found to 
contain large amount of resistance, monitoring of these areas could occur to reduce 
human interaction to decrease resistance transfer.  Risk assessments and calculations 
would be necessary as well.  To do this research appropriately, interdisciplinary research 
between clinical researchers and environmental scientists is necessary.  Creating specific 
funding pools for this research could incentivize this.  
CONCLUSION 
This chapter has focused on the issues associated with antibiotic resistance within 
the United States.  However, antibiotic resistance is a global problem that needs global 
solutions (3, 23, 76, 84).  The boundaries of antibiotic resistant bacteria are limitless.  
Human defined boundaries such as countries are not taken into account at all by bacteria 
and the ever more rapid modes of transportation only increase the reality of transfer 
between distant countries (81).  How the global community acts on this pressing issue is 
critical to the health of humans and the environment both now and in the future.  The 
antibiotic pipeline is time consuming and is not something that can be discovered 
overnight.  Action now is critical to ensuring that we do not return to a pre-antibiotic time 
period, which would significantly detract from our medical advances in the past fifty years 
and our ability to continue making improvements medically, technologically, and 
societally in the world.  
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CHAPTER 3 Antibiotic resistance in Vibrio-like bacteria is common 
at marine beaches on Cape Cod, MA  
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ABSTRACT 
Antibiotic resistance (AR) is a natural process, enhanced by anthropogenic 
antibiotic use.  Natural environments, like the ocean, act as reservoirs of resistance, but 
until recently little research has examined their dynamics.  Six beaches on Cape Cod, MA, 
with varying human impacts, were sampled over one year on nine occasions. Vibrio-like 
bacteria were isolated from wet sand, dry sand, and water from each beach and tested for 
sensitivity to five antibiotics (amoxicillin/clavulanic acid, ciprofloxacin, doxycycline, 
oxytetracycline, and trimethoprim) using the disk diffusion method. 73% of isolates 
showed resistance to at least one antibiotic, and resistance was persistent over time, 
space, and sample type.  Isolates commonly exhibited trimethoprim, ciprofloxacin, and/or 
amoxicillin resistance. 16S ribosomal DNA amplicon-based community structure varied 
along with the dominant operational taxonomic unit (OTU). Permutational multivariate 
analysis of variance (PERMANOVA) indicate that resistance patterns, prevalence, and 
bacterial community composition were often related to month of sampling. Seasonal 
environmental variables also explain AR and community structure data. Distance based 
linear models (DistLM) using arcGIS land use variables reflect homogeneity in land use 
between sites.  Estimates of Vibrio-like resistant bacteria range from 57 to 980 cells per ml 
water, accounting for 0.00057-0.0098% of the total bacteria encountered with beach 
water contact.  These results illustrate that resistance to antibiotics by Vibrio- like bacteria 
is widespread on local recreational marine beaches.  Although these resistant bacteria are 
a small percentage of the total bacteria, they may represent a potential public health issue 
through the introduction of resistance genes into human microbiomes during recreation or 
shellfish consumption.  
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INTRODUCTION 
Antibiotics are among the most important discoveries of the 20th century and have 
revolutionized the way humans treat disease (1). However, their immense benefits come 
at the cost of increasing antibiotic resistance (AR), a natural phenomenon that is 
exacerbated by the extensive use of antibiotics for human (2, 3) and animal health (4) and 
for increasing yields in agricultural and aquaculture production (2, 5–7).  Previous 
research has focused predominantly on AR in the clinical environment; but recently a 
holistic understanding called “One Health” has emerged in which human, animal, and 
environmental health are linked, and the entire system must be studied to understand the 
complex dynamics involved (8, 9). Pollution from anthropogenic sources such as hospitals 
(10–12), agriculture (13–18), human wastewater (19–24), and aquaculture (25–29) can 
contain not only antibiotics but both pathogenic and non-pathogenic bacteria carrying 
antibiotic resistance genes (ARG).  When these wastes are released into the environment, 
native environmental bacteria that have little or no connection to human disease may be 
exposed to anthropogenic antibiotics or ARG. Environmental bacteria with naturally 
occurring resistance genes, or that have acquired genes, then serve as reservoirs for 
resistance, with the potential for the transfer back to pathogens and the emergence of 
resistant infections (30).  The relative ease of gene transfer between bacteria is one of the 
primary reasons for interest in environmental antibiotic resistance (30). Despite a growing 
appreciation of these connections, studies of the environment as a reservoir of resistance 
have lagged behind research in clinical settings. The marine environment in particular is 
underexplored, even though humans routinely interact with the ocean for food and for 
recreation, providing an opportunity for antibiotic resistance transfer.  
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 Vibrio species, a genus of Gram-negative bacteria, reside primarily in brackish and 
saltwater ecosystems, and include at least twelve pathogenic species including V. cholera, 
V. alginolyticus, and V. parahaemolyticus (31). Vibrio is of interest because most species 
are free living members of the marine bacterial community, while others are known for 
their symbioses with other marine organisms such as copepods (32), fish (33, 34), shellfish 
(31), and squid (35, 36). Previous research on AR has found antibiotic resistance in Vibrio 
species in a variety of marine areas around the world including the Baltic Sea (37, 38), the 
North Sea (38), Chesapeake Bay (39), South Carolina and Georgia (40, 41), Brazil (42), 
Peru (43), and India’s Chennai coast (44).  Percentage of resistance to at least one 
antibiotic varies from 8.3% (39) to 100% (45) which may be due to the site or to the 
variety of antibiotics tested in each study, but these results indicate a general prevalence 
in Vibrio.  Prior studies have focused on one site, or multiple sites over a short period of 
time, preventing assessment of the persistence of antibiotic resistance and the effect of 
human activity and environmental conditions over time.   
The purpose of this study was to assess the prevalence and persistence of antibiotic 
resistance in Vibrio-like bacteria at marine beaches with varying levels of human activity 
by conducting a temporal and spatial survey.  The hypotheses were that beaches with 
greater human activity (denser urbanization, higher visitors) will have more isolates with 
antibiotic resistance and multiple resistance than secluded beaches, and that there will be 
a seasonal trend of more resistant bacteria in summer compared to winter and spring.  The 
secluded beaches were selected to provide a baseline for the natural level of antibiotic 
resistant bacteria in the coastal marine environment.  Finally, estimates of the amount of 
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resistant Vibrio-like bacteria encountered by humans through recreation or shellfish 
consumption were made to assess the potential for public health risk. 
METHODS  
Site Description    
Six field sites were chosen near Falmouth, Massachusetts on Cape Cod (Figure 1).  
The sites represent different watersheds, bodies of water (Buzzards Bay (BB) vs. Waquoit 
Bay (WB)), levels of human activity, and salinity gradients (for the Waquoit Bay estuarine 
sites).  The levels of human activity were assessed by the authors based on how frequently 
the beaches were used and how accessible they were. The site descriptions are given in 
detail in Table 1.  A seventh site, Elizabeth Island, was sampled once in September 2015 
to represent a more isolated site. 
Field sampling 
Samples of wet and dry sand and water were collected in June, July, August, 
September, October and December of 2014 and February, April and May of 2015.  At 
each site, three one liter water samples were collected at ~45 cm depth using sterilized 
Nalgene bottles.  Three sterile 50 ml centrifuge tubes of wet sediment were collected right 
above the water line on the beach, and three tubes of dry sediment were collected around 
the high tide line.  
For environmental measurements, a YSI Professional Plus data sonde (Yellow 
Springs, OH) was used to measure barometric pressure, dissolved oxygen, water & air 
temperatures, specific conductivity, and salinity. Previous rainfall was based upon the 
rainfall amounts for the previous two days and the day of sampling obtained from Weather 
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Underground (wunderground.com) using the weather history custom tab. For Little Island 
(LI) site, the KMAFALM06 station was used. For Old Silver Beach (OSB) site, 
KMANORTH39 station was used. For Waquoit Bay sites (SCB, WB, NRB, BDN), the 
station KMAEASTF1 was used. Amount of sunlight minutes for each site was calculated 
using an online almanac http://www.almanac.com/astronomy/rise/zipcode/02540/) and 
looking up the sunrise time for each of the sampling days. The amount of sunlight was 
then determined by subtracting the sunrise time from the sampling time. This method was 
an estimate and did not include cloudiness as a factor. Each liter of water was subsampled 
and measured for turbidity using the MicroTPW detection system (HF Scientific) and the 
three measurements were averaged.  
Sample Processing 
Three replicate water samples for each site were subsampled and mixed to create 
one composite sample used to cultivate bacteria. The three replicate samples of each sand 
type (wet or dry) were combined and carefully mixed, and 10 gm was returned to a 50 ml 
centrifuge tube to create a composite sample to be used for culturing.  20 ml of sterile 1x 
phosphate buffered saline (PBS) was added to the 10 gm of sand, shaken for two and a 
half minutes and allowed to settle.  This PBS mixture was then used for bacterial 
cultivation.  
Cultivation of Vibrio bacteria 
For samples between June 2014 and August 2014, alkaline peptone enrichment 
was used for the cultivation of Vibrio spp. A direct plating method was utilized for the 
samples collected after August 2014. For water and sediment samples collected between 
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June 2014 and August 2014, alkaline peptone enrichment was used prior to plating on 
Thiosulfate-Citrate-Bile-Sucrose (TCBS). Twenty five ml of water or 5 ml of the 1 X PBS 
elutant from sediment was inoculated into 225 ml of alkaline peptone media. All samples 
were incubated at 35-37ºC with shaking at 100 rpm for 6 hours. The incubated samples 
were then serially diluted with sterile seawater (direct inoculation or between 101 – 106 ) 
and 100 µl was spread onto TCBS agar plates for cultivation of Vibrio species. TCBS plates 
were incubated at 35-37°C for 18-24 hours. Direct plating was accomplished for all 
subsequent samples by spreading 100 to 500 µl of the water sample or the PBS sediment 
mixture onto the TCBS agar and incubation at 35-37ºC for 18-24 hours.  
Each plate total colony number was counted and up to three colonies of each 
morphology type on a given plate were picked.  Picked colonies were grown in seawater 
broth and 800 µl of the culture was added to 200 µl of sterile 80% glycerol and stored at -
80°C as sample stocks.  
Antibiotic Resistance Testing  
Antibiotics tested in this study were amoxicillin/ clavulanic acid, ciprofloxacin, 
doxycycline, oxytetracycline, and trimethoprim (Table 2).  Glycerol stocks were used to 
inoculate seawater broth, and the cultures were incubated at 35-37°C for 8 hours.  
Cultures were adjusted to a 0.5 McFarland standard (OD600 of 0.15-0.20) and used to 
swab Muller Hinton plates for growth of lawns following the procedure by CLSI (46–48).  
Antibiotic discs were placed individually on each plate using sterilized forceps followed 
by incubation at 35-37°C for 16-18 hours.  Inhibition zones around each disc were 
measured and recorded. Zone diameters were used to categorize sensitivity, intermediate 
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resistance, and resistance to the antibiotic. Resistance in this report includes both 
resistance and intermediate resistance, following previous literature (49).  Breakpoints 
used for each antibiotic are shown in Table 2. Doxycycline and trimethoprim did not have 
breakpoints available for Vibrio spp., therefore breakpoints from Enterobacteriaceae were 
used.  
16s ribosomal RNA gene Sequencing  
A portion of the 16S ribosomal RNA gene was amplified using the primers 27F and 
680R (Vibrio- specific primer, 49) and sequenced from isolates that were successfully 
tested for antibiotic resistance (406 total). Forty μl of cell culture was combined with 40 μl 
of 1X PBS in a PCR tube, lysed by incubation at 65ºC 30sec, 8ºC 30sec, 65°C 90sec, 97°C 
180sec, 8°C 60sec, 65°C 180sec, 97°C 60sec, 65°C 60sec, and 80°C 10mins (pers comm 
Paul Kirchberger). These cell lysates were amplified using the 16S primers 27F and 680R 
(Vibrio- specific primer, 49). PCR products that showed a product of the correct size (650 
base pairs) on a 1.5% agarose gel were purified using MinElute PCR Purification Kit 
(Qiagen, Hilden, Germany). Samples were sent to GeneWiz (South Plainfield, NJ, USA) for 
sequencing using primer 27F. Resulting chromatograms were assessed using 4Peaks 
(Amsterdam, Netherlands) and were corrected manually according to confidence in the 
chromatogram profile.  
Final sequences (388 total) were submitted to BLAST and a best sequence identity 
was chosen based on percent identity and top hits.  Unique sequences were assessed 
using mothur (51) and were then combined with Silva (v.1.2.11 online) Vibrio type 
sequences (search criteria: organism name- Vibrio, sequence quality- >90, strain: type).  
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Both the unique sequences and the type sequences were aligned with SINA aligner (52) 
available on Silva Online.  Molecular phylogenies were constructed using Mega (53) with 
Partial Maximum Likelihood.  Isolates that showed most similarity with Vibrio, 
Photobacterium, and unidentified organisms within the Vibrio genus were retained in the 
study, whereas isolates similar to Aeromonas (1), Bacillus (1), Exiguobacterium (14), 
Oceanimonas (3), Oceanisphaera (1), Shewanella (7), Staphylococcus (1), and samples 
unable to be sequenced (18) were eliminated. The Vibrio/Photobacterium/unidentified 
sequences were clustered into OTU groups based at 99% using mothur (51).  Sequences 
have been deposited in GenBank (54). 
arcGIS 
Spatial analysis of these sites was accomplished to have a quantitative 
measurement of the degree of human impact at each sampling site. Spatial analysis was 
completed using arcGIS (ArcMap 10.4, run in Virtual Box on a Mac, Esri, Redlands, CA) in 
order to acquire land use information and population density around the field sites.  Both 
watershed and proximity were evaluated/examined.  Proximity analysis extended to a 
radius of 840 meters around each site (Figure 1).  Watershed analysis compared sites using 
the embayments (also known as subwatersheds) on Cape Cod, available via the arcGIS 
online tool (search for embayments) or via Open Data (55).  For all analyses, census, long-
term care facility, hospital data, land use, and impervious surface were utilized.  
Information on downloading data and models are available for download (56).  
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Estimations of amounts of antibiotic resistant bacteria present in water 
Using the September 2014, for all six regularly sampled sites, and September 2015, 
for the Elizabeth Island site, water samples, the total number of Vibrio-like bacteria 
recovered from each sample was estimated from petri dish counts, divided by the amount 
of inoculum in milliliters.  The percentage of total Vibrio isolates resistant to 0, 1, 2, 3, or 4 
antibiotics was then calculated by dividing the number of resistant isolates by the total for 
each sample.  This percentage was multiplied by the estimated total of Vibrio-like bacteria 
recovered from each sample to determine the number of cells in a particular category that 
would be encountered in a milliliter of water.  The number of cells resistant to at least one 
antibiotic to provide the total number of resistant cells per ml.  These estimates were 
multiplied with ingestion estimates of how many milliliters of water individuals ingest in 
various recreational activities to estimate human exposure during beach recreation (57). 
Shellfish filtration estimates were produced by using published ranges of filtration for 
quahogs (Mercenaria mercenaria) and soft clams (Mya arenaria) (58).  For the Eastern 
oysters (Crassostrea virginica), the filtration rate of 1.5 to 10 L/h/g dry weight (59) was 
multiplied by the average dry tissue size of Cape Cod oysters, with a range from 1.36 to 
2.7 g dry tissue weight (60) to produce a range of filtration of 2.04 – 4.05 L/h.  These 
filtration estimates, both low and high range, were multiplied by the number of resistant 
cells to estimate how many culturable resistant cells a shellfish might filter in one hour.  
Multiple antibiotic resistance  
The Multiple Antibiotic Resistance (MAR) index was calculated for each individual 
sample taken at a specific time and location, as previously described (61).  A single MAR 
index was calculated for all samples to be indicative of the larger beach community.   
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Statistical analysis 
For statistical analyses, Primer 6 and PERMANOVA were used (Auckland, New 
Zealand) (63, 64).  The antibiotic resistance data was organized into two different matrices 
in order to examine patterns in the data.  The first matrix was used to examine antibiotic 
resistance patterns on an isolate basis, and consisted of each bacterial isolate as a sample 
and the sensitivity/resistance to each antibiotic as the variable.  The second matrix was 
used to examine resistance to multiple antibiotics and consisted of each location/sample 
time with the percentage of isolates resistant to 0, 1, 2, 3, or 4 antibiotics as the variables.  
Permutational multivariate analysis of variance (PERMANOVA, Primer v. 6) was 
used to test two questions: whether human impact affects resistance patterns or 
prevalence, and whether watershed affects resistance patterns or prevalence (63).  The 
isolate matrix was used to answer the question of resistance patterns, and the resistance to 
multiple antibiotic matrix was used to examine resistance prevalence.  PERMANOVA tests 
examined a Bray-Curtis resemblance matrix (with a dummy variable to eliminate zeros) 
from the AR data compared to factors associated with the data.  Tables 3 and 4 show the 
PERMANOVA tests and run parameters including the Sum of Squares- Type III (partial) 
and the permutation as unrestricted permutation of raw data. If p-values were greater than 
0.25 and had a negative variation component, the factor was pooled.  
For OTU-based community composition data, the matrix included each sample 
location/ month (for example: LI August) as the sample and the counts of OTU groups 
present as the variables. PERMANOVA tests were done using the same set-up and analysis 
as for the antibiotic resistance data, though here, the data were transformed using a 
log(x+1), and no dummy variables were used in creating the resemblance matrix.  
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To assess if environmental and land use variables were significant in structuring 
antibiotic resistance and community composition patterns, distance-based linear models 
(DistLM) in PERMANOVA+ were utilized using the Best procedure that examines all 
possible combinations along with the Bayesian Information Criterion (BIC) that provides a 
penalty for extraneous predictor variables (63).  Environmental variables included amount 
of sunlight (minutes), average turbidity (NTU), barometric pressure (mmHg), salinity (ppt), 
dissolved oxygen (mg/L), water temperature (degrees Celsius), air temperature (degrees 
Celsius), and previous rainfall (inches).   
Two separate land use variable spreadsheets were created: one from the Watershed 
Model (for the three watersheds- West Falmouth Harbor, Waquoit Bay, and Falmouth Old 
Silver Beach), and the other for the Proximity Model for each of the six regularly sampled 
sites (LI, OSB, SCB, WB, NRB, BDN).  Each matrix included percentage vacant housing, 
total population, the mean of the median age, percentage of males in the population, 
percentage of population 5 years old and under, percentage of population 6 to 18 years 
old, percentage of population greater than 65 years old, percentage of impervious 
surfaces, and percentage urbanized land use. Land use categories that are considered 
urbanized were: mining, multi-family residential, high density residential, medium density 
residential, low density residential, commercial, industrial, transitional, transportation, 
waste disposal, powerline/utility, golf course, urban public/ institutional, cemetery, very 
low density residential, and junkyard.   It should be noted that none of the analyses had 
long term care facilities or hospitals in these areas.  
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RESULTS  
Antibiotic resistance of Vibrio spp. isolates 
A total of 550 bacterial isolates were collected from beaches.  Throughout the 
process, isolates were eliminated because they did not re-grow from glycerol stocks, were 
not able to be tested for disk diffusion or sequenced, or were not Vibrio-like bacteria. 360 
of the bacterial isolates were Vibrio-like based upon sequence data and successfully tested 
using disk diffusion, and are reported on here.  The majority of the tested isolates were 
resistant to at least one antibiotic (73.1%, 263 isolates) (Figure 2, Panel A), and 32.5% 
(117 isolates) were resistant to more than one antibiotic.  There are more isolates with 
resistance to multiple antibiotics than there are isolates sensitive to all antibiotics.  Few 
isolates were resistant to four antibiotics (5 isolates, 1.38%), and no isolates were resistant 
to all five of the tested antibiotics.  Resistance varied based on antibiotic tested (Figure 2, 
Panel B): more resistance was observed to trimethoprim (47.5%), ciprofloxacin (30%), and 
amoxicillin (29.4%) than to oxytetracycline (5.8%) and doxycycline (4.2%).  Resistance 
was present throughout the year and varied seasonally (Figure 2, Panel C).  Spring, 
summer, and fall had higher percentages of isolates resistant to at least one antibiotic 
compared to the winter, though there were also fewer isolates in the winter.  Based upon 
sample type, 71.5% of dry sand (98/137), 76.2% of wet sand (109/143), and 70% of water 
isolates (56/80), were resistant to at least one antibiotic (data not shown).  The most 
prevalent antibiotic resistant categories were trimethoprim (28.9%), trimethoprim/ 
ciprofloxacin (18.3%), amoxicillin (16.3%), ciprofloxacin (9.9%), 
trimethoprim/amoxicillin/ciprofloxacin (7.6%), and trimethoprim/amoxicillin (6.6%) 
(Figure 2, Panel D).    
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 Bacterial isolates were recovered over the entire study time (Figure 3), though 
reduced recovery occurred during the winter (Table 3). As indicated in Figure 3, some 
samples had less than or equal to 5 isolates. The proportion of isolates resistant to at least 
one antibiotic was variable between sites and within a given site over the sampled months 
(Figure 3).  The Elizabeth Islands (EI) site, which was sampled as a very low impact control 
once on September 2015, had 20/24 isolates (83.3%) resistant to at least one antibiotic. At 
only three sample locations and time points (SCB 2014-06, BDN 2015-02, and WB 2015-
02) were no resistant isolates present.  Further, these samples also had very few isolates 
recovered (SCB 2014-06 and BDN 2015-02 with 1 isolate each and WB 2015-02 with 2 
isolates).  
MAR index results showed variability between 0 - 0.538 throughout the samples by 
location and time (Figure 4), and EI’s MAR value for September 2015 was 0.225.  47.6% 
of the samples have a MAR value of equal to or greater than 0.2.  A collective MAR value 
for Vibrio-like bacterial isolates at all of the beaches was 0.233.     
Statistical analyses  
The isolate matrix was used in two PERMANOVA tests to determine if human 
impact and/or watershed affect resistance patterns.  For both human impact and 
watershed, the only factor with significance was the interaction of location and month, 
explaining 12.2% of the human impact related variance and 11% of the watershed related 
variance (Table 4).   The multiple antibiotic resistance matrix allowed examination of 
human impact and watershed impact on the prevalence of multiple resistance.  For both 
tests, month alone was significant and explained about 9% of the variation (Table 4).  In 
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the watershed test, the interaction of watershed and month was also significant, explaining 
10% of the variation.  In all cases, the residual variance was ≥ 15%. 
  DistLM was used to assess the effect of environmental variables (sunlight time, 
turbidity, barometric pressure, salinity, dissolved oxygen, water temperature, air 
temperature, and previous rainfall) in explaining the isolate antibiotic resistance variation.  
The best BIC model included sunlight time, barometric pressure, and previous rainfall, 
with a R2 value of 0.12935 (12.9%). The isolate matrix was also compared to watershed 
and proximity land use variables.  The watershed best BIC model included impervious 
land use with a R2 of 2.799 x 10-2 (2.8%), while the proximity best BIC model was the 
factor of percentage of population ages 6 to 18 with a R2 of 2.2509 x 10-2 (2.3%).  When 
the multiple antibiotic resistance matrix was compared to environmental variables using 
the DistLM test, the best BIC test was a model with sunlight time and dissolved oxygen 
with a R2 value of 0.17034 (17.0%).  The multiple resistance matrix was also compared to 
the proximity and watershed variables and both tests indicated percentage of population 
male as the top factor (R2 of 5.2889 x 10-2 (5.3%) and 5.3429 x 10-2 (5.3%) respectively).   
Community composition of Vibrio isolates  
The Vibrio-like bacterial diversity changes over time (Figure 5), with some OTUs 
abundant and present throughout the year while others are less abundant and seen at 
specific points. Individual OTUs can harbor different resistance patterns, even for OTU 
groups that are not dominant (Figure 6).  OTU group 17 and OTU group 8 represent the 
most abundant isolates (Figure 5).  They not only contain diverse resistant patterns 
throughout the year, they each have a different subset of abundant resistance types (Figure 
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5). The isolates in OTU 8 show most resistance to amoxicillin and multiple antibiotic 
resistance to amoxicillin/ciprofloxacin, and oxytetracycline,/doxycycline/amoxicillin 
(Figure 7, Panel A) (56).  For OTU 17, isolates show most resistance to trimethoprim and 
ciprofloxacin and have multiple resistance to trimethoprim/ciprofloxacin, 
trimethoprim/amoxicillin/ciprofloxacin and trimethoprim/amoxicillin (Figure 7, Panel B) 
(56).  
PERMANOVA tests examining OTU composition compared to human impact 
indicate that month was the only significant factor. Month remained significant even when 
other factors were pooled (Table 4).  A PERMANOVA test examining watershed 
importance in OTU composition also indicated month as the only significant factor even 
after pooling. A DistLM Best BIC test analyzing OTU composition with environmental 
variables showed the best explanatory variable was previous rainfall with an R2 of 8.1966 
x 10-2 (8.2%).  In examining OTU composition to both proximity and watershed land use 
models, mean median age illustrates an R2 of 2.2174 x 10-2 (2.2%) and impervious 
surfaces represents an R2 of 2.8351 x 10-2 (2.8%), respectively.   
Estimations of resistant Vibrio-like bacteria in marine recreation and shellfish filtration 
The amount of resistant bacteria present was estimated and used to project the 
amount encountered by humans engaging in recreational activities (Table 6). Human 
exposure varies primarily with the amount of water ingested during a particular activity. 
Children’s swimming has the highest amount ingested (37 milliliters of water), and results 
in an estimated 2,109- 36,260 resistant bacteria ingested, depending on site.  Rowing has 
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the lowest value at 3.5 ml, and an estimated 199.5 to 3,430 resistant bacteria ingested, 
depending on site.  
Estimates of how many resistant bacteria a shellfish might filter in an hour were 
calculated for Crassostrea virginica (Eastern oyster), Mercenaria mercenaria (quahog/hard 
clam), and Mya arenaria (soft clams) (Table 7).  M. mercenaria has the lowest estimates for 
filtration with 0.3-3.6 liters filtered per hour, while C. virginica has the most with 2.04-27 
liters per hour.  C. virginica is estimated to filter between 1.2 x 105 – 2.6 x 107 resistant 
cells per hour. M. mercenaria is estimated to filter 1.7 x 104 – 3.5 x 106 resistant cells per 
hour and M.arenaria filters 9.7 x 104 – 7.2 x 106 resistant cells per hour.   
DISCUSSION 
This study was undertaken to examine the amount of antibiotic resistance present 
in Vibrio-like bacteria isolated from marine recreational beaches over temporal and spatial 
scales and with a gradient of human impact. Antibiotic resistance was found to be 
widespread in the studied samples with 73% resistant to at least one antibiotic and 32.5% 
resistant to multiple antibiotics. Overall, these reported values are consistent with previous 
research findings, and demonstrate that resistance to human-used antibiotics is not an 
anomaly for Vibrio-like species on Cape Cod. Studies examining Vibrio isolates from water 
and sediment in a Brazilian shrimp farm (45), and seawater samples from Peru (41), 
showed all isolates resistant to at least one antibiotic. Vibrio isolates from sediment and 
water from three sites on India’s Chennai coast showed ranges from 70% to 85% 
resistance to at least one antibiotic, depending on sample type and location (44).  Studies 
have also looked at specific pathogenic Vibrio species to determine their sensitivity to 
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antibiotics. In samples taken from recreational and commercial regions of the Chesapeake 
Bay, about 86.2% of V. vulnificus and 91.2% of V. parahaemolyticus expressed 
intermediate resistance to at least one antibiotic (39).  19.3% of resistant V. vulnificus. and 
70.6% V. parahaemolyticus were categorized as having expressed resistance to at least 
one antibiotic (39).  At two industrially contaminated sites and an uncontaminated control 
site in South Carolina and Georgia, 99.3% (150/151) of V. vulnificus isolates exhibited 
resistance to at least one antibiotic (40); and at these same sites, about 99.4% (348/350) V. 
parahaemolyticus isolates were resistant to at least one antibiotic (41).    
Resistance in Vibrio isolates varies by antibiotic.   
The fraction of isolates resistant to individual antibiotics in our study was 47.5% for 
trimethoprim, 30% for ciprofloxacin, 29.4% for amoxicillin, 5.8% for oxytetracycline and 
4.2% for doxycycline. Resistance prevalence results by antibiotic from other published 
studies are quite variable. Trimethoprim resistance ranges from 0% to less than 5% (38) 
and up to 72.5% (64), while ciprofloxacin resistance has values of 0% (39, 40, 45, 64) to 
22-36% (37).  Amoxicillin resistance values from other marine studies range from 0% (39) 
to < 5% (38) to 56-81% (37).  Oxytetracycline has shown resistance from <3% (40), 10-
32% (37), 10.8-12.1% (45), and 99.4% (64).  From one study, marine bacterial isolates 
exhibited no resistance to doxycycline (39). This variability may be due to locational 
differences in species composition of Vibrio or to the varied ways of reporting data.  Some 
studies report resistance as a breakpoint, while others report resistance and intermediate 
breakpoints together, as this study does.  In this study, the differences in resistance could 
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be due to a variety of factors including variations in structural targets (Table 2) and the role 
of resistance in the genus Vibrio. 
Multiple antibiotic resistance  
The MAR index of almost half of the samples in this study (47.6%) was greater than 
or equal to 0.2.  In Krumperman’s study on fecal contamination of food, samples from 
more “natural” areas (orchards, domesticated animals, wild animals) had MAR indices of 
less than 0.2, while samples from more anthropogenically affected areas (sewage, brooder 
houses, piggeries) had MAR index values of between 0.312-0.630 (61).  Therefore, an 
index value of greater than 0.2 was suggested to represent areas impacted by point-source 
contamination.  A study of antibiotic resistance in coastal vertebrates, including seabirds 
and seals, showed MAR values of greater than 0.2 for 38% of resistant bacterial isolates 
(65). The sites in this study are not samples with point source contamination, yet have 
higher values on Krumperman’s Index.  This finding may indicate that Krumperman’s 
index is not representative of impact for naturally affected areas due to its underlying 
assumptions about multiple resistance as prevalent for anthropogenically affected areas.  
Further, Krumperman’s index does not take into account the mechanism of resistance, 
which is discussed in more detail below.   
Community composition of Vibrio isolates illustrates temporal variation and shows multiple 
resistances in a given OTU.  
Vibrio-like isolates were recovered throughout the entire year on Cape Cod and 
therefore are present throughout the year in cultivatable forms. Winter had reduced 
recovery, which is expected due to the seasonal cycling of vibrios (50, 66) and community 
structure changed over time and showed varying OTUs as dominant (50). In examining 
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OTU composition relative to human impact and watershed using PERMANOVA (Table 5), 
month was the only significant factor for both tests, which supports the strong seasonality 
of Vibrio.  DistLM results indicated previous rainfall as the variable best fitting the OTU 
composition data, which relates to increased runoff and reduced salinity in the nearshore 
marine environment. 
A majority of the non-singleton OTUs showed resistance to multiple different 
antibiotics.  This result indicates that specific resistances are not likely associated with 
specific strains, and that there may naturally be a diverse selection of antibiotic resistance 
in the marine environment.  OTU 8 and 17 were the most prevalent bacterial groups and 
had differing types of resistance. The resistance differences may be due to the mechanisms 
of how these resistances are carried, or these may be due to species/strain-level variation.  
While sequences were too short to reliably assign taxonomic affiliations at the species 
level, OTU groups 6, 17 and 19 showed similarity to V. alginolyticus and V. 
parahaemolyticus, which is consistent with prior studies reporting antibiotic resistance in 
pathogenic Vibrio species from the marine environment (37, 38). With this in mind, it is 
important to consider antibiotic resistance in the context of climate change.  A previous 
study has documented increasing Vibrio abundance and infections with increasing sea 
surface temperatures (67).  With the prevalence of resistance in Vibrio shown in this study, 
and the projected increases in Vibrio abundance, the likelihood of encountering an 
antibiotic resistant Vibrio bacteria and contracting an infection could increase with a 
warming climate, though further research is necessary to elucidate the extent.  
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Human impact, watershed, land use and environmental factors have limited effect on 
antibiotic resistance. 
PERMANOVA tests to assess if human impact or watershed affected resistance 
patterns indicated that neither exerted a strong influence.  The only significant factor was 
the interaction effect of location and month, which explained less than 12% of the 
variation in each test. Tests examining the same questions for multiple resistance 
prevalence also showed month and the interaction of watershed and month as significant.  
This result is likely based on changes in bacterial species composition over time, which 
impacts the types of resistance present.  Lack of significance to individual factors of 
human impact and watershed suggest that these were not significantly different at each of 
the sites.  The residual variation was still fairly high for all of the tests, indicating that there 
are likely other factors that influence the resistance patterns that have not been accounted 
for in this work. 
The environmental variables of sunlight time, barometric pressure, dissolved 
oxygen and previous rainfall best explained the variation in antibiotic resistance patterns 
or multiple antibiotic resistance amounts in DistLM analysis.  These environmental 
variables also likely have to do with the bacterial community composition. Previous 
rainfall could influence the salinity of the water and/or contribute to the release of 
environmental bacteria from sand and impervious surfaces, thereby changing which OTUs 
may more readily thrive in the area, and ultimately what resistance may be most 
prevalent.  Sunlight time is also indicative of seasonality for this area, which also ties into 
community composition changes.  
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The land use variables impervious surfaces and percentage of the population ages 6 
to 18 years old explained less than 3% of the variability in the data in DistLM tests. This 
may suggest that on a proximity level, population of the community around the beach 
may be more important, whereas land use is of greater impact on a watershed level.  The 
human population structure may affect resistance by affecting what antibiotics are used in 
the proximal areas, though it seems unlikely that a direct relationship exists. Impervious 
land use could affect runoff that impacts particular beaches and could influence OTU 
composition, thereby influencing what types of resistance are present. Land use 
information was obtained from the 2010 Census data; and land use was not directly 
measured during the sampling period of 2014 to 2015 for this study.  Perhaps part of the 
lack of specificity to particular land use variables is due to this temporal inaccuracy.  
Overall, lack of specific relationships to particular land use variables, along with no 
significant relationships of antibiotic resistance data to individual factors such as 
watershed or human impact, and the pervasiveness of resistance throughout the study, 
indicate that these sites are all similar in environmental and human impact, at least 
considering the variables that were measured. This result is further strengthened by results 
from the isolated site on the Elizabeth Islands.  Though this site was only sampled once, in 
September 2015, 83.3% of samples were resistant to at least one antibiotic, despite 
generally limited human access and activity at the site.  Another aspect to consider is that 
the coastal ocean may be permeated with antibiotic exposure over time, with the mixture 
of natural and anthropogenic use of antibiotics.  With the coastal ocean considered 
replete with antibiotic exposure, there would be no differences between impact levels.  It 
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is also possible that conventional human impact indicators are not relevant on the 
microscale that bacteria experience. The antibiotic resistance research community may 
want to consider selecting human activity indicators with this in mind.  
Estimates of antibiotic resistant bacteria indicate potential for human interaction through 
recreation and shellfish.   
 Humans routinely interact with the ocean through recreation and food 
consumption.  If antibiotic resistant bacteria are present, it is possible that humans could 
contract a resistant infection, perhaps directly from a pathogenic Vibrio.  Alternatively, 
they could ingest a resistant Vibrio that could transfer its resistance gene to another 
microbe in the person’s GI tract or on their skin, therefore increasing resistance potential 
in the future.  The estimates shown in this study indicate that antibiotic resistant culturable 
Vibrio are a small proportion of the total bacteria ingested via beach water (0.00057-
0.0098 %).  Although small, the real impacts are unknown.  One could imagine that 
despite the potential for frequent occurrences suggested by the widespread and persistent 
presence of resistance, if the transfer rate is extremely low, the potential risk of a resistant 
infection would be small. For a back of the envelope calculation, if 57-980 resistant, 
culturable Vibrio-like bacteria are found in a milliliter of water (based on these estimates 
by site) and 10% have the ability to transfer, that leaves 5.7-98 resistant, culturable, 
Vibrio-like transferable bacteria per milliliter of water. Although occurrences and potential 
for harm seem small but possible, further research is necessary to determine actual risk. A 
key question is whether interactions with resistant bacteria result in an increased 
likelihood of gaining a resistant infection.  Answering this question requires understanding 
the mechanism of resistance and its ability to be transferred. Knowledge of what resistance 
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genes are common in the environment, their importance in health clinics, along with 
transfer rates of resistance from marine bacteria to bacteria present on the human skin or 
in the GI tract would be useful to quantify the rate at which resistance genes are likely to 
be shared.  
 To put this work into context, it may also be helpful to study amounts of antibiotic 
resistance in other environments that humans routinely interact with.  Resistance levels in 
the ocean may not present greater risk than those in other areas that humans encounter 
such as built surfaces such as bathrooms, kitchens, and desks, or even own body parts 
such as hands.   
High levels of resistance in Vibrio may be indicative of the ecological role of antibiotics 
and antibiotic resistance beyond competition for resources.  
The reported prevalence of antibiotic resistance in local Vibrio bacteria may be due 
to the bacteria’s ability to produce and resist antibiotics. A study examining pelagic 
marine bacteria illustrated that gamma proteobacteria of the orders Alteromonadales and 
Vibrionales (which includes the genus Vibrio; 74), readily produced inhibitory agents and 
were resistant to such molecules (69).  Further research into Vibrionaceae, a family that 
includes Vibrio and Photobacterium (68), showed this group readily exhibited resistance to 
antibiotics, although only some members produce antibiotics (70).  It is likely that 
antibiotics have a diverse set of uses in nature beyond growth inhibition, including 
signaling, especially at the lower concentrations that would normally be seen in the 
environment (71).  To this end, it is thought that some antibiotic resistances may originally 
have had different purposes; MDR efflux pumps that allow for resistance to quinolones 
may have allowed for signaling, and the beta lactamases may have originally worked to 
  
 
93 
make peptidoglycan (71).  Even further, intrinsic resistances may have been a part of 
bacteria living in diverse regions such as rhizospheres, where they would encounter a 
variety of toxic compounds (71).  What is now categorized as antibiotic resistance, 
especially in environmental settings, likely has different evolutionary purposes other than 
the clinical use of antibiotics.  
One specific type of intrinsic resistance is efflux pumps, which transport materials 
out of cells (including antibiotics; 69), and can be prevalent in Gram negative bacteria 
(72). Gram negative bacteria are prevalent in the ocean (73) and Vibrio are one example 
of these bacteria.  Although the mechanism of resistance was not tested, it seems possible 
that efflux pumps may represent a mechanism for the high rate of resistance seen in this 
study. A previous functional metagenomic study on antibiotic resistance found that the 
majority of known antibiotic resistance genes prevalent in ocean samples were multidrug 
efflux pumps (74). It is possible that the high amounts of resistance seen in the 
environment may not necessarily be due to the presence of specific antibiotic resistance 
genes, but to the evolutionary importance of being able to pump materials out of a cell.  
CONCLUSION 
This study illustrates that antibiotic resistance can be prevalent in Vibrio-like bacteria 
present at low human impact marine beaches. Although bacterial prevalence is related to 
seasonal conditions, resistance persists despite temporal, spatial, and environmental 
differences. Community structure of Vibrio-like bacteria varied over time, with two 
sequence-based taxonomic groups most dominant.  Resistance to a specific antibiotic was 
not associated with a particular group, but the two most abundant groups did show 
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resistance to different subsets of antibiotics. Ingestion and filtration estimates indicate that 
future research focusing on transfer of resistance from environmental bacteria would be 
useful for estimating potential risk to public health.  In addition, future studies should 
examine the mechanisms of antibiotic resistance present in the marine environment and 
what other ecological and competitive benefits the resistance genes provide to improve 
insight into the origin and importance of resistance evolutionarily.  
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Figure 1. Map of study sites. 
Map includes arcGIS information indicating proximity (840 meters around a field site) and 
watershed land use for each area.  Colors and symbols represent if it was a extra low, low, 
medium, or high human impact level.  
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Figure 2.  Resistance summary.  
 A) percentage of isolates resistant to 0,1, or more antibiotics.  B) percentage of isolates 
resistant to each of the five tested antibiotics.  Amoxicillin refers to the 
amoxicillin/clavulanic acid mixture.  C) percentage of isolates resistant to at least one 
antibiotic during each calendar season. D) percentage of resistant data illustrating 
prevalence of resistance categorization. 
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Figure 3. The percentage of isolates resistant to at least 1 antibiotic (y-axis) over time (x-axis).   
Each graph indicates a different site.  If all isolates from a sampling time point were sensitive to all antibiotics, a black dash is 
shown.  An empty point indicates no isolates from that sampling time were recovered for testing.  The less than symbol (<) 
indicates samples with 5 or fewer isolates. 
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Figure 4. The MAR index (y-axis) value over time (x-axis, also color) by sample location.  
If all isolates from a sampling time point were sensitive to all antibiotics, a black dash is shown.  An empty point indicates no 
samples from that sampling time were recovered for testing.  
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Figure 5.  OTU community comparison A) Vibrio spp. OTUs over time. 
 The OTU groupings are at 99% identity.  OTUs with only one occurrence (singletons) 
have been excluded. B) OTU Group 17 over time.  C) OTU Group 8 over time.  
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Figure 6.  Prevalence of antibiotic resistance types (color) over time (x-axis) by each OTU group (individual graph).   
The OTU groups indicated here had 2 or more occurrences. 
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Figure 7.  Percentage of resistant isolates illustrating patterns of resistance for A.) OTU Group 8 and B.) OTU Group 17.   
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Table 1. Description of study sites. 
Table indicates the sites, abbreviation, dates, and description of the studied sites.   
Site Name Code Dates Sampled 
Day-Month-Year 
Human 
Impact 
Level 
Description  Body of Water Watershed/ 
Embayment 
Other notes 
about site 
Little Island  LI 6/9/14, 7/29/14, 
8/12/14, 9/18/14, 
10/27/14, 
12/2/14,2/10/15,4/
13/15, 5/18/15 
Low Isolated beach in a 
private neighborhood  
Buzzards Bay West 
Falmouth 
Harbor 
At times during 
our study 
period, the area 
was considered 
contaminated as 
a shellfish ban 
was in place.  
Old Silver 
Beach  
OSB 6/9/14, 7/29/14, 
8/12/14, 9/18/14, 
10/27/14, 
12/2/14,2/10/15,4/
13/15, 5/18/15 
High  Large and extremely 
popular beach that has 
many visitors 
recreating in and near 
the water during the 
summer 
Buzzards Bay Falmouth 
Old Silver 
Beach 
 
Will’s Work 
Road Beach  
SCB 6/21/14, 7/31/14, 
8/14/14, 9/11/14, 
10/30/14, 
12/04/14, 
02/25/15, 4/11/15, 
5/22/15 
Low  Small, isolated, hard to 
access beach near 
South Cape Beach on 
Waquoit Bay  
Waquoit Bay,  
Nantucket 
Sound 
Waquoit 
Bay 
Closer to outlet 
of Bay  
Waquoit 
Bay 
National 
Estuarine 
Research 
Reserve 
(WBNERR) 
WB 6/21/14, 7/31/14, 
8/14/14, 9/11/14, 
10/30/14, 
12/04/14, 
02/11/15, 4/11/15, 
5/22/15 
Medium  Research beach that is 
at the top of the Bay, 
isolated due to being 
inside WBNERR, the 
area around WBNERR 
is mostly residential  
Waquoit Bay,  
Nantucket 
Sound 
Waquoit 
Bay 
At top of Bay; 
previously 
studied 
beach(75–79) 
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Waquoit 
Bay 
National 
Estuarine 
Research 
Reserve 
Beach 
Nitrogen 
Removing 
Barrier  
NRB 6/21/14, 7/31/14, 
8/14/14, 9/11/14, 
10/30/14, 
12/04/14, 
02/11/15, 4/11/15, 
5/22/15 
Medium  Same beach as WB, 
but located about 150 
meters down the beach 
and is over a nitrogen 
removing barrier that is 
placed below the sand  
Waquoit Bay,  
Nantucket 
Sound 
Waquoit 
Bay 
Studied to see if 
there were 
differences 
within the 
bacterial 
community 
within the 
nitrogen 
removing barrier 
Bayside 
Drive 
Narrows 
Beach 
BDN 6/21/14, 7/31/14, 
8/14/14, 9/11/14, 
10/30/14, 
12/04/14, 
02/11/15, 4/11/15, 
5/22/15 
High High density 
residential beach in 
Seacoast Shores 
neighborhood, main 
beach for the Seacoast 
Shores Association  
Waquoit Bay, 
Nantucket 
Sound 
Waquoit 
Bay 
Beach nourished 
in April 2014  
Elizabeth 
Island  
SE Gutter, 7 
people 
beach 
EI 9/2/15 Very 
low  
Isolated beach on an 
sporadically inhabited 
island on a small chain 
of islands off of Cape 
Cod and only 
accessible by boat 
Vineyard 
Sound 
Own 
watershed 
Beach sampled 
on only one 
occasion  
  
 
109 
Table 2. Antibiotics and resistance/sensitivity breakpoints used for Vibrio-like isolates in this study.  
 
 
Antibiotic Abbreviation Antibiotic 
Amount 
(µg) 
Antibiotic 
Class (80) 
Mechanism  
(81, 82) 
Sensitive 
(mm)  
Intermediate 
(mm) 
Resistant 
(mm) 
Organism 
From 
Source 
Amoxicillin/ 
Clavulanic acid 
AMC30 20/10 Penicillins  
(Beta 
lactams) 
Cell wall 
synthesis 
≥18 14-17 ≤13 Vibrio 
spp.(49) 
Ciprofloxacin CIP5 5 Quinolones DNA 
gyrase 
≥21,  
 
16-20,  ≤15 
 
Vibrio spp. 
(49) 
Doxycycline D30 30 Tetracycline 30S 
ribosomal 
subunit 
≥14 11-13 ≤10 Enterobacte
riaceae  
(47) 
Oxytetracycline T30 30 Tetracycline 30S 
ribosomal 
subunit 
≥19 15-18 ≤14 Vibrio spp.  
for 
tetracycline   
(49) 
Trimethoprim TMP5 5 Trimethoprim Folic acid 
metabolism 
≥16 11-15 ≤10 Enterobacte
riaceae (47) 
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Table 3. Recovery information (total isolates) for samples (by location, month, and 
sample type).  
 MAR Index included as indicated by Krumperman 1983, calculated by amount of 
resistance/ (5, which is the number of antibiotics tested, X the number of total isolates 
tested).  Amount of resistance is the total number of antibiotics all isolates were resistant 
to.  
Sample Sample 
Location 
Month Sample 
Type 
Amount of 
Resistance 
Total 
Isolates 
MAR Index 
BDN2014-06wet BDN 2014-06 wet 6 5 0.24 
BDN2014-07wet BDN 2014-07 wet 3 3 0.2 
BDN2014-09dry BDN 2014-09 dry 3 2 0.3 
BDN2014-09water BDN 2014-09 water 8 4 0.4 
BDN2014-09wet BDN 2014-09 wet 4 2 0.4 
BDN2014-10dry BDN 2014-10 dry 4 6 0.133333333 
BDN2014-10water BDN 2014-10 water 2 5 0.08 
BDN2014-10wet BDN 2014-10 wet 3 3 0.2 
BDN2014-12dry BDN 2014-12 dry 9 13 0.138461538 
BDN2014-12wet BDN 2014-12 wet 4 6 0.133333333 
BDN2015-02wet BDN 2015-02 wet 0 1 0 
BDN2015-05water BDN 2015-05 water 1 2 0.1 
EI2015-09dry EI 2015-09 dry 14 8 0.35 
EI2015-09water EI 2015-09 water 1 3 0.066666667 
EI2015-09wet EI 2015-09 wet 12 13 0.184615385 
LI2014-08dry LI 2014-08 dry 1 1 0.2 
LI2014-08wet LI 2014-08 wet 2 4 0.1 
LI2014-09dry LI 2014-09 dry 1 4 0.05 
LI2014-09water LI 2014-09 water 9 8 0.225 
LI2014-09wet LI 2014-09 wet 1 4 0.05 
LI2014-10dry LI 2014-10 dry 4 4 0.2 
LI2014-10wet LI 2014-10 wet 1 1 0.2 
LI2014-12dry LI 2014-12 dry 2 3 0.133333333 
LI2015-05dry LI 2015-05 dry 14 6 0.466666667 
LI2015-05water LI 2015-05 water 14 8 0.35 
LI2015-05wet LI 2015-05 wet 13 6 0.433333333 
NRB2014-07dry NRB 2014-07 dry 6 7 0.171428571 
NRB2014-07water NRB 2014-07 water 0 1 0 
NRB2014-07wet NRB 2014-07 wet 2 2 0.2 
NRB2014-08wet NRB 2014-08 wet 3 4 0.15 
NRB2014-09dry NRB 2014-09 dry 9 6 0.3 
NRB2014-09water NRB 2014-09 water 12 6 0.4 
NRB2014-09wet NRB 2014-09 wet 30 15 0.4 
NRB2014-10dry NRB 2014-10 dry 8 5 0.32 
NRB2014-10wet NRB 2014-10 wet 1 2 0.1 
NRB2014-12dry NRB 2014-12 dry 2 2 0.2 
NRB2014-12water NRB 2014-12 water 1 2 0.1 
NRB2015-05dry NRB 2015-05 dry 18 9 0.4 
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NRB2015-05water NRB 2015-05 water 2 1 0.4 
NRB2015-05wet NRB 2015-05 wet 4 4 0.2 
OSB2014-06water OSB 2014-06 water 1 3 0.066666667 
OSB2014-06wet OSB 2014-06 wet 7 5 0.28 
OSB2014-07dry OSB 2014-07 dry 7 3 0.466666667 
OSB2014-07wet OSB 2014-07 wet 12 7 0.342857143 
OSB2014-08water OSB 2014-08 water 7 4 0.35 
OSB2014-08wet OSB 2014-08 wet 6 6 0.2 
OSB2014-09dry OSB 2014-09 dry 1 2 0.1 
OSB2014-09water OSB 2014-09 water 6 3 0.4 
OSB2014-09wet OSB 2014-09 wet 1 4 0.05 
OSB2014-10wet OSB 2014-10 wet 1 1 0.2 
OSB2014-12wet OSB 2014-12 wet 1 1 0.2 
OSB2015-05water OSB 2015-05 water 1 1 0.2 
OSB2015-05wet OSB 2015-05 wet 5 7 0.142857143 
SCB2014-06water SCB 2014-06 water 0 1 0 
SCB2014-07dry SCB 2014-07 dry 3 4 0.15 
SCB2014-07wet SCB 2014-07 wet 4 6 0.133333333 
SCB2014-08dry SCB 2014-08 dry 0 1 0 
SCB2014-08wet SCB 2014-08 wet 3 4 0.15 
SCB2014-09water SCB 2014-09 water 7 3 0.466666667 
SCB2014-09wet SCB 2014-09 wet 10 7 0.285714286 
SCB2014-10dry SCB 2014-10 dry 13 11 0.236363636 
SCB2014-10wet SCB 2014-10 wet 1 2 0.1 
SCB2014-12dry SCB 2014-12 dry 1 3 0.066666667 
SCB2014-12water SCB 2014-12 water 1 2 0.1 
SCB2015-05water SCB 2015-05 water 4 4 0.2 
SCB2015-05wet SCB 2015-05 wet 1 1 0.2 
WB2014-06water WB 2014-06 water 3 7 0.085714286 
WB2014-07dry WB 2014-07 dry 4 6 0.133333333 
WB2014-07wet WB 2014-07 wet 2 3 0.133333333 
WB2014-08dry WB 2014-08 dry 11 7 0.314285714 
WB2014-08wet WB 2014-08 wet 3 3 0.2 
WB2014-09dry WB 2014-09 dry 4 6 0.133333333 
WB2014-09water WB 2014-09 water 5 6 0.166666667 
WB2014-09wet WB 2014-09 wet 6 5 0.24 
WB2014-10wet WB 2014-10 wet 1 3 0.066666667 
WB2014-12dry WB 2014-12 dry 2 5 0.08 
WB2014-12water WB 2014-12 water 5 4 0.25 
WB2014-12wet WB 2014-12 wet 1 2 0.1 
WB2015-02dry WB 2015-02 dry 0 2 0 
WB2015-04wet WB 2015-04 wet 1 1 0.2 
WB2015-05dry WB 2015-05 dry 34 11 0.618181818 
WB2015-05water WB 2015-05 water 1 2 0.1 
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Table 4. Results from PERMANOVA. 
Table indicates permutational multivariate analysis of variance (PERMANOVA (63)). These data do not include the Elizabeth 
Island data because this site was only sampled on one occasion.  Bolded and italicized factors indicate significant results.  
Italics only indicate factors that were pooled.   
 
Dataset Question Factors tested (factor type) Results (p value, variance percentage) 
Isolate 
Matrix 
Does human impact affect 
resistance patterns?  
Human Impact (fixed) 
Month (fixed) 
Sample Location (random) 
(nested in Human Impact) 
Impact (0.062, 4.9144) 
Month (0.158, 5.5496) 
Location (0.414, 1.1559) 
Impact x. Month (0.295, 5.5958) 
Location x Month (0.001,12.166) 
Residual variance: 23.35% 
 Does watershed affect 
resistance patterns? 
Watershed (fixed) 
Month (fixed) 
Sample Location (random) 
(nested in Watershed) 
Watershed (0.132, 6.6189)  
Month (0.232, 5.1202) 
Location (0.101, 3.5609) 
Watershed x. Month (0.12, 9.3582) 
Location x. Month (0.001, 10.975) 
Residual variance: 23.25% 
RI Count 
Matrix 
Does human impact affect 
resistance prevalence?  
Human Impact (fixed) 
Month (fixed) 
Sample Location (random) 
(nested in Human Impact) 
Impact (0.136, 4.3156) 
Month (0.039, 8.6699) 
Location (0.732, -4.2808) 
Impact x. Month (0.615, -3.7195) 
Residual variance: 17.064% 
Pooled Sample Location  
Impact (0.272, 3.0356) 
Month (0.009, 9.7047) 
Impact x. Month (0.518, -1.1029) 
Residual variance: 16.518% 
 Does watershed affect 
resistance prevalence? 
Watershed (fixed) 
Month (fixed) 
Watershed (0.625, -1.2047) 
Month (0.018, 8.4625)  
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Sample Location (random) 
(nested in Watershed) 
Location (0.322, 2.4734) 
Watershed x. Month (0.027, 10.557) 
Residual variance: 14.973% 
Pooled watershed  
Month (0.017, 8.4625) 
Watershed x. Month (0.026, 10.556) 
Residual variance: 14.973% 
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Table 5. Results from PERMANOVA for OTU composition data. 
This table shows permutational multivariate analysis of variance (PERMANOVA (63)) for the OTU composition data.  
These data do not include the Elizabeth Island data because this site was only sampled on one occasion. Bolded and 
italicized factors indicate significant results.  Italics only indicate factors that were pooled.      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dataset Question Factors tested  
(factor type) 
Results (p value, variance percentage) 
OTU 
Location 
Month 
Matrix 
 
 
Does human 
impact affect OTU 
composition? 
Human Impact (fixed) 
Month (fixed)Sample 
Location (random) 
(nested in Impact) 
Impact (0.5, 3.4295) 
Month (0.002, 24.575) 
Location (0.638, -8.3803) 
Impact x. Month (0.399 ,9.2368) 
Residual variance: 51.666% 
Pooled Location  
Impact (0.587, -5.0338) 
Month (0.003, 24.118) 
Impact x. Month (0.327, 10.729) 
Residual variance: 50.982% 
Pooled Impact  
Month (0.001, 24.575) 
Impact x. Month (0.372, 9.2368) 
Residual variance: 51.666% 
 Does watershed 
affect OTU 
composition? 
Watersheds (fixed) 
Month (fixed) 
Location (random) 
(nested in Watershed) 
Watersheds (0.324, 7.3814) 
Month (0.003, 25.166) 
Location (0.678, -7.9841) 
Watershed x. Month (0.125, 20.346) 
Residual variance: 50.101%  
Pooled Location 
Watershed (0.345, 4.7871) 
Month (0.001, 24.525) 
Watershed x. Month (0.074, 11.994) 
Residual variance: 49.46% 
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Table 6. Estimated amount of resistant bacteria ingested.  
Resistant bacteria ingested by individuals participating in a given recreational activity by site for water samples collected in 
September 2014 or September 2015 (for the Elizabeth Island site).  The amount of water ingested in each of these activities 
comes from Leonard et al. 2015.  Amount of resistant bacteria includes the estimates for bacteria resistant to 1,2, or 3 
antibiotics.  Water samples had no isolates that were resistant to four antibiotics.  
Recreational 
activity 
Amount of 
water (ml)  
BDN 
2014-09 
EI 
2015-09 
LI 
2014-
09 
NRB 
2014-09 
OSB 
2014-09 
SCB 
2014-09 
WB 
2014-
09 
Swimming-
children 
37 2.1 x 103 1.1 x 
104 
4.3 x 
103 
3.6 x 104 1.1 x 104 1.3 x 104 1.3 x 
104 
Swimming-adults 16 9.1 x 102 4.6 x 
103 
1.9 x 
103 
1.6 x 104 4.9 x 103 5.6 x 103 5.7 x 
103 
Boating 3.7 2.1 x 106 1.1 x 
103 
4.3 x 
102 
3.6 x 103 1.1 x 103 1.3 x 103 1.3 x 
103 
Rowing 3.5 2.0 x 102 1.0 x 
103 
4.1 x 
102 
3.4 x 103 1.1 x 103 1.2 x 103 1.2 x 
103 
Canoeing 3.9 2.2 x 102 1.1 x 
103 
4.5 x 
102 
3.8 x 103 1.2 x 103 1.4 x 103 1.4 x 
103 
Kayaking 3.8 2.2 x 102 1.1 x 
103 
4.4 x 
102 
3.7 x 103 1.2 x 103 1.3 x 103 13 x 
103 
Fishing 3.6 2.0 x 102 1.0 x 
103 
4.2 x 
102 
3.5 x 103 1.1 x 103 1.3 x 103 1.3 x 
103 
Wading/splashing 3.7 2.1 x 102 1.1 x 
103 
4.3 x 
102 
3.6 x 103 1.1 x 103 1.3 x 103 1.3 x 
103 
Diving 9.9 5.6 x 102 2.9 x 
103 
1.1 x 
103 
9.7 x 103 3.0 x 103 3.4 x 103 3.5 x 
103 
 
 
 
 
 
  
 
116 
Table 7. Estimated amount of resistant bacteria filtered per hour by a variety of shellfish.   
The low and high estimates are based on a range of water filtration capabilities for the organisms.  Amount of resistant 
bacteria includes the estimates for bacteria resistant to 1,2, or 3 antibiotics.  
 
Shellfish 
 
Filtration rate BDN 
2014-09 
EI 
2015-09 
LI 
2014-09 
NRB 
2014-09 
OSB 
2014-09 
SCB 
2014-09 
WB 
2014-09   
L/h ml/h 
       
Crassostrea 
virginica 
Low 
filtration  
2.04 2040 1.2 x 105 5.9 x 105 2.4 x 105 2.0 x 106 6.3 x 105 7.1 x 105 7.2 x 105 
 
High 
filtration  
27 27000 1.5 x 106 7.8 x 106 3.1 x 106 2.6 x 107 8.3 x 106 9.4 x 106 9.5 x 106 
Mercenaria 
mercenaria 
Low 
filtration 
0.3 300 1.7 x 104 8.7 x 104 3.5 x 104 2.9 x 105 9.2 x 104 1.0 x 105 1.1 x 105 
 
High 
filtration  
3.6 3600 2.1 x 105 1.0 x 106 4.2 x 105 3.5 x 106 1.1 x 106 1.3 x 106 1.3 x 106 
Mya arenaria Low 
filtration 
1.7 1700 9.7 x 104 4.9 x 105 2.0 x 105 1.7 x 106 5.2 x 105 5.9 x 105 6.0 x 105 
 
High 
filtration  
7.4 7400 4.2 x 105 2.1 x 106 8.6 x 105 7.3 x 106 2.3 x 106 2.6 x 106 2.6 x 106 
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CHAPTER	4	Heterotrophic	marine	bacteria	from	Cape	Cod	
beaches	harbor	prevalent	amounts	of	antibiotic	resistance		
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INTRODUCTION 
 
Antibiotic resistance is a growing problem with a projected ten million deaths in 
2050 caused by antibiotic resistance (1).  The global, cumulative economic cost of 
antibiotic resistance from 2016 to 2050 would be 100 trillion dollars (1).  Although 
antibiotic resistance in humans is primarily considered to arise from use in clinics and 
hospitals, recently attention has shifted to the interplay of humans, animals, and the 
environment, often called the “One Health Concept”, suggesting that understanding the 
contribution of these other avenues is critical to quantifying and elucidating the problem 
and then employing relevant solutions.  To date, a number of studies have quantified 
antibiotic resistant bacteria in humans and in animals, but the role of the environment lags 
behind in research, especially the marine environment.  The ocean is a vast space and the 
majority of the human population—4 billion people (66%) in 1998—live within 400 km 
of a coast (2).  Humans routinely interact with the ocean through food consumption and 
recreation, and the beach is one venue where these activities occur, illustrating a potential 
transfer area.  
Heterotrophic bacteria—bacteria that fulfill their carbon needs by ingesting organic 
carbon—are prevalent in the ocean (3, 4). These native bacteria may serve as a reservoir 
of antibiotic resistance (AR) genes in the marine environment, either as a natural condition 
or as the result of acquiring them from bacteria that have been introduced to the marine 
environment through anthropogenic activities. Natural environments are the origin of most 
antibiotics used in the clinical environment, and it is therefore unsurprising to also find 
resistance in these regions.  Together, this makes the ocean and beaches a potential venue 
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for transfer of resistance between anthropogenic and natural bacteria, and into humans 
through recreation or food consumption.  
Previous research has found resistance in heterotrophic bacteria in the ocean.  One 
of the first studies illustrated that resistant bacteria could be found in seawater from coastal 
and offshore samples and from surface to deep water samples (8200 m) (5).  A study 
examining the estuarine Lake Gardno in Poland showed that resistance was present and 
prevalence varied largely based on antibiotic (6).  A study in Algiers, Algeria illustrated 
that beaches with anthropogenic inputs had higher levels of resistance compared to less 
impacted sites (7).  A study in São Vicente, Brazil showed a similar trend between beaches 
of high, medium, and low pollution (8).  Mudryk’s studies have also illustrated a similar 
trend within sand on beaches, showing higher resistance on a beach with high human 
activity in Sopot, Poland compared to an isolated beach in a national park near Czolpino, 
Poland (9, 10).  All of these prior studies have firmly established that antibiotic resistant 
bacteria are present at marine beaches, particularly where anthropogenic activity is high; 
but research regarding the diversity and persistence of AR over temporal and seasonal 
scales is still lacking. 
This study seeks to examine the diversity and persistence of antibiotic resistance in 
marine heterotrophs from sand and water over temporal, spatial, and human impact scales 
at the beach.  The hypotheses are that beaches with greater human activity have higher 
occurrences of resistance, and sand samples have higher levels of resistance.  Terrestrial 
sediments are known to have a greater bacterial density (11), which can promote gene 
transfer and has often been a source of new antibiotic discoveries (12).  Winter is expected 
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to have less resistance overall than spring, summer, or fall because of reduced 
temperatures, bacterial numbers and human activity. Estimates of the number of antibiotic 
resistant bacteria filtered by shellfish or ingested by humans through recreation in water 
were calculated to better understand the potential for human exposure to these organisms 
in the marine environment.  The results are discussed with respect to the Vibrio study 
reported on in Chapter 3, to synthesize what has been learned from both efforts. 
METHODS 
 
Site description (Chapter 3,Table 1) and map (Chapter 3, Figure 1), field sampling, and 
sample processing followed the same methods found in Chapter 3.  
Cultivation of heterotrophic bacteria  
Heterotrophic bacteria were cultured by direct plating of water and/or sediment-
PBS mixture onto marine agar 2216 media (Difco).  Serial dilutions were completed and a 
variety of samples were plated from the original sample to 10-4.  100 µl of sample were 
plated.  One plate was chosen for each sample, based ideally on a plate with isolated, 
easily countable colonies.  For each plate, the total colony number was counted, and up 
to three colonies of each morphology type on a given plate were picked.  Picked colonies 
were grown in seawater broth and 800 µl of the culture was added to 200 µl of sterile 
80% glycerol and stored at -80°C as sample stocks.  
Antibiotic resistance testing through minimum inhibitory concentration testing 
Antibiotic resistance testing was completed using the minimum inhibitory 
concentration (MIC) method (13).  This method allows for testing of a wide variety of 
concentrations to obtain a more detailed understanding of MIC.  This method is especially 
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convenient for bacteria that are not well-studied in the clinical environment and do not 
have established clinical procedures, such as marine bacteria (14).   
For this method, bacteria were tested for sensitivity to four antibiotics (amoxicillin, 
ciprofloxacin, doxycycline, erythromycin) at nine different concentrations (0.1, 1, 2, 4, 8, 
16, 32, 64, 100 µg/ml).  Antibiotics were allowed to equilibrate to room temperature for 
two hours to ensure more accurate weighting. Amoxicillin (Research Products 
International) was dissolved in DMSO (Fischer) whereas ciprofloxacin (Alfa Aesar), 
doxycycline (Alfa Aesar, Research Products International), and erythromycin (MP 
Biomedicals) were dissolved in sterile distilled water.  Erythromycin at high concentrations 
often needs ethanol as a solvent, but for the concentrations used here, water worked well 
(Table 1).  All subsequent dilutions were accomplished with seawater media and were 
prepared at double the desired final concentration for dispensing into the culture plates, 
since they would be diluted by the addition of the bacteria cultures.  50 µl of each 
concentration was placed into a well of a sterile, non-tissue culture 96 well plate (USA 
Scientific).  Amoxicillin, ciprofloxacin, and doxycycline plates were placed in a freezer for 
use within two weeks.  Erythromycin plates were made fresh each time and stored in foil 
until use because freezing seemed to reduce the effectiveness of the antibiotic (personal 
observation).  
 Established bacterial controls for assessing plate to plate variability did not exist 
due to the type of bacteria being tested (marine heterotrophs), lack of species 
identification, and the use of seawater broth for growth.  Therefore, controls for the testing 
process were created using selected marine heterotroph cultures.   Cultures were chosen 
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randomly and tested multiple times to ensure reproducibility of MIC values.  The final 
chosen controls had reproducible MIC values and grew well.  A bacterial control was 
included on every plate; and if it did not perform within the standard results, the plate was 
considered a failure. More information on the isolates used for controls is available in 
Table 2.   
 For testing, bacterial isolates were grown from glycerol stocks in seawater broth 
overnight, shaking at 25 °C. Plate setup can be seen in Figure 1, where each row 
represents one tested bacterial isolate.  50 µl of seawater media was added to the plates in 
Column 10 to serve as a positive growth control well.  100 µl of seawater media was 
added to the plates on Column 12 as a sterile (negative) control.  Column 11 remained 
empty.  Each bacterial isolate was adjusted to the MacFarland turbidity standard of 0.5 
(Remel); and 50 µl was added to wells 1-10.  Once all plates were innoculated, they were 
placed in an incubator at 25 °C without shaking for 20 hours with a damp paper towel to 
help maintain moisture levels.  A successful test required the plate bacterial MIC control to 
be within limit, the growth control to have growth, and the sterile control to not have 
growth.  If these conditions were met, the MIC was measured using the definition from 
Wiegland as “MIC is the lowest concentration of the antimicrobial agent that inhibits 
visible growth of the tested isolate as observed with the unaided eye” (13).   
Determination of resistance  
Once the MIC values were recovered, a determination of resistance breakpoints for 
marine heterotrophs was necessary.  To do this, resistance was defined by examining the 
CLSI method to determine all possible definitions of resistance and sensitivity for each 
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antibiotic.  Then, the most stringent option (highest minimum inhibitory concentration) 
was chosen to define resistance for each antibiotic.  Therefore, these values should be a 
fairly conservative estimation of resistance.  Breakpoints are given in Table 1 and are 
represented in Figure 2.  
Other methods 
The arcGIS protocol followed the same methods explained in Chapter 3.  The 
estimations for shellfish filtration and human ingestion also followed the same methods as 
explained in Chapter 3, with the exception that October 2014 samples were used for the 
estimates.  Statistical analysis was the same as conducted in Chapter 3.  
RESULTS 
 
1837 bacterial isolates were collected over the nine sampling occassions at the six 
sites. In order to streamline the testing, one month was chosen to represent each season - 
August, October, February, and May.  This resulted in 952 bacterial isolates, of which 877 
were successfully tested for resistance (Table 3).  The remainder (75) were not successful 
due to inability to regrow after time in freezer, measurements for fewer than four 
antibiotics, or growth and/or contamination problems.  
The four antibiotics tested were chosen to represent a variety of antibiotic groups 
and structural targets. MIC values varied by antibiotic and are shown in Figure 3, along 
with resistance breakpoints.  Isolate amoxicillin MIC values occurred over a wide range 
between 1-8 µg/ml with a large peak at >100 µg/ml.  Ciprofloxacin MICs tended to be 
below 8 µg/ml, but the highest number of isolates had MIC values of 1 µg/ml.  Doxycyline 
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isolate MIC values peak at 64 µg/ml with another large peak at >100 ug/ml.  Erythromycin 
isolate MICs exhibit a bell-shaped distribution with a peak at 16 ug/ml.  
Antibiotic resistance of heterotrophic marine bacteria  
Of the 877 isolates tested, 95% (837 isolates) were resistant to at least one 
antibiotic and 62% (544 isolates) were resistant to more than 1 antibiotic (Figure 3A). 11% 
(104 isolates) were resistant to all four antibiotics.  The amount of resistance varied by 
antibiotic, with doxycycline having the largest number of resistant isolates (90.7%, 796 
isolates; Figure 3B).  The other three antibiotics had lower and more similar levels of 
observed resistance (Figure 3B): ciprofloxacin 42.0% (368 isolates), amoxicillin 36.0% 
(316 isolates) and erythromycin 29.6%  (260 isolates).  Resistance to at least one antibiotic 
by month showed August with 92.3% (120 resistant isolates/ 130 total), October 93.9% 
(232 resistant isolates/ 247 total), February 93.7% (150 resistant isolates/160 total), May 
98.2% (287 resistant isolates / 292 total), and September 100% (48 resistant isolates out of 
48 total, only Elizabeth Island was sampled) (Figure 3C).  
The categorization of resistance (Figure 4) illustrates the types of resistance seen in 
the 877 samples.  Doxycycline resistance was most prevalent ( 29.5% of the samples), 
followed by ciprofloxacin/doxycycline in 13.6% of the samples, resistance to all 
antibiotics in 11.9%,  and amoxicillin/doxycycline in 10.7%.  Resistances that were 
infrequently seen (<1%) were erythromycin, ciprofloxacin/erythromycin, amoxicillin, 
amoxicillin/erythromycin, amoxicillin/ciprofloxacin, and 
amoxicillin/ciprofloxacin/erythromycin.   
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Antibiotic resistance is illustrated by site, season, and sample type in Figure 5. 
Resistance of isolates to at least one antibiotic was prevalent for each particular 
site/season/type categorization (Figure 5).  The lowest value observed was no resistance to 
at least one antibiotic for two groups- OSB 2014-08 wet and SCB 2014-08 dry.  However, 
these sites are based on an isolate number of five or less (Figure 5).  One sample (OSB 
2015-02 wet) did not have any recovered isolates.  
Statistical analysis  
Permutational multivariate analysis of variance (PERMANOVA) was used to assess 
statistical significance of two main questions- 1) Does human impact affect resistance 
patterns/prevalence? and 2) Does watershed affect resistance patterns/prevalence? The 
isolate matrix was used examine resistance patterns with respect to human impact and 
showed that month (accounting for 6.9% of the variance), sample type (4.6 % of the 
variance), and the interaction of month and type (8.7% of the variance) were significant in 
affecting resistance prevalence (Table 4).   Impact and location were not significant (Table 
3).  In the second test to determine resistance patterns by watershed, watershed was not 
significant (Table 4).  Month (7.1% of the variance) and the interaction of month and type 
(8.7% of the variance) were significant, even when location was pooled as a factor.  
 To examine prevalence, the resistant isolate (RI) count matrix was used.  Here, this 
showed month as the only significant factor (7.1% of the variance) in answering the 
question of human impact, even when other factors were pooled (Table 4). To examine 
resistance prevalence by watershed, initially month showed significance, but dropped out 
when factors were pooled, leaving no factors with significance. 
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Distance-based linear models (DISTLM) were used to compare resistance data with 
environmental data of three types: 1) land use in an 840 meter radius around the sites 
(called proximity land use), 2) land use in the watershed, and 3) environmental variables 
collected at the time of sampling. 840 meters was chosen as the radius because it allowed 
for the largest amount of space without overlap from sites (barring the WB and NRB that 
are on the same site).  For proximity land use, the percentage of the population male was 
the variable that explained the most variance, although it was a very small amount of the 
total variability (0.092%).  For watershed land use, the best model was a one variable 
model with percentage of urbanized land use as the explanatory variable with 1.13% of 
the variability.  A close second was the mean median age of the watershed explaining 
1.08% of the variability.  For the environmental variables, the best model had a single 
variable of dissolved oxygen with 3.2% of the total variation.  Two close models were one 
with amount of sunlight and dissolved oxygen (4% total variation) and amount of sunlight 
and temperature (4% total variation).  
Ingestion and filtration estimates  
 
 Ingestion estimates of resistant bacteria for humans participating in recreational 
activities were made from the amount of resistant bacteria per milliliter determined from 
plate counts and previous literature estimates of how much water a person ingests during 
various activities.  SCB was the site with the highest values of resistant cells (2 x 104 
resistant bacteria per ml) and LI had the lowest (1.9 x 103 resistant bacteria per ml).  
Swimming is the activity that results in ingestion of the most water.  Children ingest 
more than two times the amount of water (37 ml) ingested by adults (16 ml).  Rowing has 
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the lowest amount at 3.5 ml.  Overall, estimates of bacteria ingested for each activity had 
a wide range from 6.6 x 103 – 7.3 x 105 resistant cells ingested per activity (Table 5). 
 Filtration estimates were also produced for three common shellfish in the area.  
Using published values of low and high filtration rates, estimates were made of the 
amount of resistant bacteria a shellfish would filter in one hour.  Mercenaria mercenaria 
has the lowest filtration rate of 300 ml/hour whereas Crassostrea virginica has the highest 
rate at 2700 ml/h.  Resistant cells filtered in one hour ranged from 5.6 x 105 to 5.3 x 108 
(Table 6).  
DISCUSSION 
Resistance is widespread in studied heterotrophic marine bacteria. 
 
 In this study, results obtained using conservative measures of resistance showed 
that antibiotic resistance was prevalent in the studied samples, with 95% of isolates 
resistant to at least one antibiotic and 12% resistant to all four antibiotics. These results are 
slightly higher, but in general are within the results from previously published literature.  
At marine beach sites in Brasil, Cardoso de Olivera et al. (8) found resistance to at least 
one antibiotic in 35.3%, 77.7%, and 80.6% of samples from three different sites.  Another 
study conducted at an isolated marine beach that humans rarely visit found 70% of 
isolates resistant to at least one antibiotic (10). As a comparison with a putatively “un-
impacted” environment, 90% of the bacterial isolates from a study of deep terrestrial 
subsurfaces were found resistant to at least one antibiotic, despite the sites being 170-259 
meters below the surface of the ground (15).   
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 In addition, it seems likely that the high amounts of resistance found in this study 
may indicate that antibiotic interactions in the coastal ocean are common and that the 
coastal ocean has reached exposure saturation with antibiotic input from both 
anthropogenic and natural inputs.  The lack of human impact differences could be due to 
this saturation.     
Resistance varies by antibiotic.   
Since the amount of resistance is dependent on the antibiotics studied and their 
mechanisms of action (6), this study examined four antibiotics with different mechanisms 
of action (Table 2).  Doxycycline resistance was prevalent with a majority of the isolates 
resistant to this antibiotic (Figure 4B). Ciprofloxacin and amoxicillin resistance were lower, 
41.9% and 36.0% respectively.  Erythromycin has the lowest value with 29.6%.  Previous 
studies indicate that in Lagos Lagoon, Nigera, resistance was measured as 10-29% for 
amoxicillin, no resistance for ciprofloxacin, and 0-25% for erythromycin, with fluctuations 
depending on the site (16).  In sand at an isolated marine beach, resistance to amoxicillin 
was 23%, ciprofloxacin 18%, doxycycline 3%, and erythromycin 18% (10).  For Brazilian 
beaches in São Vicente, resistance prevalence values varied depending on the individual 
beach and ranged from 0 to 20.8% for amoxicillin, 0 to 25% for ciprofloxacin, and 0 to 
33.3% for erythromycin (8).  For doxycycline, 20% resistance was found in Gdansk Deep 
(17) while 7% was found at a recreational marine beach on the Baltic Sea (9) and 71% 
isolates were resistant to doxycycline in the estuarine Lake Garno (6). For erythromycin, 
Baya et al. (18) studied sewage effluent, outfall diffusers, and coastal waters, with an 
average value of 27.5% resistance to erythromycin; but individual sites varied from 0 to 
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67.8% with the lowest value at the coastal ocean and the highest value in the effluent.  In 
general, the results from the current study fall well within the ranges seen in other marine 
work, though the value for doxycycline is higher than previous studies.  One possible 
factor that might influence the doxycycline resistance prevalence is that Lyme disease is 
fairly common on Cape Cod, and New England in general, and doxycycline is the primary 
antibiotic used to treat the infection. 
Mechanism of resistance may be driving high values of resistance for antibiotics.  
In this study, resistance as a phenotypic response was measured, but no 
information about the actual mechanism of resistance was obtained.  Understanding the 
mechanism would identify whether the resistance is gene-based or related to cellular 
mechanisms that are are not specific for a particular antibiotic (e.g. efflux pumps).  All 
antibiotics used in this study were selected because they should be effective on either 
Gram positive or Gram negative bacteria.  Gram negative bacteria are intrisically resistant 
to some antibiotics (e.g. vancomycin); and many marine bacteria are Gram negative, such 
as Pelagibacterales (otherwise known as SAR11 (19)).   
Previous research has shown that marine bacteria (the order Vibrionales) readily 
produce inhibitory molecules and are resistant to them (20).  Research by Cordero showed 
that within the family Vibrionaceae, few bacteria produce antibiotics whereas most are 
resistant (21).  The researchers took this as evidence of collaboration within the bacterial 
group, where many could benefit from the production of a compound without expending 
resources.  This study adds further evidence for the existence of antibiotic resistance in the 
ocean, and therefore also suggests antibiotics are likely present.  In this light, it seems 
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reasonable to see antibiotic production and resistance as part of the larger evolutionary 
interests and benefits to the bacterium.   
Bacteria have efflux pumps that pump chemicals out of the cell and can be general 
or specific in transportation processes. There are currently five main efflux pump families: 
ATP-binding cassette (ABC), major facilitator superfamily (MFS), resistance/nodulation/cell 
divison (RND), small multidrug resistance (SMR), and multidrug and toxic compound 
extrusion (MATE) (22, 23). These efflux pumps allow for movement of antibiotics (and 
other chemicals) out of the cell, but may also meet a variety of other cellular survival 
needs including: virulence, pathogencity, quorum sensing, detoxification, and biofilm 
formation (22, 24). With this in mind, efflux pumps are highly conserved, present in all 
living things, and may be considered “evolutionarily ancient elements” (22).  Efflux pumps 
are believed to be prevalent in bacterial genomes.  One estimate is that efflux pumps 
represent 10% of all transporters in a cell (22).  Transporters are genes that move materials 
in the cell, of which efflux pumps are one such transporter type. Another estimate is that 
5-10% of all genes deal with transport (25).   
Multi-drug efflux pumps are problematic in the clinic because they allow for 
resistance to a variety of antibiotics and increase difficulty in treating resistant infections 
(26).  In the marine environment, treatment for infections is less prevalent than in the 
clinics.  However, a metagenomic study found that a dominant mechanism of resistance 
in environmental samples, including some from the ocean, was through efflux pumps (27).  
Further, efflux pumps are effective with Gram negative bacteria (23) and the marine 
bacterial community is dominant with Gram negative bacteria (19).  Therefore, it may be 
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that the large amounts of resistance seen here in the coastal ocean could be due to 
prevalence of efflux pumps.  This hypothesis would require research into uncovering 
specific resistance mechanisms in marine bacteria.   
Ingestion and filtration estimates show interactions with resistant bacteria are common.  
Like in Chapter 3, ingestion and filtration estimates from this study indicate that 
humans and shellfish readily interact with marine bacteria.  Not surprisingly, there are 
more interactions with resistant heterotrophs per ml of water than resistant Vibrio-like 
bacteria. Compared to the total number of bacteria ingested, these resistant heterotrophic, 
culturable bacteria represent between 0.02 to 0.2% of the total bacteria present per 
milliliter of water (assuming 107 cells per milliliter).  While this is higher than the amount 
for Vibrio-like bacteria, it is still an extremely low percentage.  Further research needs to 
be done to determine if this low comparative abundance reduces potential risk.  
In this study, the fact that month and season were significant in structuring 
heterotrophic antibiotic resistance supports the hypothesis that changes in bacterial 
community composition may influence resistance patterns.  Because heterotrophic 
bacteria are likely a diverse collection of species, bacterial groups may be differently 
affected by particular land use or environmental characteristics, which would be masked 
by examining them as a large, homogenous group. Sequencing to identify the isolates may 
provide insights to whether there are patterns of resistance related to the types of bacteria 
present. 
 In contrast, human impact, land use, and environmental variables accounted for 
little of the variation observed in antibiotic resistance patterns of heterotrophic marine 
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bacteria. Other studies have found differences in levels of antibiotic resistance related to 
human impact in the marine environment.  Three studies on beaches in Brazil, in Algeria, 
and in Poland found greater resistance on beaches with increased human influence (7–
10).  Miller et al. (28) showed that in Antarctica, there was increased AR in areas near to 
the Palmer Station, and that multiple resistance was low in pristine environments.  
It may be that at the sites chosen for this study, the proposed impacts do not have 
enough variation to produce a difference in amounts of antibiotic resistance or types of 
resistance, and that sites more directly impacted by point source pollution would be 
needed to see a measurable difference. Impact in this area may be so widespread that a 
sufficiently pristine control (such as Antartica or deep sea marine sediments) is not 
available within the region.   
Alternatively, it may be that resistance itself is more prevalent in the marine 
environment than previously thought. Other studies in isolated regions have found higher 
than anticipated amounts of antibiotic resistance.  At the Lucky Strike hydrothermal vent 
field, Farias et al. (29) found that resistance is widespread in the marine environment 
regions without human impact.  In studying Arctic fjords, there was a higher prevalence of 
resistance than anticipated, and higher values in sediment compared to water (30).  In 
Gdansk Deep in the Baltic Sea, Mudryk et al. (17) found that many bacteria carried 
multiple antibotic resistances.  Finally, Sizemore and Colwell (5) found resistant bacteria 
at nearshore and deepsea samples, and that coastal areas lended themselves to having 
more resistant bacteria in terms of samples, but not by percentage.   
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Antibiotic resistance in Vibrio and heterotrophic bacteria  
 This study, and the study on Vibrio in Chapter 3, evaluated antibiotic resistance at 
the same sites.  These heterotrophic and Vibrio-like isolates have been functionally 
defined by the isolation media used.  Marine agar 2216 was used for heterotrophs and 
thiosulfate citrate bile salts sucrose (TCBS) for Vibrio-like bacteria. Disk diffusion was used 
for the Vibrio-like bacteria; the minimum inhibitory method was utilized for the 
heterotrophs. The heterotrophs represent one large group of bacteria, whereas as the 
Vibrio-like group represents a specific group within the larger framework.  While the 
studies did not use the same methodology to test resistance, general similarities and 
differences can be drawn from these results. 
In terms of resistance, heterotrophs were more resistant on the whole (95% resistant 
to at least one antibiotic) compared to Vibrio-like bacteria (73% resistance to at least one 
antibiotic).  Resistance to all antibiotics tested was more prevalent for heterotrophs, with 
11.9% of isolates resistant to all four tested antibiotics, whereas no Vibrio-like bacteria 
were resistant to all five of the tested antibiotics. For both groups, there were small 
variations by location, but no significance.  Temporally resistant Vibrio-like bacteria were 
less likely to be found in the winter, whereas the recovery of heterotrophs stayed fairly 
constant throughout the year. Finally, there were three antibiotics that were tested for both 
groups: amoxicillin, ciprofloxacin, and doxycycline.  Amoxicillin and ciprofloxacin 
resistance prevalences were fairly close between groups, while doxycycline resistance was 
very high in heterotrophs and very low in Vibrio-like bacteria.  These antibiotics do not 
have similar chemical structures (31). This illustrates the potential differences in 
resistances present within different marine bacteria, and more needs to be understood 
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about mechanisms of action for these resistances to understand what may be driving this 
difference.  One potential option might be that for the heterotrophs, the mechanism that 
provides resistance to doxycycline may confer a benefit that helps them survive.  This may 
not be the case for the Vibrio-like bacteria, and could even exert a cost that reduces their 
ability to survive.  
Environmental variables more readily explained the resistance variations for Vibrio 
(12.93%) then for heterotrophs (3.26%).  Since Vibrio-like bacteria are a more specific 
group, it may be easier to observe community structure and its drivers, whereas 
heterotrophs are a diverse, mixed group, masking potential differences.  These differences 
may be explored further through 16S ribosomal sequencing of the heterotrophs, allowing 
testing for different genera or species.  
CONCLUSION 
 
Taken together, results from this study and others suggest that resistance is 
prevalent in the coastal marine environment , and that high levels of resistance may be 
due to resistance serving other critical roles in the survival of marine bacteria.  While all of 
the studies discussed here tested different types of bacteria and different antibiotics, they 
ultimately paint an overall picture of widespread and abundant antibiotic resistance in 
environments with and without anthropogenic impact.  Furthermore, resistance is 
prevalent in environmental groups of bacteria.  While they do not generate the immediate 
public health concerns that pathogenic bacteria do, the fact that they grow and disperse 
means that they can propogate and share resistance with other environmental bacteria as 
well as pathogenic bacteria.  This result suggests a need to examine environmental areas 
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for emerging resistances that may be transferred to pathogens in order to understand 
potentially upcoming clinical resistances.  From an ecological perspective, it encourages 
renewed interest in the role that mechanisms of resistance play, why they are so prevalent 
in the marine enviornment, and what factors may be driving this prevalence.  
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Figure 1. Minimum inhibitory concentration. 
 96 well plate setup for a plate testing a particular antibiotic.  Growth refers to growth control, sterile refers to sterile control.  96 well plate image 
from: http://ideastocker.com/54-96-well-plate-template-gallery/96-well-plate-template-ideal-pics-plate-96-well-plate-template/ 
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Figure 2. Minimum inhibitory concentration (MIC) values. 
 MIC in µg/ml for heterotrophic bacteria for a.) Amoxicillin, b.) Ciprofloxacin, c.) Doxycycline, and d.) Erythromycin.  The 
black line indicates the breakpoint for resistance therefore, to the right of the black line indicates resistant isolates.
  
 
140 
 
 
  
 
141 
 
Figure 3: Resistance summary.   
A) percentage of isolates resistant to 0,1, or more antibiotics.  B) percentage of isolates 
resistant to each of the four tested antibiotics. C) percentage of isolates resistant to at least 
one antibiotic during each month. 
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Figure 4. Percentage of resistant data illustrating prevalence of resistance categorization.  
 Resistance categorization can include resistance to 0, 1, 2, 3, or 4 antibiotics.       
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Figure 5. The proportion of isolates resistant to at least 1 antibiotic (y-axis) over time (axis).   
Each graph indicates a different site and sample type.  If all isolates from a sampling time point were sensitive to all 
antibiotics, a black dash is shown.  An empty point indicates no samples from that sampling time were recovered for testing.  
Less than symbols indicate samples with 5 or fewer isolates. 
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Table 1. Antibiotics and resistance/sensitivity breakpoints used for isolates in this study.  
                                                        
1 HACEK: The Aphrophilus cluster of the Genus Haemophilus (i.e. H. aphrophilus, H. paraphrophilus, H. segnis), Actinobacillus 
actinomycetemcomitans, Cardiobacterium spp., Eilenella corrodens, and Kingella spp.) 
Antibiotic Antibiotic 
Class  
(37) 
Mechanism  
(12, 38) 
Activity 
(12) 
Solvent 
for 
antibiotic 
(39) 
Breakpoint for 
resistance 
Organisms from the CLSI 
guidelines with this breakpoint 
(14, 40) 
Amoxicillin 
 
Penicillins  
(Beta-
lactams) 
Cell wall 
synthesis 
Broad-
spectrum 
DMSO 32 Enterobacteriaceae 
Ciprofloxacin Quinolones DNA 
gyrase 
Broad 
spectrum 
Water 4 Entererobacteriaceae 
Pseudomonas aeruginosa  
Acinetobacter 
Non-Enterobactericeae 
Staphylococcus 
Enterococcus 
Abiotrophia/Granulicatella 
Aeromonas hydrophia complex 
& Plesiomonas shigelloides 
Bacillus spp (other than B. 
anthracis) 
Campylobacter jejuni/coli 
Corynebaterium 
HACEK group1  
Vibrio spp (not V. cholerae) 
Doxycycline Tetracycline 30S 
ribosomal 
subunit 
Broad 
spectrum 
Water 16 Enterobacteriaceae 
Acinetobacter 
Non-Enterobactericeae 
Staphylococcus 
Enterococcus 
Corynebacterium 
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Erythromycin  Macrolides 50S 
ribosomal 
subunit 
Broad-
spectrum 
Water 32 Campylobacter jejuni/coli 
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Table 2. Bacterial controls used for MIC antibiotic resistance testing.  
 
Control 
Number 
Control Name Antibiotic MIC Acceptable MIC 
values 
2048 EI 90215 wet 2 
 
Amoxicillin >100 100, >100 
1851 SCB 52215 wet H6 
 
Ciprofloxacin 4 2-8 
2048 EI 90215 wet 2 
 
Doxycycline >100 100, >100 
516 OSB 81214 WH6 
 
Erythromycin 8 4-16 
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Table 3. Isolate recovery.   
Total number of isolates recovered and tested along with the percentage of isolates 
completed.   
 
Sample Total Isolates 
(number) 
Tested Isolates 
(number) 
Completed (%) 
BDN 2014-08 dry 5 5 100 
BDN 2014-08 water 7 6 85.7 
BDN 2014-08 wet 6 6 100 
BDN 2014-10 dry 16 16 100 
BDN 2014-10 water 16 14 87.5 
BDN 2014-10 wet 11 9 81.8 
BDN 2015-02 dry 13 11 84.6 
BDN 2015-02 water 7 7 100 
BDN 2015-02 wet 8 8 100 
BDN 2015-05 dry 24 24 100 
BDN 2015-05 water 12 12 100 
BDN 2015-05 wet 25 18 72 
EI 2015-09 dry 23 23 100 
EI 2015-09 water 12 12 100 
EI 2015-09 wet 14 13 92.9 
LI 2014-08 dry 3 2 66.7 
LI 2014-08 water 3 3 100 
LI 2014-08 wet 6 6 100 
LI 2014-10 dry 26 26 100 
LI 2014-10 water 15 14 93.3 
LI 2014-10 wet 16 14 87.5 
LI 2015-02 dry 8 8 100 
LI 2015-02 water 7 4 57.1 
LI 2015-02 wet 12 11 91.7 
LI 2015-05 dry 17 17 100 
LI 2015-05 water 12 10 83.3 
LI 2015-05 wet 13 12 92.3 
NRB 2014-08 dry 21 19 90.5 
NRB 2014-08 water 5 5 100 
NRB 2014-08 wet 12 12 100 
NRB 2014-10 dry 8 7 87.5 
NRB 2014-10 water 14 14 100 
NRB 2014-10 wet 16 11 68.75 
NRB 2015-02 dry 14 13 92.9 
NRB 2015-02 water 3 3 100 
NRB 2015-02 wet 8 8 100 
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NRB 2015-05 dry 21 21 100 
NRB 2015-05 water 19 19 100 
NRB 2015-05 wet 21 21 100 
OSB 2014-08 dry 19 17 89.5 
OSB 2014-08 water 9 8 88.9 
OSB 2014-08 wet 4 2 50 
OSB 2014-10 dry 19 15 78.9 
OSB 2014-10 water 19 18 94.7 
OSB 2014-10 wet 13 12 92.3 
OSB 2015-02 dry 9 9 100 
OSB 2015-02 water 14 13 92.9 
OSB 2015-05 dry 16 14 87.5 
OSB 2015-05 water 19 18 94.7 
OSB 2015-05 wet 12 11 91.7 
SCB 2014-08 dry 3 3 100 
SCB 2014-08 water 7 7 100 
SCB 2014-08 wet 8 6 75 
SCB 2014-10 dry 18 17 94.4 
SCB 2014-10 water 7 7 100 
SCB 2014-10 wet 16 15 93.75 
SCB 2015-02 dry 19 18 94.7 
SCB 2015-02 water 13 11 84.6 
SCB 2015-02 wet 15 14 93.3 
SCB 2015-05 dry 17 16 94.1 
SCB 2015-05 water 14 14 100 
SCB 2015-05 wet 19 18 94.7 
WB 2014-08 dry 6 4 66.7 
WB 2014-08 water 5 5 100 
WB 2014-08 wet 15 14 93.3 
WB 2014-10 dry 17 15 88.2 
WB 2014-10 water 14 9 64.3 
WB 2014-10 wet 16 14 87.5 
WB 2015-02 dry 10 10 100 
WB 2015-02 water 11 10 90.9 
WB 2015-02 wet 2 2 100 
WB 2015-05 dry 18 17 94.4 
WB 2015-05 water 12 12 100 
WB 2015-05 wet 18 18 100 
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Table 4. Results from permutational multivariate analysis of variance (PERMANOVA) in Primer.  
These data do not include the Elizabeth Island data because this site was only sampled on one occasion.  Bolded and 
italicized factors indicate significant results.  Italicized only indicates factors that were pooled.  
  
Dataset Question Factors tested (factor type) Results (p value, variance percentage) 
Isolate Matrix Does human impact affect 
resistance patterns?  
Human Impact (fixed) 
Month (fixed) 
Sample Location (random) 
(nested in Human Impact) 
Sample Type (random) 
(nested in Sample Location) 
Impact (0.803, -2.0073) 
Month (0.007, 6.8562) 
Location (0.425, 1.0013) 
Impact x. Month (0.831, -3.7642) 
Type (0.001, 4.5923) 
Location x Month (0.087, 4.955) 
Month x. Type (0.001, 8.6691) 
Residual variance: 19.121% 
 
Pooled Impact  
Month (0.005, 6.8562)  
Impact x. Month (0.839, -3.7642)  
Type (0.001, 4.5923) 
Month x. location (0.086, 4.955) 
Month x. type (0.001, 8.6691) 
Residual variance: 19.121% 
 Does watershed affect 
resistance patterns? 
Watershed (fixed) 
Month (fixed) 
Sample Location (random) 
(nested in Watershed) 
Sample Type (random) 
(nested in Sample Location) 
Watershed (0.201, 3.0086)  
Month (0.016, 7.1149) 
Location (0.905, -2.7525) 
Watershed x. Month (0.882, -5.0254) 
Type (0.001, 4.5923)  
Location x. Month (0.065, 5.4856) 
Month x. Type (0.001, 8.6691)  
Residual variance: 19.121% 
 
Pooled Location  
Watershed (0.163, 2.2547) 
Month (0.024, 7.1149) 
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Watershed x. month (0.88, -5.0254) 
Month x. location (0.043, 5.4856) 
Month x. type (0.001, 8.6691) 
Residual variance: 19.121 
RI Count 
Matrix 
Does human impact affect 
resistance prevalence?  
Human Impact (fixed) 
Month (fixed) 
Sample Location (random) 
(nested in Human Impact) 
Sample Type (random) 
(nested in Sample Location) 
Impact (0.952, -1.4884) 
Month (0.01, 7.1374) 
Location (0.677, -2.5461) 
Impact x. Month (0.403, 1.8553) 
Sample Type (0.606, -2.635) 
Month x. Type (0.234, 4.5832) 
Residual variance: 16.562% 
 
Pooled Sample type 
Impact (0.934, -1.3807)  
Month (0.006, 7.2326)  
Location (0.815, -3.0815)  
Impact x month (0.42, 2.2516) 
Month x. location (0.182, 4.6667) 
Residual variance: 16.351% 
 
Pooled Location 
Impact (0.726, -2.1694) 
Month (0.005, 7.1374) 
Impact x. Month (0.426, 1.8553) 
Month x. Location (0.241, 4.5832) 
Residual variance: 16.562 
 
Pooled Impact  
Month (0.011, 7.1374) 
Impact x. Month (0.437, 1.8553)  
Sample Type (0.648, -2.635) 
Month x. Location (0.208, 4.5832) 
Residual variance: 16.562%  
 Does watershed affect Watershed (fixed) Watershed (0.165, 4.1049) 
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resistance prevalence? Month (fixed) 
Sample Location (random) 
(nested in Watershed) 
Sample Type (random) 
(nested in Sample Location) 
Month (0.024, 7.9884)  
Location (0.949, -3.7711 
Watershed x. Month (0.236,5.4489) 
Sample type (0.625, -2.635) 
Month x. Location (0.303, 3.7651) 
Residual variance: 16.562% 
 
Pooled Sample Type 
Watershed (0.166, 4.2208)  
Month (0.021, 8.0297)  
Location (0.993, -4.1455) 
Watershed x. month (0.212, 5.5031)  
Month x. location (0.271, 3.9999)  
Residual variance: 16.351% 
 
Pooled Sample Location 
Watershed (0.105, 3.2492) 
Month (0.028, 7.9884) 
Watershed x. month (0.228, 5.4489)  
Month x. location (0.288, 3.7651) 
Residual variance: 16.562% 
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Table 5. Estimated amount of resistant bacteria ingested. 
Ingested bacteria by individuals participating in a given recreational activity by site for water samples collected in October 
2014.  The amount of water ingested in each of these activities comes from Leonard (41). Amount of resistant bacteria 
includes the estimates for bacteria resistant to 1,2, 3, or 4 antibiotics.  
 
Recreational 
activity 
Amount of 
water (ml)  
BDN 2014-
10 water 
LI 2014-10 
water 
NRB 2014-10 
water 
OSB 2014-
10 water 
SCB 2014-
10 water 
WB 2014-
10 water 
Swimming-children  
37 1.6 x 105  6.9 x 104 1.6 x 105 4.8 x 105 7.3 x 105 18 x 105 
Swimming-adults  
16 7.1 x 104  3.0 x 104 6.9 x 104 2.1 x 105 3.2 x 105 7.7 x 104 
Boating  
3.7 1.6 x 104 6.9 x 103 1.6 x 104 4.8 x 104 7.3 x 104 1.8 x 104 
Rowing  
3.5 1.6 x 104 6.6 x 103 1.5 x 104 4.6 x 104 6.9 x 104 1.7 x 104 
Canoeing  
3.9 1.7 x 104 7.3 x 103 1.7 x 104 5.1 x 104 7.7 x 104 1.9 x 104 
Kayaking  
3.8 1.7 x 104 7.1 x 103 1.6 x 104 5.0 x 104 7.5 x 104 1.8 x 104 
Fishing  
3.6 1.6 x 104 6.8 x 103 1.6 x 104 4.7 x 104 7.1 x 104 1.7 x 104 
Wading/splashing  
3.7 1.6 x 104 6.9 x 103 1.6 x 104 4.8 x 104 7.3 x 104 1.8 x 104 
Diving  
9.9 4.4 x 104 1.9 x 104 4.3 x 104 1.3 x 105 2.0 x 105 4.8 x 104 
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Table 6. Estimated amount of resistant bacteria filtered per hour by a variety of shellfish.   
The low and high estimates are based on a range of water filtration capabilities for the organisms.  Amount of resistant 
bacteria includes the estimates for bacteria resistant to 1,2,3, or 4 antibiotics.  
 
Shellfish 
 
Filtration 
rate 
 
BDN 
2014-
10 
water 
LI 
2014-
10 
water 
NRB 
2014-10 
water 
OSB 
2014-
10 
water 
SCB 
2014-10 
water 
WB 
2014-10 
water 
  
L/h ml/h 
      
Crassostrea 
virginica 
Low 
filtration 
rate 
 
2.04 
 
2040 9.0 x 
106  
3.8 x 
106 8.8 x 106  
2.7 x 
107 4.0 x 107 9.8 x 106   
High 
filtration 
rate 
 
27 
 
27000 1.2 x 
108  
5.1 x 
107  1.2 x 108 
3.5 x 
108 5.3 x 108 1.3 x 108 
Mercenaria 
mercenaria 
Low 
filtration 
rate 
 
0.3 
 
300 1.3 x 
106 
5.6 x 
105 1.3 x 106  
3.9 x 
106  
5.9E x 
106 1.4 x 106   
High 
filtration 
rate 
 
3.6 
 
3600 1.6 x 
107  
6.8 x 
106  1.6 x 107 
4.7 x 
107 7.1 x 107 1.7 x 107 
Mya arenaria Low 
filtration 
rate 
 
1.7 
 
1700 7.5 x 
106 
3.2 x 
106  7.3 x 106  
2.2 x 
107 3.4 x 107 8.2 x 106   
High 
filtration 
rate 
 
7.4 
 
7400 3.3 x 
107  
1.4 x 
107 3.2 x 107 
9.7 x 
107 1.5 x 108 3.6 x 107 
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CHAPTER 5 Diversity of antibiotic resistance associated genes and 
elements in coastal marine metagenomes 
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Introduction 
In recent years, a greater understanding of the environment as a reservoir for 
antibiotic resistance has emerged.  Within this idea are two important subtopics.  One is 
that anthropogenic use of antibiotics can allow antibiotics and antibiotic resistant bacteria 
to enter into natural environments (1).  The second is often forgotten, that resistance is a 
natural process that has existed long before humans ever started utilizing antibiotics for 
their own needs (2, 3).  This idea of the innerconnectedness between humans and the 
natural environment, along with animals, is often called the “One Health” concept and 
views that these areas should be studied as one connected system instead of separate 
spheres that do not overlap.  
The ocean is both a natural environment, containing native bacteria with antibiotic 
resistance genes (ARGs) and also often a dumping ground for anthropogenic waste, 
including industrial and wastewater pollution.  Industrial pollution often includes metals, 
which are believed to allow for co-selection to antibiotic resistance (4, 5). One study from 
2000 showed that a stream affected by industrial pollution had higher levels of resistance 
compared to the reference stream (6). Wastewater pollution represents a more direct 
antibiotic impact from humans as up to 90% of these drugs are excreted in waste products 
(7) and most wastewater facilities are not able to remove these chemicals due to the high 
cost and effort necessary. Wastewater treatment plants are also known to be hotspots for 
antibiotic resistance transfer (8) and have increased resistance downstream of a given 
wastewater plant compared to upstream (9). These results indicate that higher levels of 
resistance may be present in coastal marine environments that have been affected by 
industrial and/or wastewater pollution. 
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Sequencing technology has transformed biology and allowed for a greater 
understanding of the microbial world that otherwise can be invisible and difficult to 
culture.  Metagenomics, or the sequencing of DNA directly from the environment, is 
critical in the understudied marine environment.  Metagenomics in the ocean has allowed 
discoveries of novel enzymes (10, 11) to nitrogen fixing microbes in the surface ocean (12) 
to strategies of marine viruses (13). Even more discoveries can be anticipated as 
sequencing becomes less expensive and more accessible, allowing for experiments that 
once seemed unattainable to become reality.   
With respect to antibiotic resistance (AR), metagenomics facilitates the detection of 
both known and novel resistance genes from environmental samples, where it is estimated 
that only ~1% of the bacteria are successfully cultured (14–16).  The caveat for this 
method is that metagenomics only allows for assessment of AR potential because it is 
unknown if resistance is being actively expressed in a particular organism or when that 
occurred. Port et al 2012 used early sequencing technology to elucidate 18 antibiotic 
resistance determinants in coastal samples (17) and an expanded study illustrated that site 
and season were important in determining the amount of resistance determinants (18).  
Nesme et al. 2014 completed a meta-analysis showing that resistance was present in 
ocean samples and in fact, every environmental sample surveyed (19). In a more recent 
study, Uyaguari-Diaz et al found fewer types and copies of ARGs in low impact freshwater 
environmental samples, while more impacted samples had greater abundance and 
diversity of resistance (7).  Hatsoy and Martiny studied antibiotic resistance genes in the 
ocean through the use of functional metagenomics, cloning DNA from an environmental 
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sample into E.coli and then selecting and sequencing isolates demonstrating resistance to 
specific antibiotics (20).  They found a variety of known and unknown resistance genes, 
providing evidence of the ocean not only as a reservoir for resistance to antibiotics but as 
a potential source for new resistance.   
This study seeks to better describe the diversity and distribution of antibiotic 
resistance genes in coastal marine environments with different environmental conditions.  
Samples were collected from sites with industrial or wastewater pollution impacts, as well 
as unimpacted sites deemed as reference sites, to compare the effect of these different 
conditions on ARG diversity and abundance.  The diversity and abundance of ARGs are 
examined by using metagenomic sequence analysis.  Samples of sediment and water not 
only allow an understanding of what resistance genes are present, but can also serve as a 
proxy for time. Understanding the diversity and prevalence of ARG facilitates better 
interpretation of humans’ interaction with, and influence on, aquatic systems and how it 
may result in the environment playing a role in the persistence and spread of antibiotic 
resistance. Environments with more anthropogenic environmental impact likely have 
overall a greater abundance of resistance genes.  Previous research showed lower relative 
abundance and diversity in unimpacted samples (7).   Therefore the less anthropogenically 
impacted environmental samples in this study could have fewer ARGs and reduced 
diversity compared to more impacted environments.    
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METHODS 
Study Sites  
Samples were collected from ten sites: Charles River, New Bedford Harbor, Plymouth, 
West Falmouth Harbor, Little Island, Race Point Beach, Falmouth Wastewater Treatment 
Influent and Effluent, Boston Harbor, and Boston Deer Island Outfall.  More details about 
the sites are available in Table 1.   
Field sampling collections  
For samples with both water and sediment collected (Charles River, New Bedford Harbor, 
Plymouth, West Falmouth Harbor, Little Island, Race Point Beach), three one liter 
autoclaved acid washed bottles were used to collect water at roughly 30-40 cm depth.  
Three sterile 50 ml centrifuge tubes were used to collect sediment underlying the water 
column at the same point. For the Falmouth wastewater treatment plant samples, water 
samples were collected by pulling up water from influent or effluent tanks and then 
pouring into three one-liter autoclaved acid washed bottles. For these sites, environmental 
measurements were collected (Table 2).  
Water from Boston Harbor and Deer Island outfall was collected in 50 liter 
carboys.  Triplicate samples were collected from all sites except Boston Harbor and the 
Deer Island outfall. All samples other than the Boston Harbor and Deer Island site were 
transported in coolers back to the laboratory and processed immediately.  The Boston 
Harbor and Deer Island carboys were put at 4°C upon arrival back in the laboratory on 
April 26, 2016 and then were filtered on April 29, 2016.  
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Laboratory sample filtration 
Water samples other than Boston Harbor and Outfall samples were serially filtered 
through an acid-washed 5 um mesh filter and then onto an autoclaved 47 mm 0.22 
micron Durapore filter (Millipore). Amounts of water filtered are given in Table 1 in detail. 
For the Boston Harbor and outfall samples, about three liters for both were filtered through 
sequential filters of an 80 micron filter to 35 micron to 0.22 micron filter.  
For sediment samples, 5 grams of sediment was measured and added to 15 ml of 
sterile 1x phosphate buffered saline (PBS).  The sample was lightly shaken (15 times back 
and forth) to allow cells to be dislodged from sediment.  The sample was allowed to sit for 
a few minutes for settling of large sediment particles, then the PBS was filtered through 5 
micron mesh onto 0.22 micron filter (Durapore; Millipore).  After filtration, all samples 
were stored at -80 °C until extraction.  
DNA Extraction  
For sediment and water DNA extraction from filters, the Genomic-tip 20/G process was 
used (Qiagen).  The lysis protocol was followed (21) with modifications.  To lyse cells, 
each filter was rinsed with Qiagen Buffer B1 and then 5 µl of 250 U/µl Ready-Lyse 
Lysozyme (Epicentre Illumina) was added for 30 minutes at room temperature.  To remove 
RNA and protein, 2 µl RNAse A (Qiagen) along with 45 µl of protease (Qiagen) was added 
and incubated for thirty minutes at 37 °C.  For some samples, two filters were used to 
increase DNA yield and in these cases, doubled amounts of reagents were used for the 
additional increase of Buffer B1.  The Qiagen protocol for Bacteria was continued at Step 
6, with the addition of Buffer B2 and the DNA extraction process was followed for 20/G 
tips (Qiagen).     
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Metagenomic sequencing  
DNA samples were sent to Georgia Genomics and Bioinformatics Core for library 
preparation and sequencing.  Library preparation used the Kapa Hyper Kit (KK8504) with 
fragmentation and dual SPRI size selection following the Illumina TruSeq protocol.  
Sequencing occurred on an Illumina NextSeq machine with 150 base pair paired end 
sequencing. Upon receipt of the sequence data, it was determined that four samples 
needed to be resequenced due to low read numbers.  These samples were LI Water 1, LI 
Water 2, NBH Water 3, and the Outfall Water.  
Bioinformatic analysis   
Bioinformatic analysis utilized MetaStorm (22).  MetaStorm is an online server that allows 
for a user-friendly metagenomic pipeline that can be customized to the users needs.  The 
general data flow is illustrated in Figure 1.  Two different pipelines were utilized in the 
data analysis: an assembly based pipeline and a read matching pipeline.  The assembly 
based pipeline was used for the identification of antibiotic resistance related genes 
whereas the read matching was used for bacterial taxonomic identification and diversity. 
MetaStorm uses a variety of software for data processing: quality control (Trimmomatic), 
assembly (IDBA-UD), gene prediction (PRODIGAL), taxonomy annotation (BLAST, 
DIAMOND, GreenGenes for 16S rRNA for the read matching pipeline) and functional 
annotation (DIAMOND for the assembly pipeline).  A CLAssification of Mobile genetic 
Elements (ACLAME), Antibiotic Resistance Database (ARDB), Comprehensive Antibiotic 
Resistance Database (CARD), and Antibacterial Biocide and Metal Resistance Genes 
Database (BacMet) databases were used for annotation of the assembly pipeline data.  
ACLAME is a database full of mobile genetic elements and is available at 
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http://aclame.ulb.ac.be/.  ARDB is a non-currently updated database of antibiotic 
resistance genes which is available at https://ardb.cbcb.umd.edu/.  CARD is an updated 
database of antibiotic resistance genes and can be found at 
https://card.mcmaster.ca/about.  BacMet includes biocide and metal resistance genes and 
is available at http://bacmet.biomedicine.gu.se/.  To account for different total read 
recovery for each sample, gene abundances were normalized to RPKM for the read 
matching (taxonomy) analysis and to 16S read abundance for the assembly (ARG) 
analyses. 
Statistical analysis  
Statistical analysis was completed using Primer version 7 (23).  Permutational multivariate 
analysis of data (PERMANOVA) was utilized to compare gene diversity and prevalence.  
PERMANOVAs were completed on gene abundance data, metagenomic sample matrices, 
and efflux pump data.  Gene abundance data was analyzed for significant differences in 
the normalized gene abundance between samples using a nested PERMANOVA with 
sample type nested in site nested in impact type.  This test was completed for data from 
each database: ACLAME, ARDB, CARD, BacMet, and GreenGenes.   
Eight different types of metagenomic sample datasets were created to address a 
variety of questions.  The datasets are: all samples, all water samples, water samples 
without effluent and influent, six main sites that included sediment and water, wastewater 
water and sediment, wastewater (water only), influent/effluent, and the WFH gradient 
(effluent, influent, WFH Water). For each of these eight datasets, a matrix was created for 
each of six databases: ARDB gene, ARDB antibiotic, BacMet, CARD gene, CARD 
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antibiotic, and GreenGenes.  In addition, similarity percentages (SIMPER) were run on the 
top ten genes or group for each of five databases (ACLAME, ARDB, CARD, BacMet, and 
GreenGenes) to examine what similarities and differences were present between sites and 
between sample types.  
RESULTS 
Sampling sites 
10 different sites were sampled during this study in the summer/autumn of 2016.  Six sites 
were sampled for both sediment and water whereas the other four sites were sampled 
solely for water (Table 1).  Environmental characteristics of the sampling sites varied with 
conductivity, salinity, turbidity, dissolved oxygen and temperature (Table 2).  Barometric 
pressure and previous rainfall had less variability among the sites. Turbidity varied 
between the sites with influent having the highest value, while the industrial sites of New 
Bedford Harbor and Charles River have the next highest amounts.  Both of these sampling 
points can be considered having estuarine or riverine influences (the New Bedford Harbor 
site is on the Acushnet River), which may increase the sediment load as the flow moves 
along and less flushing occurs in these systems.  Salinity also varied among sites, with 
New Bedford Harbor, West Falmouth Harbor, Little Island, and Provincetown having the 
highest salinities whereas Charles River and Plymouth were very low, reflecting the 
freshwater influence on these coastal regions.   
Metagenome assembly results  
Metagenomes analyzed resulted in total raw reads from 9 to 25 million per sample (Table 
3).  The unassembled read matching pipeline (Figure 1) was used to determine taxonomic 
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structure of the samples with GreenGenes.  Total reads that had hits to GreenGenes were 
less than one percent for all samples, and this was consistent with results from a TARA 
sample (Table 3).  The assembled data showed that usually >30% of total reads were 
assembled for the coastal and TARA water samples (Table 4).  Sediment samples often had 
fewer assembled reads (<10%), fewer scaffolds and ultimately fewer predicted genes 
compared to corresponding water samples (Table 4), but this was not always the case (e.g. 
NBH Sed 1&2 vs NBH Water 1&2). The number of predicted genes from all samples 
ranged from 5,959 (Ptown Sed 3) to 623,044 genes (NBH Sed 1).  Using the assembled 
pipeline, four different databases were utilized to identify genes associated with antibiotic 
resistance (ARDB, CARD), metal resistance (BacMet), and mobile genetic elements 
(ACLAME).  Overall, antibiotic resistance associated genes comprised <10% of the total 
genes in a sample (Table 5).  ACLAME had the most (0.02 to 7%) followed by BacMet (0 
to 0.4%), CARD (0 to 0.29%), and ARDB (0 to 0.16%).      
Top database hits  
Plasmids (ACLAME) were the most prevalent of the AR associated elements within the 
metagenomic data.  Seven of the top twenty most abundant plasmid types have 
oxidoreductase activity while three are ATP-binding cassettes (Table 6). The remaining 
groups have diverse descriptions and mechanisms; two of particular interest are plasmid 2 
(associated with toxicity via the Type III secretion pathway) and plasmid 74 (carries 
insertion element IS407).  For the ARDB database, the top twenty genes contain a variety 
of resistance mechanisms that impact different antibiotic groups (Table 7).  Efflux related 
genes are in the majority with twelve out of twenty genes related to this process.  The 
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CARD top 20 list has similar diversity to the ARDB database (Table 8).  In addition, eleven 
out of twenty genes for the CARD database were related to efflux.  BacA, dfrB6, macB, 
and tet34 are the four genes that are included on both the CARD and ARDB top 20 lists. 
The BacMet database illustrated a variety of metal resistance associated genes, with the 
category “other” as the top amount (Table 9).  This category includes genes that have 
multiple annotations or other compounds.  GreenGenes top 20 genera includes several 
“unknown bacteria” in addition to taxa commonly found in marine samples (Table 10).  
Figure 7 shows the larger expanse of prokaryotic diversity, instead of the top 20 samples.   
PERMANOVA tests 
Gene abundance  
A nested PERMANOVA test was run on a matrix for each database (ACLAME, ARDB, 
BacMet, CARD, and GreenGenes) containing gene abundance values for each sample.  
For all databases, sample type (sediment vs water) was significant (Table 11).  Significance 
of sample type remained even if the factor of impact was pooled in the analysis (Table 11).  
Figure 2 illustrates that although sediment tended to have higher relative recovery 
abundances than water from the same site, the pattern did vary.  
Analysis of all sample matrix 
A matrix of all samples was created for each database to evaluate the diversity between 
samples.  In addition, separate matrices were created for the antibiotic resistance 
databases ARDB and CARD for antibiotic group.  Each database condensed all ARG into 
broader antibiotic groups (e.g. penicillin, tetracyclines) and then these matrices were 
tested as well.  A nested PERMANOVA tested the significance of three factors: impact type 
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(wastewater, Boston wastewater, industrial, reference), site, and sample type (sediment or 
water) (Table 12, Column 2, red).  For ARDB genes and antibiotic, CARD genes and 
antibiotic, and GreenGenes, sample type was significant at a p value of 0.001. The 
amount of variance sample type explained changed between databases- ARDB genes 
(25.406), ARDB-antibiotic (25.44), CARD-antibiotic (23.284), CARD-gene (25.505), 
GreenGenes (22.031). For BacMet, impact and sample type were not significant after the 
site factor was pooled. 
All water samples matrix 
Matrices of all water samples were created and were tested by PERMANOVA using a site 
nested in impact type (Table 12, Column 3, orange).  Site was significant for all of the 
database results; ARDB genes (p = 0.001, 30.572), ARDB- antibiotic (p=0.002, 23.587), 
BacMet (p=0.007, 11.718), CARD-antibiotic (0.001, 31.16), CARD-gene (p=0.001, 
33.587), and GreenGenes (p=0.001, 30.155).  Figure 3 shows an nMDS plot using the 
ARDB gene data to illustrate the groupings by site.  Some samples are extremely close 
together such as Influent and Effluent while others, like Provincetown, are more variable.  
 A water sample matrix without the effluent and influent samples was run (Table 12, 
Column 4, yellow). Site remained significant for CARD- gene (p=0.005, 17.868) and 
GreenGenes (0.001, 22.291) while it was not for ARDB genes, ARDB antibiotic, BacMet, 
and CARD- antibiotic.  Figure 4 uses the GreenGenes matrix to illustrate that variability 
between site groups is larger than variability within groups for most samples.  
Sediment and water sites only 
Matrices of the six sites for which sediment and water were collected (CR, LI, NBH, 
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Plymouth, Provincetown, WFH) tested using PERMANOVA with sample type nested in 
site nested in impact type (Table 12, Column 5, green).  As for the all sample analysis, 
type was significant, although in this case it was significant for all databases other than 
CARD-gene. For each database, the significant results for type were: ARDB genes (0.002, 
23.734), ARDB antibiotic (0.001, 24.338), BacMet (0.001, 17.695), CARD antibiotic 
(0.001, 22.234) and GreenGenes (0.001, 28.524).  
Wastewater samples only 
All wastewater samples, including sediment and water samples, were tested by a 
PERMANOVA with type nested in site nested in impact type (Table 12, Column 6, light 
blue).  Sample type was significant for all of the datasets; ARDB genes (0.001, 32.448), 
ARDB- antibiotic (0.001, 31.233), BacMet (0.001, 21.503), CARD-antibiotic (0.011, 
20.412) CARD-gene (0.002, 24.904), and GreenGenes (0.001, 26.497). Impact type was 
also significant for BacMet (0.023, 19.356). When site was pooled for BacMet, due to its p 
value and negative significance, the significance of sample type was not able to be tested. 
Site was only significant for CARD- antibiotic (0.026, 27.141).  
 A matrix of wastewater water samples only was tested using site nested in impact 
type (Table 12, Column 7, dark blue).  Site was again a significant factor with this setup for 
all datasets; ARDB genes (0.001, 38.585), ARDB antibiotic (0.001, 30.004), BacMet 
(0.004, 15.237), CARD antibiotic (0.001, 37.061), CARD-gene (0.001, 45.091), and 
GreenGenes (0.039, 22.099). Figure 5 Panels A and B show the wastewater water sample 
nMDS results and illustrates that effluent and influent form distinct groups and cluster 
away from the other samples.  In addition, taxonomy differences were also shown within 
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these samples, which may be related to the differences in resistance (Figure 5 Panel D). 
Influent and effluent were then tested for differences by site within PERMANOVA (Table 9, 
Column 8, purple), but site was not shown to be significant for any database.  
WFH Gradient  
The WFH Gradient samples (influent, effluent, WFH water) were tested for PERMANOVA 
by site (Table 12, Column 9, beige).  Site was significant for all databases: ARDB genes 
(0.006, 47.04), ARDB antibiotic (0.005, 35.492), BacMet (0.003, 20.041), CARD-
antibiotic (0.007, 45.932), CARD gene (0.006, 49.961), GreenGenes (0.004, 40.487).  The 
sites samples cluster into are shown in Figure 6.   
Antibiotic resistance results across methods: Little Island comparison  
Little Island was a site studied in three chapters of this dissertation (3- Vibrio, 4- 
heterotroph, and in this chapter, in coastal metagenomes).  Antibiotic resistance for each 
chapter is illustrated in Table 13.  Vibrio isolates had higher amounts of resistance for 
amoxicillin (a penicillin), ciprofloxacin (a quinolone), and trimethoprim than for 
doxycycline (a tetracycline) and oxytetracyline (a tetracycline). Heterotrophs had higher 
resistance for doxycycline and reduced levels for amoxicillin, ciprofloxacin, and 
erythromycin (a macrolide).  Within the coastal metagenomes, a diverse set of resistance 
genes was found.  Macrolide, bacitracin, lincosamide/streptogramin_b/macrolide 
grouping, kasugamycin, and tetracycline were the most abundant, and genes related to the 
identified active resistances in the bacteria were also found.   
Similarities between sites and sample type using SIMPER  
Similarity percentage (SIMPER) tests, which discriminate dissimilarities between samples, 
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were performed on the top 10 genes or groupings over all samples for each database to 
determine the genes/taxa that characterized each site or sample type and contributed to 
the significant PERMANOVA results.  Table 14 shows the SIMPER results by sample type 
while Table 15 reports on results of specific comparisons between sample types and sites. 
The plasmid (ACLAME database) and BacMet genes had the least variation in type 
abundances.  Overall water vs sediment dissimilarity was 17% and 26% (Table 11), while 
the dissimilarity between different sites was < 22% and < 35%, for plasmids and BacMet 
respectively (Table 12).  The greatest dissimilarity in the BacMet dataset was between 
influent and Deer Island outfall samples (36% dissimilarity; mercury, copper & zinc higher 
for influent; selenium & chromium higher for outfall).  BacMet was the only dataset to 
show significance for sample impact, and with SIMPER the largest dissimilarity (28%) was 
between Boston wastewater (Outfall, Boston Harbor) and wastewater (effluent, influent, 
Plymouth, WFH), with Boston showing more chromium and selenium genes, while 
wastewater had more mercury, arsenic and copper genes. 
ARDB and CARD results had the largest variability within samples (between 
replicates) with similarity values ranging from 14% up to 89% (Table 15).  Sediment and 
water were more distinct here with dissimilarity values for ARDB and CARD of 58% and 
47%, respectively (Table 14). The genes driving these differences in ARDB were AcrB for 
sediment and KsgA and mexW for water.  In CARD, the genes were CRP for sediment and 
pmrE and qacH for water.  Provincetown as a site had the lowest average similarity value 
(ARDB 19%; CARD 47%) reflecting the large differences observed in the location of 
replicate samples on MDS plots (Figure 3).  In ARDB dataset site comparisons, those with 
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Provincetown tended to have the largest dissimilarity values (66%-80%), and were 
influenced by the increased abundance of tet34 and AcrB in the Provincetown samples 
relative to the others.  A similar pattern was observed for CARD (38%-58%), with the 
genes CRP and msrB usually of higher abundance in Provincetown samples.   
Although impact was not significant in most of the PERMANOVA results, it was 
possible to identify genes associated with the distinction of influent and effluent samples, 
as well as wastewater.  In ARDB, effluent was distinguished from influent by larger 
amounts of dfrB6 and BacA, and lower amounts of RosA, while wastewater as an impact 
type tended to have higher mexW gene abundances.  mtrA, qacH and rpoB genes from 
the CARD database were generally of greater abundance in effluent samples, while pmrE 
and CRP were more abundant in influent.  Wastewater showed an increase in the effluent 
and influent genes, qacH and pmrE, in addition to msrB and dfrA3. 
Within the GreenGenes dataset, there was little variability between most sample 
replicates, and often also between sediment and water from the same site (Table 14, 15).  
A notable exception was the Provincetown Total sample where the low similarity value 
indicated the water and sediment differences between these communities.  GreenGenes 
results yielded the greatest variation in site dissimilarity values, ranging from 8% (Boston 
Harbor vs outfall) up to 75% (Provincetown vs influent). Due to the limited number of taxa 
used, the same species were generally found in each comparison, while the abundances 
were different.  An exception to this observation was that the presence and abundance of 
Arcobacter did characterize wastewater impact from others. 
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Prevalence of efflux mechanisms 
Prevalence of efflux pumps was tested using PERMANOVA for three different data 
matrices: all samples, the six samples where sediment and water were collected, and the 
WFH gradient (Table 16).  Only the WFH gradient showed a significant difference in the 
prevalence of efflux pumps with site being significant (p value 0.005, variation explained 
8.022%).  Influent had a higher amount of efflux pumps than effluent.  WFH Water had 
lower values than both effluent and influent.   
DISCUSSION 
Resistance is prevalent and widespread.  
This study examined the prevalence and diversity of antibiotic resistance and metal 
resistance genes in coastal samples—both freshwater and marine—exhibiting different 
environmental impacts.  In examining normalized gene abundance among the five 
databases, sample type was significant for all database categories.  The pattern of sediment 
having a greater percentage of resistance genes/elements for total genes recovered than 
water makes sense from the perspective that sediments tend to have higher numbers of 
bacteria and are thought to have higher levels of horizontal gene transfer activity (24).  
The exceptions to this pattern suggest that there are likely additional factors that are 
important to structuring these relationships that have not been evaluated in this study.  
These factors may include: taxonomic diversity within samples and what bacterial groups 
may more readily transfer genes, physical forcing on sediment from the water column, and 
sediment-water mixing/interactions at the sediment-water interface. 
ARDB and CARD indicate complementary ARG in marine metagenomes.  
The top 20 gene hits for both ARDB and CARD indicate complementary, but 
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different, antibiotic resistance groups and mechanisms of resistance with only four genes 
shared between the lists (BacA, dfrB6, macB, and tet34).  This indicates that database 
choice is important and can affect the outcome of studies, and that using multiple 
databases to examine samples is preferable.   
There are many of the same hits of top genes to other marine metagenomes, 
indicating that these may be players in the general marine antibiotic resistome.  Several of 
our top 20 genes were also found in studies examining pristine (deep ocean sediments) 
and an anthropogenically polluted area (Pearl River Estuary) in China: macB (ARDB, 
CARD), acrB (ARDB), and arnA (CARD); (25) and tet34 (ARDB, CARD), tetPB (ARDB), 
ermF (ARDB) and mexW (ARDB); 26). One key player is bacA.  bacA was found in three 
different marine metagenomes from around the world: in sediments in China (25), 
functional metagenomes of a variety of United States seawater samples (20), and 
mariculture systems in China (26). bacA was found more often in the polluted region, 
which led the authors to suggest that bacA may indicate anthropogenic activity.  The 
mariculture system study found bacA in all studied samples.  In this study, bacA was the 
most prevalently found resistance gene among all samples for ARDB.  Within this study’s 
results and previous literature, it seems that further research into bacA prevalence in the 
marine environment would be worthwhile as an indicator and as a greater understanding 
to its importance for marine bacteria.  The bacA gene for undecaprenyl pyrophosphate 
phosphatase activity confers bacitracin resistance through overexpression (27).  
Both ARDB and CARD illustrate that efflux pumps are a majority of resistance genes.  
The two databases coalesce on the hypothesis that efflux genes are prevalent in marine 
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samples, with ARDB’s top 20 samples having 12/20 efflux genes and CARD with 11/20. 
The only significant variation in the amount of efflux vs. non-efflux genes present was 
between the WFH gradient samples. Efflux genes are prevalent in other ARG studies: 
32.5% of genes were efflux pumps in a study of Chinese estuarine sediments (28) and 
17.6% of those for Antarctic and marine samples (29).  In a study of the relatively pristine 
South China Sea, efflux pumps are considered a prominent type of AR whereas a polluted 
area had greater diversity of ARGs/type (25).  In a metagenomic study of a variety of 
environments, percentage of efflux gene diversity compared to the total resistance gene 
diversity varied dramatically from 0-74%, depending on the sample (30).  In terms of 
specific genes, acrB and macB - both MultiDrug Resistance (MDR) efflux pumps - were 
found across all sites in a estuarine study of an anthropogenically impacted estuary as well 
as more pristine deep ocean sediments (25).   
All of these results indicate an important aspect of antibiotic resistance –the 
mechanism of resistance.  Assessing the mechanism of resistance is important to 
determining how easily resistances can be spread and shared.  Efflux genes serve the 
purpose of ridding the cell of materials.  In antibiotic resistance work, this is primarily 
focused on antibiotics, but it likely that these pumps are serving many other evolutionary, 
cellular needs such as detoxification, virulence, homeostasis, and signal trafficking (31). 
While non-specific efflux pumps were present and may be responsible for a portion of the 
prevalent resistance observed, known genes that are directly associated with resistance 
were also present.  These genes were largely associated with antibiotic target alteration, 
and their presence suggests that some of the prevalent active resistance observed in the 
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cultures could have resulted either through exposure to particular antibiotics or to the 
acquisition of altered genes.  Recent research has shown that subtherapeutic levels of 
antibiotics, such as those found in natural environments, can select for resistant bacteria 
(32, 33).  In marine environments, these subtherapeutic levels could be from 
anthropogenic activities or could even be from the natural occurrence of antibiotics.  
Little Island antibiotic resistance shows phenotypic resistance and resistance genes for 
similar antibiotic groups.  
Little Island is a site in Falmouth, MA that has been studied in three chapters of this 
dissertation- Chapter 3 for active resistance in Vibrio bacterial cultures, Chapter 4 for 
active resistance in general marine heterotroph cultures, and finally, in Chapter 5 for 
metagenomic ARG diversity.  The prevalence of phenotypic resistance does not have a 
direct correlation to prevalence of resistance genes (e.g. higher resistance to amoxicillin in 
Vibrio does not correspond to higher amounts of resistance genes for amoxicillin). This 
lack of direct correspondence is not surprising: there were temporal delays between when 
the culture samples and the metagenomic samples were collected, active resistance is 
based on specific antibiotics and the particular groups of bacteria that are able to be 
cultured, and metagenomics looks at the available DNA which may not represent actively 
expressed genes.  
WFH water is distinct from wastewater effluent and influent, indicating change through 
groundwater process and salinity changes.  
In Falmouth, the wastewater effluent is transported through groundwater to West Falmouth 
Harbor likely over a period of about ten years (personal communication).  This area 
allowed for a unique test of resistance in these sites with the knowledge that samples are 
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not being tested all on the same time scale.  Although influent/effluent were not 
significantly different within the databases, the addition of WFH to the comparison made 
site significant for all databases.  In addition, the difference in number of efflux pumps 
between these sites was significant (SI Table 4).  This illustrates that resistance and metal 
genes change over the course of filtration through groundwater and fits with previous 
work that has shown that removal of antibiotic resistance genes depends largely on the 
groundwater recharge system (34). Since sediment is also a diverse source of antibiotics, it 
is also possible that resistance genes could be picked up during the process. A study 
examining swine waste showed that groundwater is affected by waste, but also shows 
novelty from the environmental community (35). 
Impact type does not structure samples, further indicating widespread resistance. 
For the studied samples, there are not significant differences between impact type.  This 
result indicates that antibiotic impacts are likely diffuse throughout the studied regions, 
which fits in with the results seen in Chapter 3 and Chapter 4 of this dissertation.  Overall, 
this result may indicate that pollution (e.g. metal, antibiotic) or other anthropogenic 
impacts affecting the studied databases may be more widespread and less tied to 
particular point sources.  As a recent study examining metal resistance and antibiotic 
resistance in mangroves eloquently described “genes involved in both heavy metals and 
antibiotics are ubiquitous, irrespective of the ecosystem examined” (36).  It could also be 
that the levels seen are indicative of this area at large, representing coastal areas that have 
been impacted by humans.   
In general, previous metagenomic studies of resistance genes have found that 
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similar environments group together (18, 37, 38).  In a study of estuarine sediments with 
diverse and abundant ARG, the researchers found that anthropogenic activity contributes 
to resistance (28). Due to this study’s results showing lack of impact, it seems that these 
sites lack a substantial, direct anthropogenic impact that was able to be measured here.  
One explanation for this lack of impact could be that legacy pollution sources, such as 
industrial, may not be seen in the samples examined because sampling was at the top of 
the water column and the sediment.  Legacy pollution sources may be better represented 
deeper in the sediment where reduced physical forces from the overlying water can act 
upon it.  Another explanation may be that pollution did, at one point, affect these 
resistance communities, but their resiliency allowed them to spring back.  Previous 
research shows this as a possibility.  In a study of extreme flooding in Colorado, flooding 
reduced the levels of resistance (likely by dilution), but ten months post flood, the greater 
abundance of resistance genes returned (39).  
Marine water samples group together.  
In this study, marine water samples generally grouped together while the more 
freshwater-influenced, river related samples were separated (Charles River, New Bedford 
Harbor, and Plymouth).  Charles River and New Bedford Harbor sites are both in rivers so 
the physical flow of water may be different compared to other samples.  Charles River and 
Plymouth had very low salinities, indicating an abundance of freshwater.  These impacts 
could change the taxonomy and potentially even the resistances present.  Provincetown, 
which is perhaps the most “open ocean area” and whose water is least constrained 
geographically, shows the highest variability on the nMDS from sample to sample.     
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Interestingly enough, when all water samples except for effluent and influent were 
tested, site was no longer significant for ARDB (genes and antibiotic) and BacMet, whereas 
it was for CARD and GreenGenes.  This indicates that the differences between all water 
samples for ARDB and BacMet were being driven by effluent and influent.  In an nMDS 
plot for the GreeGenes data, similarities can be seen between sample replicates and a 
range of variability for the sites is evident.  These results show that regardless of the site 
differences indicated by taxonomy, the genes and their abundances identified by ARDB 
and BacMet remain similar. For BacMet, it is interesting that despite the taxonomic 
changes, the difference between sites is not significant.  This result may lend itself towards 
and understanding that coastal environments may share similar metal resistances 
regardless of location.  Another option may be that BacMet categorizes by metal and not 
the specific gene, so variations may occur by gene that are not being adequately captured 
by this examination.  
Effluent and influent are distinct from other wastewater related samples.  
Examining just the water samples illustrates that effluent and influent are different 
from each other and from the rest of the wastewater influenced samples.  Influent and 
effluent are different from environmentally derived samples, which is not particularly 
surprising, as it would be expected that wastewater influent would be different from these 
samples.  The spatial separation between influent and effluent on the nMDS plots indicate 
that changes do occur in the process of wastewater treatment (8, 40, 41). Effluent shows 
greater variability than the influent, indicating lower predictability throughout the 
wastewater treatment process.  Effluent shows more similarity in structuring with 
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environmental samples that have been influenced by wastewater.  With SIMPER testing, 
key players do change between effluent and influent for ARDB, CARD, and GreenGenes, 
further illustrating these changes.  
In examining the wastewater influenced water only samples, there is a high degree 
of similarity (Figure 5B and 5C).  These are all water samples that have been influenced by 
wastewater outfalls/groundwater flows.  There are two Plymouth samples that appear to be 
outliers and can be seen most clearly in Figure 5C.  The Plymouth outliers may be due to 
the fact that when sampling at low tide, the Plymouth outfall pipe was spatially removed 
from the rest of the Plymouth water body.  The Plymouth sample may be more indicative 
of outflow and less so of the marine environment, which may be driving that difference.  
Conclusion 
This study has utilized metagenomic sequencing to show the diversity of mobile genetic 
elements, antibiotic and metal resistances, and taxonomic groups present in differently 
impacted coastal environments in Massachusetts, US.  Results indicate that resistance is 
prevalent and widespread among a variety of coastal sites. Results also show that impact 
type is not significant while site and sample type are.  In these coastal environments, 
humans and organisms that humans consume, can readily interact with water and 
sediment that contain resistance genes.  Now that resistance genes have been found to be 
prevalent in these areas, the next step would be to determine the transfer rates of 
resistance genes from bacteria to bacteria and to humans to estimate risk potential. 
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Figure 1. Figure of metagenomic analysis process.  
This figure has been modified from Figure 2 of Arango-Argoty et al. 2016 (22) and shows the data processing of metagenomic 
data using MetaStorm. 
Raw Reads Trim and QC
Read 
Matching
16S rRNA 
(Bowtie2)
Taxonomy 
Annotation
Assembly Pre-processing 
Taxonomy 
Database 
Assembly 
(scaffolds-
IDBA)
Gene Scan 
(predicted 
genes-
PRODIGAL)
Alignment 
(DIAMOND) Normalization
  183 
 
 
Figure 2.  Percentage of total assembled genes. 
This figure illustrates the percentage of total assembled genes for each database.  For the top panel, GreenGenes, BacMet, 
CARD, and ARDB are illustrated.  For the bottom panel, ACLAME is shown.  
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Figure 3. nMDS plot illustrating all water samples. 
Data shown is for antibiotic resistance database (ARDB) and is categorized by site.   
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Figure 4. nMDS plot illustrating all water samples other than influent and effluent.  
Data shown is for taxonomy through GreenGenes and is categorized by site.   
 
  186 
 
 
A 
 
 
 
 
 
 
 
 
 
B 
 
 
 
 
 
 
 
 
 
C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  187 
Figure 5. nMDS plot illustrating CARD gene and GreenGene wastewater samples  
by A.) CARD gene water and sediment samples by site (color) and by type (text), B.) CARD gene only water 
samples, C.) CARD gene water samples without effluent and influent., and D.) GreenGenes only water 
wastewater samples.   
 
D 
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Figure 6. nMDS plot illustrating WFH gradient water samples (effluent, influent, and WFH).   
Data shown is for biocide/metal resistance with BacMet data and is categorized by site.   
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 Figure 7. Prokaryotic diversity in metagenomic samples.   
This figures illustrates the prokaryotic diversity illustrated from the metagenomic samples. A. Tree indicates the bacterial 
diversity.  B. Tree indicates the archaeal diversity.  
A 
 
B 
 
  190 
Table 1. Explanation of field sites.  
Field sites used in this study indicate the abbreviation used, location, and other pertinent sampling information.   
 
Site  Abbreviations Location Type Sample 
collected 
Sampling 
Date 
Filters: water Amount for 
metagenomes 
Notes 
Charles 
River 
CR Cambridge, 
MA 
Industrial Water, 
sediment 
August 
28, 2016 
4- 250 mls For each sample 
replicate, two 
filters used for 
total of 500 mls 
filtered.  
freshwater 
New 
Bedford 
Harbor 
NBH Acushnet, 
MA 
Primary: 
Industrial 
Wastewater 
as well 
Water, 
sediment 
August 
25, 2016 
1- 500 mls 
2- 250 ml 
3- 250 ml  
Sample 1- 500 
mls 
Sample 2- 500 
mls  
Sample 3- 500 
mls 
 
Plymouth Ply Plymouth, 
MA 
Wastewater Water, 
sediment 
Septembe
r 2, 2016 
4 -250 ml  For each sample 
replicate, two 
filters used for 
total of 500 mls 
filtered.  
direct discharge 
of wastewater 
treatment to the 
ocean 
freshwater at time 
because water 
flow low and at 
low tide 
West 
Falmouth 
Harbor 
WFH West 
Falmouth, 
MA 
Wastewater Water, 
sediment 
Septembe
r 12, 
2016  
4- 250 ml For each sample 
replicate, two 
filters used for 
total of 500 mls 
filtered.  
indirect 
wastewater 
treatment through 
groundwater and 
then released into 
WFH that takes 
~10 years 
Little Island LI Falmouth, 
MA 
Reference Water, 
sediment  
 4- 250 ml For each sample 
replicate, two 
filters used for 
total of 500 mls 
filtered.  
 
Race Point Ptown Provinceto Reference Water, Septembe 4- 250 ml For each sample  
  191 
Beach wn, MA sediment r 18, 
2016 
replicate, two 
filters used for 
total of 500 mls 
filtered.  
Falmouth 
Wastewater 
treatment 
Effluent 
Effluent Falmouth, 
MA 
Wastewater
-output  
Water October 
12, 2016 
3- 250 ml Sample 1- 250 
mls 
Sample 2- 250 
mls  
Sample 3- 250 
mls 
freshwater 
Influent, 
Falmouth 
Wastewater 
Treatment 
Plant 
Influent Falmouth, 
MA 
Wastewater
-input 
Water October 
12, 2016 
3- 100 ml 
samples  
Sample 1- 100 
mls 
Sample 2- 100 
mls  
Sample 3- 100 
mls 
freshwater 
Boston 
Harbor 
BH  Industrial Water April 25, 
2016 
~ 3 liters ~ 3 liters  
Boston 
Deer Island 
Outfall 
Outfall  Wastewater Water April 25, 
2016 
~ 3 liters ~ 3 liters  
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Table 2. Available environmental characteristics from sampling sites.   
Environmental characteristics collected from a YSI probe, turbidity meter, or local rain collection are shown here.    
 
Site Date Time Barometer 
(mmHg) 
Conductivity 
(uS/cm) 
Salinity 
(PSU) 
Dissolved 
Oxygen 
(mg/L) 
Temperature 
(C) 
Air 
Temperature 
(C)  
Previous 
Rainfall 
(in) 
Turbidity 
(NTU) 
New Bedford 
Harbor 
(NBH) 
8/25/16 10:23 
AM 
765 45715 29.0 4.7 26.0 27.13 0 23.9 
Charles River 
(CR) 
8/28/16 11:52 
AM 
768 2610 1.3 9.3 27.3 26.39 0 11.6 
Little Island 
(LI) 
8/31/16 12:50 
PM 
761 46047 29.5 12.1 25.6 24.67 0 1.2 
Plymouth 
(PLY) 
9/2/16 7:00 
AM 
761 823 0.5 8.4 14.1 18.36 0.15 0.5 
West 
Falmouth 
Harbor 
(WFH) 
9/12/16 9:30 
AM 
768 39968 26.4 5.5 23.4 20.47 0 1.8 
Race Point 
Beach, 
Provincetown 
(PRO) 
9/18/16 9:16 
AM 
764 40176 29.8 8.0 18.5 23.76 0.002 1.3 
Falmouth 
Effluent 
10/12/1
6 
9:00 
AM 
771 1127 0.6 4.7 20.5 NA  NA 1.6 
Falmouth 
Influent 
10/12/1
6 
9:00 
AM 
771 1063 0.6 4.3 20.3 NA  NA 79.5 
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Table 3.  Read matching summary.   
Table illustrates how many reads matched for each database using the unassembled MetaStorm read matching pipeline. 
GreenGenes numbers include all hits to GreenGenes, regardless of taxonomic identity. 
  
Samples Raw Reads Reads after QC GreenGenes 
 
GreenGenes  
% total reads after QC 
BH Water  17,569,196   16,313,539   11,312  0.07 
CR Sed 1  10,717,930   9,347,555   2,148  0.02 
CR Sed 2  10,942,791   9,903,829   2,409  0.02 
CR Sed 3  8,856,114   7,409,217   1,778  0.02 
CR Water 1  12,876,089   12,095,985   4,754  0.04 
CR Water 2  13,936,865   13,058,636   5,506  0.04 
CR Water 3  10,284,930   9,264,552   2,836  0.03 
Effluent Water 1  10,135,451   6,689,153   2,084  0.03 
Effluent Water 2  10,413,694   8,808,664   3,529  0.04 
Effluent Water 3  11,198,174   8,653,199   2,307  0.03 
Influent Water 1  12,239,120   11,452,426   14,912  0.13 
Influent Water 2  10,450,415   9,591,164   10,892  0.11 
Influent Water 3  12,468,439   11,513,547   15,679  0.14 
LI Sed 1  11,927,925   10,942,165   1,857  0.02 
LI Sed 2  10,919,494   9,954,408   1,811  0.02 
LI Sed 3  11,367,628   9,551,334   1,610  0.02 
LI Water 1  6,011,514   5,794,961   3,305  0.06 
LI Water 2  8,661,529   8,208,452   5,059  0.06 
LI Water 3  25,019,878   23,153,017   8,272  0.04 
NBH Sed 1  24,086,706   22,539,857   8,129  0.04 
NBH Sed 2  12,624,416   11,693,903   5,850  0.05 
NBH Sed 3  19,775,842   17,642,703   1,888  0.01 
NBH Water 1  14,486,114   13,688,036   1,324  0.01 
NBH Water 2  12,732,898   11,815,072   1,086  0.01 
  194 
NBH Water 3  6,292,873   6,091,006   2,152  0.04 
Outfall Water   8,207,017   7,865,451   7,994  0.10 
Ply Sed 1  9,478,710   8,831,923   2,389  0.03 
Ply Sed 2  17,325,108   15,944,565   4,514  0.03 
Ply Sed 3  9,645,693   9,104,579   2,644  0.03 
Ply Water 1  4,940,451   4,225,490   2,072  0.05 
Ply Water 2  11,882,806   11,044,861   5,819  0.05 
Ply Water 3  11,966,780   10,665,428   4,989  0.05 
Ptown Sed 1  5,900,784   3,334,588   4,577  0.14 
Ptown Sed 2  10,717,447   7,986,612   11,192  0.14 
Ptown Sed 3  3,959,679   3,268,273   2,746  0.08 
Ptown Water 1  5,238,338   4,751,025   2,375  0.05 
Ptown Water 2  11,329,640   10,787,124   4,527  0.04 
Ptown Water 3  10,109,892   9,567,706   4,620  0.05 
WFH Sed 1  13,703,960   13,155,786   3,198  0.02 
WFH Sed 2   9,873,667   9,341,867   1,951  0.02 
WFH Sed 3  16,555,462   15,753,093   1,689  0.01 
WFH Water 1  11,474,498   11,004,451   6,772  0.06 
WFH Water 2  9,222,470   8,787,950   5,150  0.06 
WFH Water 3  9,746,918   9,105,440   4,974  0.05 
TARA_023_SRF_0.22-1.6 37,310,366 36,946,964 42,078 0.11 
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Table 4. Metagenome assembly.   
Table includes metagenome results from the MetaStorm gene assembly pipeline.  A Tara Oceans sample (42) is included for 
comparison.   
 
Sample Raw Reads Input Reads after 
QC (after QC 
and assembly 
preprocessing) 
Average 
read 
length 
(bps) 
Assembled 
reads (#) 
Assembled 
reads (%) 
Scaffolds Average 
scaffold 
length 
(bps) 
N50 of 
scaffolds 
(bps) 
Total 
predicted 
genes 
Average 
gene length 
(bps) 
BH Water 17,569,196 16,307,303 128 8,873,112 54.4 367,998 717 1731 444,235 494 
CR Sed 1 10,717,930 9,344,234 128 290,132 3.1 29,567 630 712 41,482 387 
CR Sed 2 10,942,791 9,900,291 128 339,483 3.4 36,706 610 681 50,429 382 
CR Sed 3 8,856,114 7,406,448 128 245,628 3.3 22,321 648 724 32,000 397 
CR Water 1 12,876,089 12,091,399 128 5,663,485 46.8 250,149 881 1,597 409,642 475 
CR Water 2 13,936,865 13,053,718 128 6,249,315 47.9 273,334 890 1,604 448,550 479 
CR Water 3 10,284,930 9,261,359 128 4,001,995 43.2 182,967 872 1,370 310,518 458 
Effluent 
Water 1 
10,135,451 6,686,830 128 2,607,413 39.0 98,743 823 1,204 163,807 435 
Effluent 
Water 2 
10,413,694 8,805,621 128 3,452,494 39.2 137,817 871 1,303 237,233 445 
Effluent 
Water 3 
11,198,174 8,650,027 128 3,578,187 41.4 126,728 801 1,170 207,379 428 
Influent 
Water 1 
12,239,120 11,448,274 128 4,486,556 39.2 284,720 606 1,109 312,719 443 
Influent 
Water 2 
10,450,415 9,587,841 128 3,495,244 36.5 205,405 694 1,291 264,394 445 
Influent 
Water 3 
12,468,439 11,509,288 128 4,417,443 38.4 260,986 692 1,359 330,767 451 
LI Sed 1 11,927,925 10,938,312 128 363,795 3.3 56,338 558 561 72,360 357 
LI Sed 2 1,0919,494 9,950,863 128 305,242 3.1 47,368 557 572 59,799 357 
LI Sed 3 11,367,628 9,547,835 128 235,592 2.5 34,518 590 607 45,640 366 
LI Water 1 6,011,514 5,793,830 128 1,931,129 33.3 134,313 712 928 191,012 445 
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LI Water 2 8,661,529 8,206,915 128 3,212,905 39.1 194,823 698 1,060 250,523 471 
LI Water 3 25,019,878 23,144,390 128 9,957,572 43.0 614,719 558 1,311 620,855 444 
NBH Sed 1 24,086,706 22,531,554 128 10,607,120 47.1 649,744 543 1,273 634,044 445 
NBH Sed 2 12,624,416 11,689,557 128 4,358,160 37.3 265,397 645 1,445 308,821 461 
NBH Sed 3 19,775,842 17,635,794 128 1,953,605 11.1 205,619 591 680 290,123 359 
NBH Water 
1 
14,486,114 13,683,012 128 732,971 5.6 93,655 596 661 135,533 351 
NBH Water 
2 
12,732,898 11,810,695 128 632,973 5.4 74,633 613 712 113,585 349 
NBH Water 
3 
6,292,873 6,089,860 128 3,237,984 53.2 208,062 620 971 258,368 430 
Outfall 
Water  
8,207,017 7,863,900 128 3,944,694 50.2 168,545 815 1,101 252,318 482 
Ply Sed 1 9,478,710 8,828,784 128 913,533 10.3 112,764 481 588 111,376 368 
Ply Sed 2 17,325,108 15,938,428 128 2,431,131 15.3 265,766 574 670 306,696 400 
Ply Sed 3 9,645,693 9,101,193 128 1,691,768 18.6 212,720 466 700 178,032 381 
Ply Water 1 4,940,451 4,223,881 128 189,505 4.5 20,277 662 731 28,927 409 
Ply Water 2 11,882,806 11,040,668 128 3,797,051 34.4 204,870 830 1,362 317,647 472 
Ply Water 3 11,966,780 10,661,251 128 1,104,754 10.4 108,308 575 647 127,649 405 
Ptown Sed 1 5,900,784 3,333,424 128 44,980 1.3 5,814 515 543 6,071 363 
Ptown Sed 2 10,717,447 7,983,812 128 210,541 2.6 30,366 517 579 34,913 353 
Ptown Sed 3 3,959,679 3,267,021 128 414,555 1.3 5,685 491 515 5,959 353 
Ptown 
Water 1 
5,238,338 4,749,194 128 816,078 17.2 61,485 817 1,162 99,884 446 
Ptown 
Water 2 
11,329,640 10,783,198 128 1,044,062 9.7 90,881 593 769 106,323 412 
Ptown 
Water 3 
10,109,892 9,567,706 128 2,935,215 30.7 166,086 822 1,320 261,469 460 
WFH Sed 1 13,703,960 13,150,879 128 1,152,060 8.8 101,960 695 891 158,549 383 
WFH Sed 2  9,873,667 9,338,611 128 2,346,231 25.1 68,786 942 1,745 118,286 476 
WFH Sed 3 16,555,462 15,747,377 128 565,519 3.6 79,851 570 610 115,901 340 
WFH Water 
1 
11,474,498 11,000,199 128 5,320,541 48.4 268,157 701 1,444 331,836 479 
WFH Water 
2  
9,222,470 8,784,848 128 4,094,289 46.606 189,763 790 1,761 267,535 483 
WFH Water 
3  
9,746,918 9,102,122 128 4,300,452 47.247 202,185 763 1,772 275,345 479 
TARA_023 37,310,366 34,641,768 NA 16,847,647 48.6 581,069 750 898 831,320 481 
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SRF 0.22-1.6  
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Table 5.  Resistance gene prevalence among samples.  
The number of resistance genes are normalized to a total percentage of genes that were identified using different databases 
with MetaStorm.  
 
Samples Total  
genes  
ACLAME  
genes 
ACLAME  
% total 
assembled 
genes 
BacMet 
genes 
BacMet    
% total 
assembled 
genes 
CARD 
genes 
CARD 
% total 
assembled 
genes 
ARDB 
genes 
ARDB  
% total 
assembled 
genes 
BH Water 444,235  13,044  2.94 437 0.10 203 0.05 28 0.01 
CR Sed 1 41,483  2,406  5.80 123 0.30 36 0.09 18 0.04 
CR Sed 2 50,429  2,755  5.46 126 0.25 42 0.08 27 0.05 
CR Sed 3 32,000  2,240  7.00 91 0.28 36 0.11 22 0.07 
CR Water 1 409,642  10,400  2.54 527 0.13 309 0.08 40 0.01 
CR Water 2 448,550  11,850  2.64 610 0.14 327 0.07 57 0.01 
CR Water 3 310,518  7,150  2.30 342 0.11 227 0.07 27 0.01 
Effluent Water 1 163,807  4,545  2.77 222 0.14 136 0.08 69 0.04 
Effluent Water 2 237,233  6,299  2.66 288 0.12 144 0.06 61 0.03 
Effluent Water 3 207,379  5,207  2.51 244 0.12 106 0.05 44 0.02 
Influent Water 1 312,719  15,235  4.87 1180 0.38 881 0.28 492 0.16 
Influent Water 2 264,394  13,252  5.01 1030 0.39 602 0.23 432 0.16 
Influent Water 3 330,767  16,945  5.12 1249 0.38 945 0.29 512 0.15 
LI Sed 1 72,360  2,672  3.69 90 0.12 33 0.05 10 0.01 
LI Sed 2 59,799  2,230  3.73 69 0.12 17 0.03 6 0.01 
LI Sed 3 45,640  1,647  3.61 52 0.11 25 0.05 11 0.02 
LI Water 1 191,012  6,936  3.63 250 0.13 92 0.05 12 0.01 
LI Water 2 250,523  9,990  3.99 341 0.14 124 0.05 15 0.01 
LI Water 3 620,855  16,560  2.67 596 0.10 233 0.04 22 0.00 
NBH Sed 1 634,044  18,352  2.89 641 0.10 231 0.04 32 0.01 
NBH Sed 2 308,821  11,272  3.65 404 0.13 152 0.05 18 0.01 
NBH Sed 3 290,123  3,147  1.08 186 0.06 67 0.02 24 0.01 
NBH Water 1 135,533  1,876  1.38 107 0.08 37 0.03 12 0.01 
NBH Water 2 113,585  1,185  1.04 74 0.07 23 0.02 10 0.01 
NBH Water 3 258,368  7,329  2.84 237 0.09 72 0.03 8 0.00 
Outfall Water  252,318  9,298  3.69 273 0.11 99 0.04 19 0.01 
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Ply Sed 1 111,376  4,689  4.21 180 0.16 59 0.05 24 0.02 
Ply Sed 2 306,696  14,636  4.77 584 0.19 176 0.06 62 0.02 
Ply Sed 3 178,032  6,249  3.51 227 0.13 71 0.04 18 0.01 
Ply Water 1 28,927  2,433  8.41 105 0.36 47 0.16 19 0.07 
Ply Water 2 317,647  13,635  4.29 378 0.12 145 0.05 22 0.01 
Ply Water 3 127,649  6,924  5.42 338 0.26 93 0.07 37 0.03 
Ptown Sed 1 6,071  273  4.50 24 0.40 13 0.21 7 0.12 
Ptown Sed 2 34,913  1,393  3.99 123 0.35 84 0.24 42 0.12 
Ptown Sed 3 5,959  262  4.40 20 0.34 16 0.27 7 0.12 
Ptown Water 1 99,884  4,869  4.87 130 0.13 65 0.07 4 0.00 
Ptown Water 2 106,323  5,865  5.52 287 0.27 100 0.09 38 0.04 
Ptown Water 3 261,469  10,592  4.05 272 0.10 124 0.05 9 0.00 
WFH Sed 1 13,150,879  2,472  0.02 157 0.00 65 0.00 31 0.00 
WFH Sed 2  118,286  4,999  4.23 379 0.32 75 0.06 44 0.04 
WFH Sed 3 115,901  1,261  1.09 79 0.07 33 0.03 10 0.01 
WFH Water 1 331,836  14,928  4.50 474 0.14 195 0.06 26 0.01 
WFH Water 2 267,535  11,964  4.47 370 0.14 143 0.05 21 0.01 
WFH Water 3 275,345  12,156  4.41 372 0.14 149 0.05 23 0.01 
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Table 6. Top twenty mobile genetic element hits from ACLAME and their associated descriptions.  
Mobile genetic elements are important in determining transfer potential.  
Name Description 
family:plasmids:1 go:0004009|ATP-binding cassette (ABC) transporter activity|OBSOLETE  
(was not defined before being made obsolete). 
family:plasmids:3 go:0000155|two-component sensor activity|Catalysis of the phosphorylation of a specific transcription regulator in 
response to the presence of a particular signal substance outside the cell.;go:0000160|two-component signal 
transduction system (phosphorelay)|A conserved series of molecular signals found in prokaryotes and eukaryotes; 
involves autophosphorylation of a histidine kinase and the transfer of the phosphate group to an aspartate that then 
acts as a phospho-donor to response regulator proteins.;go:0000156|two-component response regulator 
activity|Alters the level of transcription of target genes, usually by binding to a transcription factor, when 
phosphorylated by a sensor that detects the presence of a particular signal substance outside the cell. 
family:plasmids:6 go:0016491|oxidoreductase activity|Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical 
reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a 
hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and 
becomes reduced. 
family:plasmids:321 go:0016772|transferase activity, transferring phosphorus-containing groups|Catalysis of the transfer of a 
phosphorus-containing group from one compound (donor) to another (acceptor). 
family:plasmids:26 go:0016491|oxidoreductase activity|Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical 
reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a 
hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and 
becomes reduced.lua 
family:plasmids:11 go:0016491|oxidoreductase activity|Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical 
reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a 
hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and 
becomes reduced. 
family:plasmids:53 go:0016491|oxidoreductase activity|Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical 
reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a 
hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and 
becomes reduced. 
family:plasmids:2 phi:0000262|toxin|Poisonous activity, especially of proteins or conjugated proteins produced by certain animals, 
higher plants, and pathogenic bacteria.;go:0052049|interaction with host via protein secreted by type III secretion 
system|An interaction with the host organism mediated by a substance secreted by the other organism by a type III 
secretion system. The host is defined as the larger of the organisms involved in a symbiotic interaction. 
family:plasmids:9 go:0004009|ATP-binding cassette (ABC) transporter activity|OBSOLETE (was not defined before being made 
obsolete). 
family:plasmids:9456 No description 
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family:plasmids:99 go:0016491|oxidoreductase activity|Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical 
reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a 
hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and 
becomes reduced. 
family:plasmids:25 go:0016152|mercury (II) reductase activity|Catalysis of the reaction: Hg + NADP+ + H+ = Hg2+ + NADPH + 
H+.;go:0050787|detoxification of mercury ion|Any process that reduce or remove the toxicity of mercuric ion. 
These include transport of mercury away from sensitive areas and to compartments or complexes whose purpose 
is sequestration of mercury ion and/or reduction of mercury ion (Hg[II]) to metallic mercury (Hg[0]). 
family:plasmids:16 go:0004009|ATP-binding cassette (ABC) transporter activity|OBSOLETE (was not defined before being made 
obsolete). 
family:plasmids:205 phi:0000184|transcription factor activity|Any transcription regulator activity that prevents or downregulates 
transcription. 
family:plasmids:74 phi:0000153|DDE-based recombinase activity|Recomoinases with aDDE transposase have a related amino-acid 
motif (the DDE motif), which forms the active site of the transposase and is responsible for coordinating the 
cleavage and joining steps of transposition. Breakage of the DNA occurs at the end of the element (usually a 
hydrolysis) and is followed by breakage and integration at the target site (a transesterification 
reaction).;aclame:function:555|IS3 family|group IS407;phi:0000136|transpositional DNA recombination|A process 
that moves a DNA region from one to another location in a genome via a DNA intermediate. 
family:plasmids:5648 No description 
family:plasmids:64 go:0016491|oxidoreductase activity|Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical 
reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a 
hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and 
becomes reduced. 
family:plasmids:48 go:0016491|oxidoreductase activity|Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical 
reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a 
hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and 
becomes reduced.;go:0047829|D-nopaline dehydrogenase activity|Catalysis of the reaction: N2-(D-1,3-
dicarboxypropyl)-L-arginine + NADP+ + H2O = L-arginine + 2-oxoglutarate + NADPH. 
family:plasmids:10905 No description 
family:plasmids:665 No description 
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Table 7. Top twenty hits for ARDB database, an antibiotic resistance gene database.  
 The table includes description, antibiotic resistance group, and if the gene is considered an efflux pump.  
Name Description Antibiotic Resistance Group Efflux 
Pumps 
BacA Undecaprenyl pyrophosphate phosphatase, which consists in the 
sequestration of Undecaprenyl pyrophosphate.  
bacitracin Non-efflux 
dfrB6 Group B drug-insensitive R67 dihydrofolate reductase, which can not be 
inhibited by trimethoprim. 
trimethoprim Non-efflux 
KsgA Specifically dimethylates two adjacent adenosines in the loop of a 
conserved hairpin near the 3'-end of 16S rRNA in the 30S particle. Its 
inactivation leads to kasugamycin resistance. 
kasugamycin Non-efflux 
RosB Efflux pump/potassium antiporter system. RosA: Major facilitator 
superfamily transporter. RosB: Potassium antiporter.  
fosmidomycin Efflux 
AcrB Resistance-nodulation-cell division transporter system. Multidrug resistance 
efflux pump. 
aminoglycoside, glycylcycline, 
macrolide,beta_lactam,acriflavin 
Efflux 
CeoB Resistance-nodulation-cell division transporter system. Multidrug resistance 
efflux pump. 
chloramphenicol Efflux 
MacB Resistance-nodulation-cell division transporter system. Multidrug resistance 
efflux pump. Macrolide-specific efflux system.  
macrolide Efflux 
VanRA VanA type vancomycin resistance operon genes, which can synthesize 
peptidoglycan with modified C-terminal D-Ala-D-Ala to D-alanine--D-
lactate. 
vancomycin,teicoplanin Non-efflux 
MexF Resistance-nodulation-cell division transporter system. Multidrug resistance 
efflux pump. 
chloramphenicol,fluoroquinolone Efflux 
MexW Resistance-nodulation-cell division transporter system. Multidrug resistance 
efflux pump. 
Multidrug Efflux 
MexB Resistance-nodulation-cell division transporter system. Multidrug resistance 
efflux pump. 
aminoglycoside,tigecycline, 
fluoroquinolone, beta_lactam, 
tetracycline 
Efflux 
AcrA Resistance-nodulation-cell division transporter system. Multidrug resistance 
efflux pump. 
aminoglycoside,glycylcycline,macr
olide,beta_lactam, acriflavin 
Efflux 
MdtH Major facilitator superfamily transporter. Multidrug resistance efflux pump. deoxycholate, fosfomycin Efflux 
RosA Efflux pump/potassium antiporter system. RosA: Major facilitator 
superfamily transporter. RosB: Potassium antiporter.  
fosmidomycin Efflux 
arnA Bifunctional enzyme that catalyzes the oxidative decarboxylation of UDP-
glucuronic acid (UDP-GlcUA) to UDP-4-keto-arabinose (UDP-Ara4O) and 
the addition of a formyl group to UDP-4-amino-4-deoxy-L-arabinose (UDP-
polymyxin Non-efflux 
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L-Ara4N) to form UDP-L-4-formamido-arabinose (UDP-L-Ara4FN). The 
modified arabinose is attached to lipid A and is required for resistance to 
polymyxin and cationic antimicrobial peptides. 
tet34 Xanthine-guanine phosphoribosyltransferase. Mechanism detail unknown. tetracycline Non-efflux 
BcrA ABC transporter system, bacitracin efflux pump.  bacitracin Efflux 
tetPB Ribosomal protection protein, which protects ribosome from the translation 
inhibition of tetracycline. 
tetracycline Non-efflux 
EmrE Multidrug resistance efflux pump. aminoglycoside Efflux 
ErmF rRNA adenine N-6-methyltransferase, which can methylate adenine at 
position 2058 of 23S rRNA, conferring resistance to erythromycin. 
lincosamide,streptogramin_b,macr
olide 
Non-Efflux 
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Table 8.  Top twenty gene matches over all samples for the CARD database.  
The CARD database examines antibiotic resistance genes.  The table gives a description and explanation of efflux vs. non-
efflux pumps. 
Name Description Efflux Pumps 
qacH efflux-pump-complex-or-subunit-conferring-antibiotic-resistance;fluoroquinolone-
antibiotic;small-multidrug-resistance-(SMR)-antibiotic-efflux-pump;antibiotic-efflux; 
Efflux 
Nocardia-rifampin-
resistant-beta-
subunit-of-RNA-
polymerase-(rpoB2) 
rifampin;rifapentine;rifabutin;peptide-antibiotic;rifamycin-resistant-beta-subunit-of-RNA-
polymerase-(rpoB);antibiotic-target-replacement;antibiotic-target-alteration;rifamycin-
antibiotic;rifaximin; 
Non-efflux 
dfrB6 iclaprim;trimethoprim;brodimoprim;tetroxoprim;diaminopyrimidine-
antibiotic;antibiotic-target-replacement;trimethoprim-resistant-dihydrofolate-reductase-
dfr; 
Non-efflux 
kdpE kanamycin-A;kdpDE;aminoglycoside-antibiotic;protein(s)-and-two-component-
regulatory-system-modulating-antibiotic-efflux;antibiotic-efflux; 
Efflux 
msbA nitroimidazole-antibiotic;metronidazole;ATP-binding-cassette-(ABC)-antibiotic-efflux-
pump;antibiotic-efflux;efflux-pump-complex-or-subunit-conferring-antibiotic-resistance; 
Efflux 
mtrA penam;antibiotic-efflux;resistance-nodulation-cell-division-(RND)-antibiotic-efflux-
pump;protein(s)-and-two-component-regulatory-system-modulating-antibiotic-
efflux;macrolide-antibiotic;efflux-pump-complex-or-subunit-conferring-antibiotic-
resistance;penicillin;azithromycin;erythromycin; 
Efflux 
msrB streptogramin-antibiotic;ATP-binding-cassette-(ABC)-antibiotic-efflux-pump;antibiotic-
efflux;macrolide-antibiotic;efflux-pump-complex-or-subunit-conferring-antibiotic-
resistance; 
Efflux 
sav1866 efflux-pump-complex-or-subunit-conferring-antibiotic-resistance;ATP-binding-cassette-
(ABC)-antibiotic-efflux-pump;antibiotic-efflux; 
Efflux 
Streptomyces-
rishiriensis-parY-
mutant-conferring-
resistance-to-
aminocoumarin 
aminocoumarin-self-resistant-parY;clorobiocin;aminocoumarin-
antibiotic;novobiocin;coumermycin-A1;antibiotic-target-alteration;aminocoumarin-
resistant-parY; 
Non-efflux 
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mexK antibiotic-efflux;triclosan;resistance-nodulation-cell-division-(RND)-antibiotic-efflux-
pump;macrolide-antibiotic;efflux-pump-complex-or-subunit-conferring-antibiotic-
resistance;tetracycline-antibiotic;tetracycline;erythromycin; 
Efflux 
pmrE pmr-phosphoethanolamine-transferase;peptide-antibiotic;antibiotic-target-alteration; Non-efflux 
bacA peptide-antibiotic;undecaprenyl-pyrophosphate-related-proteins;bacitracin-B;bacitracin-
F;bacitracin-A;antibiotic-target-alteration; 
Non-efflux 
macB efflux-pump-complex-or-subunit-conferring-antibiotic-resistance;ATP-binding-cassette-
(ABC)-antibiotic-efflux-pump;antibiotic-efflux;macrolide-antibiotic;erythromycin; 
Efflux 
dfrA3 iclaprim;trimethoprim;brodimoprim;tetroxoprim;diaminopyrimidine-
antibiotic;antibiotic-target-replacement;trimethoprim-resistant-dihydrofolate-reductase-
dfr; 
Non-efflux 
CRP penam;antibiotic-efflux;resistance-nodulation-cell-division-(RND)-antibiotic-efflux-
pump;protein(s)-and-two-component-regulatory-system-modulating-antibiotic-
efflux;norfloxacin;macrolide-antibiotic;efflux-pump-complex-or-subunit-conferring-
antibiotic-resistance;oxacillin;cloxacillin;fluoroquinolone-antibiotic;erythromycin; 
Efflux 
novA efflux-pump-complex-or-subunit-conferring-antibiotic-resistance;ATP-binding-cassette-
(ABC)-antibiotic-efflux-pump;aminocoumarin-antibiotic;novobiocin;antibiotic-efflux; 
Efflux 
tet34 tetracycline-antibiotic;antibiotic-target-alteration;tetracycline-inactivation-
enzyme;antibiotic-inactivation;tetracycline; 
Non-efflux 
vgaC dalfopristin;pleuromutilin;ATP-binding-cassette-(ABC)-antibiotic-efflux-pump;antibiotic-
efflux;pristinamycin-IIA;pleuromutilin-antibiotic;madumycin-II;griseoviridin;efflux-
pump-complex-or-subunit-conferring-antibiotic-resistance;streptogramin-antibiotic; 
Efflux 
arnA pmr-phosphoethanolamine-transferase;peptide-antibiotic;antibiotic-target-alteration; Non-efflux 
pmrF pmr-phosphoethanolamine-transferase;peptide-antibiotic;antibiotic-target-alteration; Non-efflux 
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Table 9. Top 20 metal resistance groups from BacMet, a metal resistance databases.  
 
BacMet 
Others 
Mercury 
Copper 
Arsenic 
Chromium 
Tellurium 
Selenium 
Zinc 
Cobalt 
Nickel 
Iron 
Silver 
Lead 
Antimony 
Cadmium 
Manganese 
Magnesium 
Tungsten 
Molybdenum 
Gold 
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Table 10. Top 20 prokaryotic genera from GreenGenes, a taxonomy database.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genus  Domain 
unknown unknown 
Sodalis Bacteria 
Arcobacter Bacteria 
unknown unknown 
unknown unknown 
Flavobacterium Bacteria 
CandidatusPortiera Bacteria 
Bacteroides Bacteria 
Acinetobacter Bacteria 
OM60 Bacteria 
Octadecabacter Bacteria 
Coraliomargarita Bacteria 
ACK-M1 Bacteria 
Sulfurospirillum Bacteria 
Tolumonas Bacteria 
HTCC2207 Bacteria 
Hydrogenophaga Bacteria 
Synechococcus Bacteria 
Polaribacter Bacteria 
Fluviicola Bacteria 
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Table 11. PERMANOVA results examining gene abundance.   
Nested PERMANOVA tests examining impact type, site, and sample type were used to test significance.  Abundance values 
were normalized to the total number of genes.    
 
 
ACLAME ARDB BacMet CARD GreenGenes 
Test Results Impact: 0.516 ( -3.8193) 
Site: 0.447 (4.2197)  
Type: 0.005 (14.746) 
Residual: 20.341  
Pooled Impact  
Type: 0.006 (14.746)  
Residual: 20.341 
Impact: 0.69 (-14.04) 
Site: 0.113 (25.772) 
Type: 0.001 (24.314) 
Residual: 18.038  
Pooled Impact  
Type: 0.001 (24.314) 
Residual: 18.038 
Impact: 0.739 (-9.6711) 
Site: 0.183 (14.412)  
Type: 0.005 (15.949) 
Residual: 20.627  
Pooled Impact 
Type: 0.006 (15.949) 
Residual: 20.627 
Impact: 0.892 (-
13.914) 
Site: 0.066 (23.067)  
Type: 0.004 
916.739)  
Residual: 20.358 
Pooled Impact  
Type: 0.004 
(16.739)  
Residual: 20.358 
Impact: 0.331 
(7.911) 
Site: 0.485 
(2.5611) 
Type: 0.001 
(24.989) 
Residual: 15.936 
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Table 12. Results of PERMANOVA tests for a variety of data subsets.   
ARDB-genes and CARD-genes indicate the data matrix with each entry being an individual gene.  ARDB-antibiotics and 
CARD-antibiotics have been condensed into antibiotic groups. Bolded values indicate significance.  
Database All Sample 
Matrix 
All Water 
Samples Matrix  
(BH, CR, 
Effluent, 
Influent, LI, 
NBH, Outfall, 
Ply, Ptown, 
WFH) 
All Water 
Samples  
No 
Effluent/Influent  
(BH, CR, LI, 
NBH, Outfall, 
Ply, Ptown, 
WFH) 
6 nested setup 
(CR, LI, NBH, 
Ply, Ptown, 
WFH)  
Wastewater 
Water + 
Sediment 
(BH, Effluent, 
Influent, 
Outfall, Ply sed 
+ water, WFH 
sed + water)  
 
Wastewater 
Water 
 (BH, 
Effluent, 
Influent, 
Outfall, Ply 
water, WFH 
water)  
 
Influent vs. 
Effluent  
(Influent, 
Effluent) 
WFH Gradient 
(Effluent, 
Influent, WFH 
Water)  
 
 PERMANOVA 
type nested in 
site nested in 
impact type 
PERMANOVA 
site nested in 
impact type 
PERMANOVA 
site nested in 
impact type 
PERMANOVA 
type nested in 
site nested in 
impact type 
PERMANOVA 
type nested in 
site nested in 
impact type 
PERMANOVA 
site nested in 
impact type 
PERMANOVA 
by site 
PERMANOVA 
by site 
ARDB  genes Impact: 0.196 
(10.21) 
Site: 0.06 
(20.018) 
Type: 0.001 
(25.406) 
Residual: 
43.925 
Impact; 0.192 
(12.142) 
Site: 0.001 
(30.572) 
Residual: 
44.602 
Impact: 0.214 
(12.02) 
Site: 0.105 
(17.03) 
Residuals: 
50.023  
Impact: 0.411 
(-2.8875)  
Site: 0.146 
(14.07)  
Type: 0.001 
(23.734) 
Residuals: 
46.646 
Pooled impact 
Type: 0.002 
(23.734) 
Residuals: 
46.646 
Impact: 0.223 
(15.862) 
Site: 0.202 
(18.419) 
Type: 0.001 
(32.448) 
Residual: 36.38 
Impact: 0.468 
(10.606) 
Site: 0.001 
(38.585) 
Residual: 
37.418 
Site: 0.094 
(41.788) 
Residual: 
21.229 
Site: 0.006 
(47.04) 
Residuals: 
30.103 
ARDB - 
antibiotic 
Impact: 0.162 
(11.43)  
Site: 
0.221(13.136)  
Type: 0.001 
(25.44) 
Residual: 
Impact: 0.093 
(14.393) 
Site: 0.002 
(23.587) 
Residual: 
35.382 
Impact: 0.279 
(10.472) 
Site: 0.108 
(16.149) 
Residual: 
39.868 
Impact: 0.34 
(7.6838) 
Site: 0.26 
(9.4476) 
Type: 0.001 
(24.338) 
Residuals: 37.3 
Impact: 0.496 
(-8.3442) 
Site: 0.398 
(9.229) 
Type: 0.001 
(31.233) 
Residual: 
Impact: 0.718 
(-12.487) 
Site: 0.001 
(30.004)  
Residual: 
29.618 
Pooled 
Site: 0.101 
(30.629) 
Residual: 
15.461 
Site: 0.005 
(35.492) 
Residuals: 
20.94 
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35.024 29.021 
Pooled impact  
Type: 0.001 
(31.233) 
Residual: 
29.021 
impact 
Pooled 0.001 
(29.204) 
Residual: 
29.618 
 
BacMet Impact: 0.049 
(9.5955) 
Site: 0.895 (-
11.181) 
Type: 0.001 
(18.029) 
Residual: 
16.205 
Pool site  
Impact: 0.11 
(7.9805) 
Residual: 
16.205  
 
Impact: 0.105 
(9.9685) 
Site: 0.007 
(11.718) 
Residual: 
14.081 
Impact: 0.093 
(9.2251) 
Site: 0.325 
(4.4263) 
Residual: 
15.758 
Impact: 0.541 
(1.9182) 
Site: 0.774 (-
8.739) 
Type: 0.001 
(17.695) 
Residuals: 
17.272 
Pooled Impact:  
Type: 0.001 
(17.695) 
Residuals: 
17.272 
Impact: 0.023 
(19.356) 
Site: 0.973 (-
16.78) 
Type: 0.001 
(21.503) 
Residuals: 
12.893  
Pool site  
Impact: 0.037 
(18.809) 
Residual: 
12.893 
Impact: 0.138 
(13.767) 
Site: 0.004 
(15.237) 
Residual: 
10.494 
Site: 0.099 
(8.1492) 
Residual: 
6.9431 
Site:: 0.003 
(20.041) 
Residuals: 
6.3683 
CARD - 
antibiotic 
Impact: 0.295 
(7.4159) 
Site: 0.078 
(18.841) 
Type: 0.001 
(23.284) 
Residual: 
36.466 
Impact: 0.407 
(1.3705) 
Site: 0.001 
(31.16) 
Residual: 
30.146 
Impact: 0.666 (-
6.0564) 
Site: 0.017 
(16.603) 
Residual: 
32.485 
Pooled impact 
Pooled: 0.015 
(15.651) 
Residuals: 
32.485 
Impact: 0.679 
(-5.7476) 
Site: 0.304 
(7.1015) 
Type: 0.001 
(22.234) 
Residuals: 
38.382 
Pooled Impact  
Type: 0.001 
(22.234) 
Residuals: 
38.382 
Impact: 0.568 
(-9.1313) 
Site: 0.026 
(27.141) 
Type: 0.013 
(20.412) 
Residual: 
32.106 
Pooled impact  
Type: 0.011 
(20.412) 
Residual: 
32.106 
Impact: 0.621 
(-12.02) 
Site: 0.001 
(37.061) 
Residual: 
28.149 
Pool impact 
Pooled: 0.001 
(36.464) 
Residual: 
28.149 
 
Site: 0.101 
(38.307) 
Residual: 
21.664  
Site: 0.007 
(45.932) 
Residuals: 
19.434 
CARD - gene Impact: 0.367 
(5.8597) 
Site: 0.078 
(19.34) 
Impact: 0.373 
(2.0516) 
Site: 0.001 
(33.587) 
Impact: 0.675 (-
8.8519) 
Site: 0.01 
(19.513)  
Impact: 0.647 
(1.392) 
Site: 0.595 (-
5.7921) 
Impact: 0.534 
(-9.8907) 
Site: 0.07 
(28.342) 
Impact: 0.938 
(-27.018) 
Site: 0.001 
(45.091) 
Site: 0.094 
(44.227) 
Residual: 
26.175 
Site: 0.006 
(49.961) 
Residuals: 
23.282 
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Type: 0.001 
(25.505) 
Residuals: 
39.138 
Residual: 
32.975 
Residual: 
34.948  
Pool Impact 
Site: 0.005 
(17.868) 
Residual: 
34.948 
 
Type: 0.001 
(24.566) 
Residuals: 
40.901 
Pooled site 
Impact: 0.48 (-
3.0406) 
Residuals: 
40.901 
Type: 0.005 
(24.904) 
Residual: 
34.763  
Pooled impact 
Type: 0.002 
(24.904) 
Residuals: 
34.763 
 
 
Residual: 
31.502  
Pooled 
impact 
Pooled: 0.001 
(39.522) 
Residuals: 
31.502  
 
GreenGenes Impact: 0.178 
(10.784) 
Site: 0.136 
(16.819) 
Type: 0.001 
(28.752) 
Residual: 
22.031 
Impact: 0.338 
(7.2045) 
Site: 0.001 
(30.155) 
Residual: 
22.551 
Impact: 0.189 
(10.475) 
Site: 0.001 
(22.291) 
Residual: 
24.387 
Impact: 0.254 
(7.6726) 
Site: 
0.105(12.453)  
Type: 0.001 
(28.524) 
Residuals: 
22.904 
Impact: 0.186 
(18.223) 
Site: 0.165 
(19.983) 
Type: 0.001 
(26.497) 
Residual: 
21.966 
Impact: 0.206 
(14.293) 
Site: 0.039 
(22.099) 
Residual: 
31.282 
 
Site: 0.102 
(41.997) 
Residual: 
15.811 
Site: 0.004 
(40.487) 
Residual: 
13.241 
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Table 13.  Testing at Little Island.  
Little Island testing across Chapter 3 (Vibrio), Chapter 4 (heterotrophs), and Chapter 5 (coastal metagenomes) for comparison.  
Vibrio testing of amoxicillin also included clavulanic acid, a beta lactam.  The coastal metagenome categories come from 
ARDB.  
 
  Observed % Resistance     
Antibiotic Antibiotic Type Vibrio Heterotroph Coastal Metagenomes 
% Resistance 
Genes 
Amoxicillin Penicillin 29.4 36 Penicillin 0.3 
Ciprofloxacin Quinolones 30 42    
Doxycycline Tetracycline 4.2 90.7 Tetracycline 13.5 
Erythromycin Macrolide   29.6 Macrolide 16.9 
Oxytetracycline Tetracycline 5.8      
Trimethoprim Trimethoprim 47.5  Trimethoprim 1.6 
    Chloramphenicol, Fluoroquinolone 0.3 
    Fosmidomycin 1.1 
    Aminoglycoside,Glycylcycline,Macrolide,Beta_Lactam,Acriflavin 1.2 
    T_Chloride,Acriflavine,Puromycin 2.1 
    Chloramphenicol 4.3 
    Streptogramin_A 4.7 
    Multidrug 7.6 
    Kasugamycin 15.2 
    Lincosamide,Streptogramin_B,Macrolide 15.4 
    Bacitracin 15.7 
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Table 14. SIMPER results for sample type.  
SIMPER tests were completed through PRIMER to test each database for the most important components of the top 10 genes/ 
groupings for each database.  
 
 ACLAME ARDB BacMet CARD GreenGenes 
Water Avg similarity: 
86.71 
Plasmids 1, 321, 
205, 6, 11, 9456 
Avg similarity: 
40.97 
BacA, MacB 
Avg similarity: 
78.79 
Others, Copper, 
Chromium, 
Tellurium, Arsenic 
Avg similarity: 
58.17 
rpoB2, pmrE, msrB 
Avg similarity: 
68.42 
Unknown, Sodalis 
Sediment Avg similarity: 
80.53  
Plasmids 1, 321, 
205, 11, 6 
Avg similarity: 
41.51 
BacA, MacB 
Avg similarity: 
71.90 
Others, Copper, 
Arsenic, 
Chromium, 
Tellurium 
Avg similarity: 
51.79 
rpoB2, msbA 
Avg similarity: 
63.09 
Unknown, Sodalis 
Average 
dissimilarity 
17.16 58.18 26.04 47.29 36.06 
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Table 15. SIMPER results for site.  
SIMPER tests were completed through PRIMER to test each database for the most important components of the top 10 genes/ 
groupings for each database.  
 
Sample ACLAME ARDB CARD BacMet GreenGenes 
BH Water Too few samples Too few samples Too few samples Too few samples Too few samples 
CR Total 82.66 
Plasmids 1, 321, 205, 6, 
11 
68.09 
BacA 
58.15 
rpoB2 
87.32 
Others, Arsenic, Copper, 
Chromium 
83.93 
Unknown1, Unknown2 
CR Water 96.27 
Plasmids 1, 321, 9456, 
5648, 6, 205 
71.44 
BacA 
89.95 
rpoB2, mtrA, 
Streptomyces 
94.85 
Others, Copper, Arsenic, 
Chromium, Iron 
95.09  
Unknown1, 
Flavobacterium 
CR Sediment 87.70  
Plasmids 1, 9, 205, 6, 
321 
64.66 
BacA 
50.60 
rpoB2 
88.48 
Arsenic, others, 
Chromium, Copper 
95.10 
Unknown1, Unknown2 
Effluent Total 93.01 
Plasmids 1, 6, 321, 26, 
11, 53 
88.12 
BacA, dfrB6 
71.88 
rpoB2, qacH, msbA 
88.90 
Others, Arsenic, Copper, 
Mercury, Chromium, 
Tellurium 
78.67 
Unknown1, Sodalis 
Influent Total 96.49 
Plasmids 1, 205, 321, 
5648, 9 
89.36 
BacA, AcrB, RosA, 
KsgA 
87.95 
pmrE, CRP, qacH, 
rpoB2 
95.97 
Others, Arsenic, Copper, 
Zinc, Mercury, 
Tellurium 
93.14 
Arcobacter, unknown1 
LI Total 91.96 
Plasmids: 1, 6, 205, 9, 
321, 11 
46.71 
MacB, BacA 
57.55 
rpoB2, msrB 
74.67 
Others, Chromium, 
Tellurium, Selenium, 
Copper  
87.88 
Unknown1, Sodalis 
LI Water 95.19 
Plasmids 1, 6, 11, 205, 
321, 9 
50.20 
KsgA, MacB, BacA 
78.05 
rpoB2, msrB, pmrE 
93.96 
Others, Chromium, 
Tellurium, Selenium, 
Copper 
90.70 
Unknown1, Sodalis 
LI Sediment 90.98 
Plasmids 1, 205, 9, 6, 
321, 11 
46.80 
MacB, BacA 
 
45.31 
rpoB2, sav1866 
88.74 
Others, Arsenic, 
Chromium, Tellurium, 
Selenium 
92.77 
Unknown1, Sodalis 
NBH Total 80.42  
Plasmids 1, 205, 321, 
40.71 
BacA, MexW, MacB 
53.49 
rpoB2, 
74.67 
Copper, Others, 
76.05 
Unknown1, Unknown3 
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11, 9456 Streptomyces Chromium, Arsenic, 
Tellurium 
NBH Water 77.55 
Plasmids 1, 205, 321, 
11 
25.19 
BacA, arnA, MexW 
31.70 
rpoB2 
69.02 
Copper, Chromium, 
Arsenic, others, 
Tellurium 
76.91 
Unknown1, Unknown3 
NBH Sediment 82.64 
Plasmids 1, 321, 205, 
11, 9456 
49.11 
BacA, MacB 
70.40 
rpoB2, Steptomyces 
73.94 
Others, Copper, 
Chromium, Tellurium, 
Selenium 
75.97 
Unknown1 
Outfall Total Too few samples Too few samples Too few samples Too few samples Too few samples 
Ply Total 90.94 
Plasmids 1, 6, 9, 321, 
11, 205 
72.64 
BacA 
60.81 
rpoB2, pmrE, msbA 
79.71 
Others, Copper, Arsenic, 
Chromium, and 
Tellurium 
87.07 
Unknown1, Unknown2 
Ply Water 90.65 
Plasmids 1, 6, 321, 11, 
9, 205 
61.18 
BacA 
52.01 
rpoB2, msrB, pmrE 
81.13 
Others, Arsenic, 
Tellurium, Chromium, 
Copper 
85.36 
Unknown1, Unknown3 
Ply Sediment 94.64 
Plasmids 1, 6, 9, 11, 
321  
80.03 
BacA 
70.95 
rpoB2, msbA, pmrE 
87.27 
Copper, Others, Arsenic, 
Zinc, Chromium 
94.85 
Unknown1, Unknown2 
Ptown Total 78.99 
Plasmids 1, 321, 11, 6, 
26, 205 
19.75 
Tet34, AcrB 
47.63 
rpoB2, msrB 
61.65  
Others, Copper, Arsenic, 
Tellurium 
53.03 
Sodalis, Unknown1 
Ptown Water 92.87 
Plasmids 1, 6, 321, 11, 
5648, 205 
14.21 
MacB 
74.67 
rpoB2, msrB, pmrE 
81.19 
Others, Tellurium, 
Chromium, Arsenic 
76.13 
Unknown1, Sodalis 
Ptown Sediment 68.39 
Plasmids 1, 321, 11, 26 
36.94 
AcrB 
26.08 
rpoB2 
63.17 
Copper, Others, Cobalt 
95.35 
Sodalis 
WFH Total 85.12 
Plasmids 1, 205, 
321,9456, 6, 5648 
41.20 
BacA, MexW 
68.91 
rpoB2, pmrE, msrB 
69.95 
Others, Copper, Arsenic, 
Chromium, Tellurium 
79.98 
Unknown1, unknown2 
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WFH Water 96.62 
Plasmids 1, 6, 321, 205, 
11, 9 
62.69 
MexW, MacB 
88.52 
rpoB2, pmrE, msrB 
94.73 
Others, Chromium, 
Tellurium, Selenium, 
Copper 
95.66 
Unknown1, Sodalis 
WFH Sediment 84.56 
Plasmids 1, 205, 321, 
9456, 5648 
54.46 
BacA 
58.89 
rpoB2, dfrA3, msbA 
72.72 
Copper, Arsenic, Others, 
Zinc, Chromium 
85.89 
Unknown1, Unknown3 
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PERMANOVA tests were run on the percentage of CARD genes with “efflux” in their name.  
This table illustrates tests to determine if there is significance of percentage of efflux genes between samples.  
 
Name All Six Main Samples WFH Gradient 
Samples included All Samples 
 
CR, LI, NBH, Ply, Ptown, 
WFH  
Sediment + water 
Effluent, Influent, WFH Water 
Test type PERMANOVA type nested in site 
nested in impact type 
PERMANOVA type nested in 
site nested in impact type 
PERMANOVA by site 
Results Impact: 0.286 (2.8216) 
Site: 0.535 (-1.4378) 
Type: 0.205 (3.9668) 
Residual: 9.5236 
Pool site 
Impact: 0.228 (2.7371) 
Residual: 9.5236 
Impact: 0.396 (1.9965) 
Site: 0.32 (3.1517)  
Type: 0.374 (2.2871)  
Residual: 10.459 
Site: 0.005 (8.022) 
Residual: 2.6004 
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CHAPTER	6	Conclusion	
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Contributions from this Dissertation to the Environmental Antibiotic 
Resistance Field  
Antibiotic resistance is widespread and persistent in coastal marine environment. 
 
  This dissertation has illustrated that antibiotic resistance is widespread and 
persistent in coastal marine environments, contributing to the concept that antibiotic 
resistance is a natural occurrence.  For the sites studied on Cape Cod, there were not 
resistance differences based on perceived human or environmental impacts (for cultured 
bacteria seen in Chapter 3 or 4; for coastal metagenomic samples seen in Chapter 5). This 
result was surprising because other studies have illustrated impact differences (1–3).  The 
lack of an effect in this work suggested that the impacts were not substantial, the 
environment recovered rapidly, or a combination of both. Further, the lack of human 
impact effect may illustrate that the coastal ocean has already reached saturation to 
antibiotics before the study period. Even in the absence of significant impact, antibiotic 
resistance was found at all of the local study sites and persisted throughout the seasons 
with little change in the overall percentage recovered. It may be possible that prevalence 
of antibiotic resistance is fairly homogenous throughout regions of the world, other than 
through comparisons of highly polluted point sources (a lake with effluent from antibiotic 
production in India or polluted beaches with fecal contamination in Brazil).  
This work has also shown that resistance can be prevalent, even in what could be 
defined as relatively low impact areas; more isolates were resistant to at least one 
antibiotic than sensitive to all antibiotics.  Additionally, specific resistance was not 
associated with a single strain/OTU, but rather individuals in an OTU hosted a collection 
of antibiotic resistance types. This suggests some flexibility or exchange of antibiotic 
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resistance between bacteria and supports the concept of the natural environment as a 
reservoir of resistance (4–10). As a reservoir, the marine environment can act as a region 
for exchange of genes between both pathogenic and non-pathogenic activity and in this 
way, potentially be a source of future clinically important resistances (11, 12). This 
dissertation provides increased evidence for One Health, that the environment, animals, 
and humans are all interconnected and their health are all intertwined (13, 14).  
The metagenomic analysis of water and sediment from six sites revealed the 
presence of a diverse collection of genes and elements associated with resistance to 
antibiotics.  This substantially expands a growing body of knowledge regarding the types 
of resistance genes present in natural environments, particularly those with low 
anthropogenic impacts.  It also supported the observed prevalence of active resistance by 
the presence of general resistance genes (e.g. efflux pumps) as well as specific genes (e.g. 
target modification).  Perhaps most importantly, the presence of plasmids and insertion 
elements in the metagenomes implies the potential for movement of some resistance 
genes between bacteria. This makes the transfer of these genes into human associated 
bacteria a real possibility. 
The prevalence of resistance in the marine environment provides support for the 
concept that there are diverse uses of antibiotics besides killing other bacteria.  Instead, it 
is likely that antibiotics and resistance provide other important ecological and 
evolutionary uses such as cellular signaling or attenuating cell interactions (15).  
Examining the microbial perspective and scales would provide a greater understanding of 
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this, instead of assuming that antibiotics are used for destruction, which is an 
anthropogenic-centric perspective.  
Future directions 
Test marine environments on a distinct scale (e.g. mesocosms) to see results of antibiotic 
resistance and changes.  
Natural environments are affected by a collection of different impacts that can be difficult 
to discriminate.  Therefore, it may be useful to create mesocosms to study distinct 
anthropogenic impacts on the marine environment.  Direct studies such as this could 
uncover how different types of pollution change the environmental resistance profiles and 
what practices cause significant increases in resistances relevant to human disease 
treatment.  
Determine evolutionary roles of efflux pumps in the marine environment.  
Efflux pumps are an interesting type of antibiotic resistance, and just like antibiotics, likely 
have many other cellular purposes: resistance to toxic metals/solvents, colonization 
processes, homeostasis and detoxification, virulence, and cell to cell signaling (16).  
Understanding efflux pumps larger purpose in all environments, and particularly in the 
marine environment is an open question.  Greater understanding of the evolutionary 
process of efflux genes could be explored.  This study would be interesting from a basic 
science standpoint to understand more about the structure of marine bacterial cells and 
the evolution of efflux genes.  It could also be applied to produce mechanisms to work 
around efflux pumps clinically and provide a better understanding of their future evolution 
and how that may affect clinical resistance.  
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Determine actual risks, if any, of human exposure to environmental antibiotic resistance 
genes and antibiotic resistant bacteria.   
In terms of human exposure, the pressing future direction is if prevalence of resistance 
provides adverse outcomes to humans and how to quantify that risk. There are two main 
knowledge gaps that would need to be addressed to determine what risk, if any, is present.  
One knowledge gap is gene transfer between environmental bacteria and those associated 
with humans (commensals and pathogens). Knowledge of transfer abilities and rates 
between one marine bacterium to another, a non-pathogenic bacteria to pathogen, and 
from pathogenic/non-pathogenic bacteria to human-associated microbiota, such as those 
present in skin or in the gastrointestinal tract, are necessary to begin estimating the actual 
risk of obtaining a resistance gene from the environment.  The other knowledge gap is if 
transfer rates are proved to be possible, examination of adverse health impacts from the 
transfer into the human body would need to be determined.  This would likely be hard to 
study as it would be necessary to show that ingestion of resistant bacteria or resistance 
genes later prove harmful, and this harm would need to be a certain level to necessitate 
action. The consumption of aquatic organisms is a viable route of exposure to antibiotic 
resistance for humans.  In this dissertation it was shown that eating raw shellfish could 
result in exposure to bacteria that actively express antibiotic resistance.  Even further, 
water associated wildlife had higher AR compared to terrestrial animals in the African 
savanna (17). For humans, this may mean that water-derived food might have higher 
levels of resistance to consider.  
Standardization within the antibiotic resistance community is necessary to allow 
monitoring of resistance.    
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In terms of addressing the growing antibiotic resistance crisis, it is necessary to create 
standardized methods for the environmental antibiotic resistance community to allow 
effective comparison and monitoring to take place (8, 18).  Much like clinical 
microbiologists can compare resistances across regions and hospitals, ideally so should 
environmental microbiologists across biomes and geographic boundaries. The methods 
should ideally be inexpensive and require little specialized machinery, so they can be 
utilized by all countries, regardless of their resources. Bacteria do not know geographic 
boundaries and if the goal is the continued use of antibiotics, there is a need to work 
together for the common good.   
To work together across geographic boundaries, a mechanism to share and 
compare these results is necessary. To allow for comparisons between studies, at a 
minimum, published papers should make their raw data accessible.  In addition, standards 
of how to report resistance (e.g. whether total resistance includes intermediate resistance) 
would be helpful.  A recent paper created a dashboard application to share resistance data 
that seems promising to compare data across clinical and natural environments (19).     
 In past years, focus on particular organisms and types of antibiotics/resistance for 
monitoring have been discussed (20–23).  These conversations should continue, but not at 
the expense of beginning to create a program. The O’Neill report estimates that 10 million 
lives per year and a cumulative 100 trillion USD will be affected by AR in 2050 (24).  
Even though the exact number of deaths is being debated (25), the discrepancy is not with 
the reality that there will be an effect of antibiotic resistance; instead, the discrepancy is to 
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what extent will humans be impacted.  Therefore, the time for forward thinking action is 
now.  
Action is necessary to protect the use of antibiotics.  
This dissertation adds to the large amount of evidence indicating that action is necessary 
to protect antibiotics (24, 26–29).  Clinical microbiology has already shown this, in great 
detail, and lately, environmental microbiology has been further illustrating that resistance 
is prominent in what were before believed to be relatively pristine regions.  Together, 
these allow for a robust amount of knowledge that changes must be made if humans want 
to continue to use the wonders of antibiotics.  
Overall, areas of focus to protect AR would be to reduce antibiotic use, increase 
antibiotics in the pipeline, and decrease resistance (29). Reducing antibiotic use would not 
only affect humans, but their environments and food consumption.  A recent paper 
showed that pharmaceutical concentrations in a stream carry up the food chain and allow 
organisms such as trout and platypus to ingest dosages of a given pharmaceutical that 
would be considered a percentage of the daily human dose (30). An environmental study 
in Botswana showed that humans impact flow of antibiotic resistance and simply reducing 
antibiotic use in agriculture likely will not have large benefits due to transmission and flow 
of resistance (31).  Collignon et al. 2018 illustrates that simply a reduction of antibiotics 
cannot just be done to address AR as contagion and other public health infrastructure is 
important (32). Changes would likely necessitate policy change on the national and global 
stages.  Policy makers would be well served to include impacts of climate change in these 
policies as its impacts will change resistance outcomes (33). 
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INTRODUCTION  
 
Antibiotics have long existed in nature (1) before humans discovered their capabilities and 
began exploiting these chemicals for their own therapeutic uses.   Despite this knowledge, 
antibiotics and subsequently, antibiotic resistance are often understudied in natural 
environments as researchers focus on clinical resistance in order to better inform patient 
management.  While this makes sense in regards to patient management, it ignores the 
interconnected nature of humans to animals and the natural environment (e.g. the One 
Health concept, which seeks to study the connections between human health, animal 
health, and environmental health).  Therefore, the natural environment provides an 
interesting study region to assess environmental health.  Examining natural environments 
also allows assessment of basic scientific questions about antibiotics and antibiotic 
resistance such as prevalence of resistance in regions less impacted by humans, which 
allows for better assessment about the evolution of antibiotics/resistance and uses of these 
beyond cellular death.  
 To gain insight into these questions, the ocean was used as a study site for this 
chapter.  The ocean is an area that humans readily interact with through food 
consumption and through recreation and is also affected by anthropogenic impacts (2–4).  
Chapters 3-5 in this thesis have illustrated that resistance is prevalent in coastal regions.  
These results beg the question: is this resistance common for all areas of the ocean or only 
coastal regions that have increased proximity to anthropogenic impacts?  
 To answer this question, this appendix explores the TARA oceans project (5).  
TARA oceans was a global sampling expedition that explored all basins of the ocean 
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between 2009 and 2013 to explore the diversity of the marine environment at a variety of 
scales (spatial and organismal).  This project has already yielded many discoveries about 
the ocean (5–13).  Further, this project has spent considerable time and energy making 
their data accessible, allowing an increased impact. With this open access data source, 
the TARA oceans project allows a unique opportunity to test hypothesis without the need 
for five years of sampling and the necessary associated resources.   
 This appendix assesses the diversity of 25 surface water samples throughout the 
world’s ocean.  The hypothesis was that surface water samples would group by biome and 
geographic region.  
METHODS	
Samples  
25 samples were used from the TARA oceans dataset.  Information about collection, date, 
latitude, and longitude can be found in Table 1.  All samples were surface water samples 
at five meters depth (14).  These samples represent a wide range of ocean biomes and 
have been categorized by three different measures (Table 1).  One is the Longhurst 
biomes, which groups all areas of the ocean into four main categories: polar, westerlies, 
trades, and coastal biomes (15, 16).  Longhurst also has a more detailed categorization 
called provinces.  Another categorization is the International Hydrographic Organization’s 
General Sea Areas (17).  All of these groupings are to better understand and analysis the 
ocean by its similar regions.  Samples were all processed by the TARA Oceans group (14).   
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Data acquisition  
Raw sequencing reads were downloaded from European Nucleotide Archive.  Raw reads 
were then uploaded into MetaStorm, an online server to process metagenomic data (18).  
This server was also used in Chapter 5 and more details about it can be read there.  
However, for this appendix, only the assembly pipeline was used.  
Statistics  
As in chapter 5, permutational multivariate analysis of variance (PERMANOVA) was 
utilized in Primer (version 7) (19).  For this data, normalized gene abundance for each 
database was tested across the samples using a one way PERMANOVA for each biome 
categorization- Longhurst marine biomes, Longhurst marine provinces, and IHO ocean 
and sea regions. The same tests were also run on normalized prevalence of all genes for 
each database.   
To compare coastal and open ocean samples from the TARA data, normalized gene 
abundance was tested using one way PERMANOVAs.  
RESULTS	
Metagenomic sampling  
Most samples had 20-40 million raw read, though there were a few samples that had 
significantly less reads at 7 million raw reads (Table 2).  A little less than half of the reads 
were able to be assembled.  ACLAME, the mobile genetic element database had the 
highest percentage of genes annotated to it between 0-4%.  BacMet followed with 0-
0.13%, then CARD and ARDB.  CARD had substantially more database hits than ARDB.  
  233 
Top Genes  
The top twenty genes of each grouping or database were determined.  ACLAME showed a 
variety of plasmid families relating to oxidoreductase activity and ATP binding cassettes.  
BacMet showed a diversity of genes focusing on many metals, but the top spot was for 
copper. ARDB’s top 20 ARG included many different antibiotics.  11/20 of the top 20 
genes in ARDB are efflux genes and 15/ 20 were efflux genes in the CARD samples.  
Genes shared between both databases were mexF and mexB.   
PERMANOVA results  
All tests of gene abundance by database for each biome were significant, except for 
CARD.  For tests looking at gene prevalence among samples, almost all tests were 
significant.  The one insignificant test is CARD for the Longhurst 2007.  An nMDS plot 
shows data for BacMet grouping primarily by biome, in this case Longhurst province 
(Figure 1). Finally, for the comparisons between coastal and open ocean samples, gene 
abundance was significant for all databases.  
DISCUSSION	
This study represents one of the first, to our knowledge, to elucidate what resistance genes 
are present in the open ocean.   
Gene recovery  
In all but two samples, ARG were found for both CARD and ARDB.  The two samples that 
did not have ARG actually appeared to have other issues within the metagenomic analysis 
and perhaps should not be included.   In general, CARD had a higher number of hits 
compared to ARDB, which is the same as what was seen for Chapter 5 with the coastal 
samples.  
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 Gene abundance significance   
Gene abundance was significant for all databases, but CARD.  This indicates that amounts 
of genes are significantly different between these biomes. Further research would be 
necessary to determine what differences are found and between which samples.   
Biogeography dynamics  
The significance between biomes indicates that areas of the ocean are distinct from each 
other, based on their biome grouping for mobile genetic elements, antibiotic and metal 
resistance genes. It also indicates that samples are relatively stable in these regions and 
groupings because these areas are distinct even though samples were taken at different 
time periods.  Grouping by Longhurst province can be seen in Figure 1.  This indicates 
that studying the evolutionary aspects of resistance in the open ocean has interesting and 
compelling potential.   
Comparison between coastal and TARA samples  
There were a remarkable number of similarities in the top 20 ACLAME families 
between coastal and TARA with 13 shared families (1, 6, 5648, 321, 26, 11, 53,9,205,64, 
48, 10905, 665).  These represent groupings that are avenues to more deeply examine 
why they may be prevalent globally and what affects they may have on resistance.   For 
BacMet, different top genes were shown and the top group for coastal metagenomes 
(“Other”) was not even on the list for the TARA samples, indicating some differences in 
abundance here. Perhaps the other category includes more prevalent anthropogenic 
materials that are less prevalent in the open ocean.  For the antibiotic resistance databases, 
there were more efflux genes in CARD for the open ocean prevalence compared to the 
coastal area.  PERMANOVA illustrated that there are distinctions in efflux gene abundance 
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between the four coastal impacts in Chapter 5 (industrial, wastewater, reference, and 
wastewater Boston) and the four Longhurst biomes (coastal, westerlies, polar, and trades). 
This provides further acknowledgement that efflux genes are prevalent in the ocean and 
that their underlying purpose/evolutionary process would provide interesting research.   It 
also provides the potential that coastal regions may have more specific resistance genes 
because of their exposures to anthropogenic activities.   
Future Directions  
As seen in this overview for this appendix, there are a remarkable number of leads to 
follow.  One is examining all the available surface ocean samples for TARA, which is 
currently in process, but did not happen to fit into this dissertation.  Next, analyzing 
samples with ocean depth to see if there are similarities across depths.  In addition, both of 
these should be studied in detail to see what genes may be driving any similarities or 
differences.  
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Figure 1. nMDS plot of 25 TARA samples data. 
Data is categorized with the BacMet data using the Longhurst detailed marine biomes 
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Table 1.  TARA metagenomic sample information.  
This table illustrates the samples used for this appendix with location and oceanic biome categorization.  Information is from 
the TARA project (14). 
Sample ID Tara 
Station  
Date/Time 
[yyyy-mm-
ddThh:mm] 
Latitude 
[degrees 
North] 
Longitude 
[degrees 
East] 
depth 
[m] 
Size 
fraction 
lower 
threshold 
[um] 
Size 
fraction 
upper 
threshold 
[um] 
Longhurst 
marine 
biomes 
  
Longhurst 
marine 
provinces2 
IHO 
General 
Sea 
Areas 3 
ERR315858 
TARA_023_
SRF_0.22-
1.6 
23 2009-11-
18T08:41 
42.2038 17.715 5 0.22 1.6 Westerlies MEDI MS 
ERR315861 
TARA_023_
SRF_0.22-
1.6 
23 2009-11-
18T08:41 
42.2038 17.715 5 0.22 1.6 Westerlies MEDI MS  
ERR594317 
TARA_009_
SRF_0.22-
1.6 
9 2009-09-
28T12:18 
39.1633 5.916 5 0.22 1.6 Westerlies MEDI MS 
ERR598943 
TARA_102_
SRF_0.22-3 
102 2011-04-
21T20:07 
-5.2529 -85.1545 5 0.22 3 Trades PEOD SPO 
ERR598945 
TARA_084_
SRF_0.22-3 
84 2011-01-
03T11:05 
-60.2287 -60.6476 5 0.22 3 Polar ANTA SO  
                                                        
2 Abbreviations for Longhurst marine provinces: (ANTA) Antarctic Province, (ARAB) Northwest Arabian Sea Upwelling Province, (CHIL) Chile-Peru 
Current Coastal Province, (EAFR) Eastern Africa Coastal Province, (ISSG) Indian South Subtropical Gyre Province, (MEDI) Mediterranean Sea, Black 
Sea Province, (MONS) Indian Monsoon Gyres Province, (NAST-E) North Atlantic Subtropical Gyral Province, (PEOD) Pacific Equatorial Divergence 
Province, (REDS) Red Sea, Persian Gulf Province, (SATL) South Atlantic Gyral Province, (SPSG) South Pacific Subtropical Gyre Province, North and 
South 
3 Abbreviations for International Hydrographic Organization (IHO) ocean and sea regions IO: Indian Ocean, MS: Mediterranean Sea, NPO: North 
Pacific Ocean, RS: Red Sea, SAO: Southern Atlantic Ocean, SO: Southern Ocean, SPO: Southern Pacific Ocean 
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ERR598951 
TARA_025_
SRF_0.22-
1.6 
25 2009-11-
23T09:12 
39.3888 19.3905 5 0.22 1.6 Westerlies MEDI MS  
ERR598959 
TARA_034_
SRF_0.22-
1.6 
34 2010-01-
20T04:27 
18.3967 39.875 5 0.22 1.6 Coastal  REDS RS  
ERR598966 
TARA_036_
SRF_0.22-
1.6 
36 2010-03-
12T06:06 
20.8183 63.5047 5 0.22 1.6 Coastal  ARAB IO  
ERR598969 
TARA_031_
SRF_0.22-
1.6 
31 2010-01-
09T07:15 
27.16 34.835 5 0.22 1.6 Coastal  REDS  RS  
ERR598970 
TARA_064_
SRF_0.22-3 
64 2010-07-
07T04:48 
-29.5019 37.9889 5 0.22 3 Coastal  EAFR IO  
ERR598979 
TARA_065_
SRF_0.22-3 
65 2010-07-
12T05:59 
-35.1728 26.2868 5 0.22 3 Coastal EAFR IO  
ERR598997 
TARA_109_
SRF_0.22-3 
109 2011-05-
12T14:00 
1.9928 -84.5766 5 0.22 3 Coastal CHIL NPO 
ERR599003 
TARA_004_
SRF_0.22-
1.6 
4 2009-09-
15T11:30 
36.5533 -6.5669 5 0.22 1.6 Westerlies NAST-E NAO 
ERR599010 
TARA_076_
SRF_0.22-3 
76 2010-10-
16T09:55 
-20.9354 -35.1803 5 0.22 3 Trades SATL SAO  
ERR599022 
TARA_078_
78 2010-11-
04T10:04 
-30.1367 -43.2899 5 0.22 3 Trades SATL  SAO  
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SRF_0.22-3 
ERR599088 
TARA_064_
SRF_0.22-3 
64 2010-07-
07T04:48 
-29.5019 37.9889 5 0.22 3 Coastal EAFR  IO  
ERR599098 
TARA_052_
SRF_0.22-
1.6 
52 2010-05-
17T04:10 
-16.957 53.9801 5 0.22 1.6 Trades ISSG IO 
ERR599105 
TARA_072_
SRF_0.22-3 
72 2010-10-
05T08:00 
-8.7789 -17.9099 5 0.22 3 Trades SATL SAO  
ERR599114 
TARA_125_
SRF_0.22-3 
125 2011-08-
08T17:33 
-8.9111 -
142.5571 
5 0.22 3 Trades SPSG SPO] 
ERR599119 
TARA_125_
SRF_0.22-3 
125 2011-08-
08T17:33 
-8.9111 -
142.5571 
5 0.22 3 Trades SPSG SPO  
ERR599135 
TARA_070_
SRF_0.22-3 
70 2010-09-
21T06:55 
-20.4091 -3.1759 5 0.22 3 Trades SATL SAO  
ERR599141 
TARA_042_
SRF_0.22-
1.6 
42 2010-04-
04T02:47 
6.0001 73.8955 5 0.22 1.6 Trades MONS IO  
ERR599155 
TARA_032_
SRF_0.22-
1.6 
32 2010-01-
11T07:21 
23.36 37.2183 5 0.22 1.6 Coastal REDS RS  
ERR599158 
TARA_038_
SRF_0.22-
1.6 
38 2010-03-
15T03:35 
19.0393 64.4913 5 0.22 1.6 Trades MONS IO  
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ERR599171 
TARA_068_
SRF_0.22-3 
68 2010-09-
14T06:55 
-31.0266 4.665 5 0.22 3 Trades SATL SAO  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  244 
Table 2. Metagenomics summary statistics of TARA ocean samples.  
 
Sample ID  Raw Reads Input Reads 
after QC  
Assembled 
reads (#) 
Assembled 
reads (%) 
Scaffolds Average 
scaffold 
length 
(bps) 
N50 of 
scaffolds 
(bps) 
Total 
predicted 
genes 
Average 
gene 
length 
(bps) 
ERR315858 
TARA_023_SRF_0.22-1.6 
37,472,639 34,182,891 16,559,385 48.44 568,091 752 903 814,908 481 
ERR315861 
TARA_023_SRF_0.22-1.6 
37,310,366 34,641,768 16,847,647 48.63 581,069 750 898 831,320 481 
ERR594317 
TARA_009_SRF_0.22-1.6 
72,867,764 70,801,473 34,471,816 48.69 608,841 903 1,264 994,513 506 
ERR598943 
TARA_102_SRF_0.22-3 
36,334,542 33,347,889 14,657,180 43.95 503,857 730 803 754,203 453 
ERR598945 
TARA_084_SRF_0.22-3 
33,639,827 33,146,520 15,362,545 46.35 372,645 688 717 501,024 436 
ERR598951 
TARA_025_SRF_0.22-1.6 
30,171,447 25,956,492 12,369,958 47.66 374,720 785 928 584,442 461 
ERR598959 
TARA_034_SRF_0.22-1.6 
39,588,227 35,693,819 17,780,301 49.81 425,517 791 939 651,012 477 
ERR598966 
TARA_036_SRF_0.22-1.6 
43,069,804 39,554,266 20,340,871 51.43 461,948 738 834 705,798 449 
ERR598969 
TARA_031_SRF_0.22-1.6 
34,486,935 28,632,499 10,341,392 36.12 351,635 652 681 494,871 426 
ERR598970 
TARA_064_SRF_0.22-3 
42,483,957 35,174,262 11,921,822 33.89 442,596 613 641 598,568 417 
ERR598979 
TARA_065_SRF_0.22-3 
47,194,699 31,671,906 11,294,401 35.66 364,330 707 760 529,558 449 
ERR598997 
TARA_109_SRF_0.22-3 
26,789,701 24,707,354 9,864,950 39.93 315,629 706 760 461,401 448 
ERR599003 
TARA_004_SRF_0.22-1.6 
28,822,442 24,126,231 10,337,916 42.85 328,016 718 777 489,051 445 
ERR599010 
TARA_076_SRF_0.22-3 
30,059,067 20,001,993 3,143,478 15.72 179,691 548 539 230,211 367 
ERR599022 31,241,187 26,048,500 6,456,093 24.78 275,739 616 628 376,169 400 
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TARA_078_SRF_0.22-3 
ERR599088 
TARA_064_SRF_0.22-3 
41,574,000 34,535,732 11,650,309 33.73 432,251 612 642 584,307 417 
ERR599098 
TARA_052_SRF_0.22-1.6 
29,188,354 27,026,575 11,091,963 41.04 330,478 711 774 489,789 443 
ERR599105 
TARA_072_SRF_0.22-3 
34,374,500 29,896,086 7,830,010 26.19 347,212 597 597 489,626 387 
ERR599114 
TARA_125_SRF_0.22-3 
31,492,000 31,073,278 14,372,530 46.25 435,122 728 793 641,675 459 
ERR599119 
TARA_125_SRF_0.22-3 
41,818,200 41,239,998 19,741,818 47.87 565,216 730 796 831,787 460 
ERR599135 
TARA_070_SRF_0.22-3 
7,588,000 7,365,300 884,282 12.01 87,941 502 476 105,102 363 
ERR599141 
TARA_042_SRF_0.22-1.6 
36,435,982 30,438,279 12,711,905 41.76 380,677 687 749 563,061 431 
ERR599155 
TARA_032_SRF_0.22-1.6 
22,345,279 19,414,565 7,200,570 37.09 204,321 665 694 298,991 419 
ERR599158 
TARA_038_SRF_0.22-1.6 
39,699,921 34,587,590 14,834,066 42.89 407,687 666 694 597,738 420 
ERR599169 
TARA_100_SRF_0.22-3 
14,532,000 14,242,668 36,714 0.26 8 36,013 34,959 281 867 
ERR599171 
TARA_068_SRF_0.22-3 
36,508,689 9,403,028 1,092,485 11.62 91,303 511 493 111,955 366 
ERR599176 
TARA_085_SRF_0.22-3 
37,811,950 37,323,096 48,802 0.13 5 50,294 49,047 241 963 
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Table 3. Gene recovery information for each database.   
 
Sample ID  Total genes ACLAME 
genes 
% 
ACLAME 
BacMet 
Genes 
% 
BacMet 
CARD 
genes 
% 
CARD 
ARDB 
genes 
% 
ARDB 
ERR315858 
TARA_023_SRF_0.22-1.6 
814,908 35,548 4.36 1098 0.13 575 0.07 62 0.01 
ERR315861 
TARA_023_SRF_0.22-1.6 
831,320 35,792 4.31 1,130 0.14 595 0.07 64 0.01 
ERR594317 
TARA_009_SRF_0.22-1.6 
994,513 34,214 3.44 1082 0.11 539 0.05 80 0.01 
ERR598943 
TARA_102_SRF_0.22-3 
754,203 21,133 2.80 637 0.08 341 0.05 20 0.00 
ERR598945 
TARA_084_SRF_0.22-3 
501,024 15,852 3.16 526 0.10 212 0.04 28 0.01 
ERR598951 
TARA_025_SRF_0.22-1.6 
584,442 22,651 3.88 689 0.12 319 0.05 44 0.01 
ERR598959 
TARA_034_SRF_0.22-1.6 
651,012 18,778 2.88 559 0.09 297 0.05 15 0.00 
ERR598966 
TARA_036_SRF_0.22-1.6 
705,798 21,445 3.04 519 0.07 315 0.04 14 0.00 
ERR598969 
TARA_031_SRF_0.22-1.6 
494,871 17,295 3.49 474 0.10 241 0.05 15 0.00 
ERR598970 
TARA_064_SRF_0.22-3 
598,568 19,307 3.23 587 0.10 335 0.06 17 0.00 
ERR598979 
TARA_065_SRF_0.22-3 
529,558 15,346 2.90 415 0.08 214 0.04 10 0.00 
ERR598997 
TARA_109_SRF_0.22-3 
461,401 15,442 3.35 428 0.09 244 0.05 16 0.00 
ERR599003 
TARA_004_SRF_0.22-1.6 
489,051 19,337 3.95 513 0.10 277 0.06 41 0.01 
ERR599010 230,211 7,384 3.21 261 0.11 115 0.05 16 0.01 
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TARA_076_SRF_0.22-3 
ERR599022 
TARA_078_SRF_0.22-3 
376,169 13,443 3.57 371 0.10 186 0.05 25 0.01 
ERR599088 
TARA_064_SRF_0.22-3 
584,307 19057 3.26 551 0.09 332 0.06 15 0.00 
ERR599098 
TARA_052_SRF_0.22-1.6 
489,789 15,331 3.13 421 0.09 259 0.05 22 0.00 
ERR599105 
TARA_072_SRF_0.22-3 
489,626 12,288 2.51 475 0.10 188 0.04 39 0.01 
ERR599114 
TARA_125_SRF_0.22-3 
641,675 22,272 3.47 750 0.12 412 0.06 28 0.00 
ERR599119 
TARA_125_SRF_0.22-3 
831,787 28,601 3.44 1074 0.13 548 0.07 37 0.00 
ERR599135 
TARA_070_SRF_0.22-3 
105,102 2725 2.59 113 0.11 38 0.04 9 0.01 
ERR599141 
TARA_042_SRF_0.22-1.6 
563,061 17,879 3.18 586 0.10 321 0.06 37 0.01 
ERR599155 
TARA_032_SRF_0.22-1.6 
298,991 8814 2.95 251 0.08 146 0.05 9 0.00 
ERR599158 
TARA_038_SRF_0.22-1.6 
597,738 15,489 2.59 428 0.07 248 0.04 27 0.00 
ERR599169 
TARA_100_SRF_0.22-3 
281 1 0.36 0 0.00 0 0.00 0 0.00 
ERR599171 
TARA_068_SRF_0.22-3 
111,955 2806 2.51 105 0.09 52 0.05 16 0.01 
ERR599176 
TARA_085_SRF_0.22-3 
241 0 0.00 0 0.00 0 0.00 0 0.00 
 
